CHEBI ONTOLOGY - ANNOTATIONS
The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/ . The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/ ). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
Term: vancomycin
Accession: CHEBI:28001
browse the term
Definition: A complex glycopeptide from Streptomyces orientalis. It inhibits a specific step in the synthesis of the peptidoglycan layer in the Gram-positive bacteria Staphylococcus aureus and Clostridium difficile.
Synonyms: exact_synonym: (3S,6R,7R,11R,23S,26S,30aS,36R,38aR)-44-[2-O-(3-amino-2,3,6-trideoxy-3-C-methyl-alpha-L-lyxo-hexopyranosyl)-beta-D-glucopyranosyloxy]-3-(carbamoylmethyl)-10,19-dichloro-2,3,4,5,6,7,23,25,26,36,37,38,38a-tetradecahydro-7,22,28,30,32-pentahydroxy-6-(N-methyl-D-leucyl)-2,5,24,38,39-pentaoxo-1H,22H-23,36-(epiminomethano)-8,11:18,21-dietheno-13,16:31,35-di(metheno)[1,6,9]oxadiazacyclohexadecino[4,5-m][10,2,16]benzoxadiazacyclotetracosine-26-carboxylic acid
related_synonym: (1S,2R,18R,22S,25R,28R,40S)-22-(2-amino-2-oxoethyl)-48-[2-O-(3-amino-2,3,6-trideoxy-3-methyl-alpha-L-lyxo-hexopyranosyl)-beta-D-glucopyranosyloxy]-5,15-dichloro-2,18,32,35,37-pentahydroxy-19-[(N-methyl-D-leucyl)amino]-20,23,26,42,44-pentaoxo-7,13-dioxa-21,24,27,41,43-pentaazaoctacyclo[26.14.2.2(3,6).2(14,17).1(8,12).1(29,33).0(10,25).0(34,39)]pentaconta-3,5,8(48),9,11,14,16,29(45),30,32,34,36,38,46,49-pentadecaene-40-carboxylic acid; (2.2Sp,3.5Sa,2.6Sp)-O(4.2),C(3.4):C(5.4),O(4.6):C(3.5),C(2.7)-tricyclo[N-methyl-D-leucyl-3-chloro-(R)-beta-hydroxy-D-tyrosyl-L-asparaginyl-D-2-(4-{[2-O-(3-amino-2,3,6-trideoxy-3-C-methyl-alpha-L-lyxo-hexopyranosyl)-beta-D-glucopyranosyl]oxy}phenyl)glycyl-D-2-(4-hydroxyphenyl)glycyl-3-chloro-(R)-beta-hydroxy-L-tyrosyl-L-2-(3,5-dihydroxyphenyl)glycine]; Formula=C66H75Cl2N9O24; InChI=1S/C66H75Cl2N9O24/c1-23(2)12-34(71-5)58(88)76-49-51(83)26-7-10-38(32(67)14-26)97-40-16-28-17-41(55(40)101-65-56(54(86)53(85)42(22-78)99-65)100-44-21-66(4,70)57(87)24(3)96-44)98-39-11-8-27(15-33(39)68)52(84)50-63(93)75-48(64(94)95)31-18-29(79)19-37(81)45(31)30-13-25(6-9-36(30)80)46(60(90)77-50)74-61(91)47(28)73-59(89)35(20-43(69)82)72-62(49)92/h6-11,13-19,23-24,34-35,42,44,46-54,56-57,65,71,78-81,83-87H,12,20-22,70H2,1-5H3,(H2,69,82)(H,72,92)(H,73,89)(H,74,91)(H,75,93)(H,76,88)(H,77,90)(H,94,95)/t24-,34+,35-,42+,44-,46+,47+,48-,49+,50-,51+,52+,53+,54-,56+,57+,65-,66-/m0/s1; InChIKey=MYPYJXKWCTUITO-LYRMYLQWSA-N; SMILES=CN[C@H](CC(C)C)C(=O)N[C@@H]1[C@H](O)c2ccc(Oc3cc4cc(Oc5ccc(cc5Cl)[C@@H](O)[C@@H]5NC(=O)[C@H](NC(=O)[C@@H]4NC(=O)[C@H](CC(N)=O)NC1=O)c1ccc(O)c(c1)-c1c(O)cc(O)cc1[C@H](NC5=O)C(O)=O)c3O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O[C@H]1C[C@](C)(N)[C@H](O)[C@H](C)O1)c(Cl)c2; Vancocin; vancomicin; vancomicina; vancomycine; vancomycinum
alt_id: CHEBI:27276; CHEBI:49941; CHEBI:9931
xref: Beilstein:3132; CAS:1404-90-6; DrugBank:DB00512; Drug_Central:2807; KEGG:C06689; KEGG:D00212; KNApSAcK:C00016052
xref_mesh: MESH:D014640
xref: MetaCyc:CPD-12245; PDBeChem:VAN; PMID:11028184; PMID:11408222; PMID:11688538; PMID:11864951; PMID:11886013; PMID:11980329; PMID:12019070; PMID:12541895; PMID:12852813; PMID:13370625; PMID:13521912; PMID:14605050; PMID:14702667; PMID:15047516; PMID:15081082; PMID:15465645; PMID:15590714; PMID:15792257; PMID:16183423; PMID:16184232; PMID:16420976; PMID:16596002; PMID:16720708; PMID:17027219; PMID:17184835; PMID:17299012; PMID:17594206; PMID:18030187; PMID:18159039; PMID:18162343; PMID:18260149; PMID:18361944; PMID:18462092; PMID:18582342; PMID:18817166; PMID:18983037; PMID:19107100; PMID:19830166; PMID:20956604; PMID:21109901; PMID:21458937; PMID:21466775; PMID:21664803; PMID:21719238; PMID:21951032; PMID:22011388; PMID:22015328; PMID:22027450; PMID:22124537; Patent:US3067099; Reaxys:3132; Wikipedia:Vancomycin
cyclic_relationship: is_conjugate_base_of CHEBI:76842
G
A2m
alpha-2-macroglobulin
increases expression
EXP
Vancomycin results in increased expression of A2M mRNA
CTD
PMID:18289764
NCBI chr 4:154,897,770...154,947,787
Ensembl chr 4:154,897,877...154,947,786
G
Aadac
arylacetamide deacetylase
increases expression
ISO
Vancomycin results in increased expression of AADAC mRNA
CTD
PMID:18930951
NCBI chr 2:144,163,436...144,186,086
Ensembl chr 2:144,135,319...144,174,734
G
Aadat
aminoadipate aminotransferase
increases expression
ISO
Vancomycin results in increased expression of AADAT mRNA
CTD
PMID:18930951
NCBI chr16:29,509,392...29,544,332
Ensembl chr16:29,509,394...29,544,332
G
Aass
aminoadipate-semialdehyde synthase
increases expression
ISO
Vancomycin results in increased expression of AASS mRNA
CTD
PMID:18930951
NCBI chr 4:51,606,461...51,663,136
Ensembl chr 4:51,606,462...51,663,136
G
Abat
4-aminobutyrate aminotransferase
increases expression
ISO
Vancomycin results in increased expression of ABAT mRNA
CTD
PMID:18930951
NCBI chr10:6,996,688...7,092,835
Ensembl chr10:6,999,819...7,092,835
G
Abca1
ATP binding cassette subfamily A member 1
decreases expression multiple interactions
ISO
Vancomycin results in decreased expression of ABCA1 mRNA [Vancomycin co-treated with Neomycin co-treated with Ampicillin co-treated with Metronidazole co-treated with Amphotericin B] results in decreased expression of ABCA1 mRNA
CTD
PMID:18930951 PMID:36464106
NCBI chr 5:67,678,267...67,801,162
Ensembl chr 5:67,681,297...67,801,170
G
Abca13
ATP binding cassette subfamily A member 13
increases expression
ISO
Vancomycin results in increased expression of ABCA13 mRNA
CTD
PMID:18930951
NCBI chr14:83,873,397...84,376,138
Ensembl chr14:83,873,940...84,375,075
G
Abcb11
ATP binding cassette subfamily B member 11
multiple interactions
ISO
[Vancomycin co-treated with Imipenem] results in increased expression of ABCB11 mRNA; [Vancomycin co-treated with Neomycin co-treated with Ampicillin co-treated with Metronidazole co-treated with Amphotericin B] results in increased expression of ABCB11 mRNA
CTD
PMID:24657338 PMID:36464106
NCBI chr 3:54,016,854...54,112,797
Ensembl chr 3:54,017,127...54,112,730
G
Abcb1a
ATP binding cassette subfamily B member 1A
multiple interactions increases expression decreases expression
ISO EXP
[Vancomycin co-treated with Imipenem] results in decreased expression of ABCB1A mRNA; [Vancomycin co-treated with Neomycin co-treated with Ampicillin co-treated with Metronidazole co-treated with Amphotericin B] results in increased expression of ABCB1A mRNA Vancomycin results in increased expression of ABCB1A mRNA Cilastatin inhibits the reaction [Vancomycin results in decreased expression of and affects the localization of ABCB1 protein]; Vancomycin results in decreased expression of and affects the localization of ABCB1 protein Vancomycin results in decreased expression of ABCB1A mRNA; Vancomycin results in decreased expression of ABCB1A protein JBP 485 inhibits the reaction [Vancomycin results in decreased expression of ABCB1A mRNA]; JBP 485 inhibits the reaction [Vancomycin results in decreased expression of ABCB1A protein]
CTD
PMID:18930951 PMID:24657338 PMID:28549670 PMID:29964132 PMID:36464106
NCBI chr 4:25,357,467...25,529,941
Ensembl chr 4:25,158,362...25,442,709
G
Abcb1b
ATP-binding cassette, sub-family B member 1B
increases expression
ISO
Vancomycin results in increased expression of ABCB1B mRNA
CTD
PMID:18930951
NCBI chr 4:25,242,761...25,325,194
Ensembl chr 4:25,242,798...25,325,199
G
Abcc2
ATP binding cassette subfamily C member 2
multiple interactions decreases expression
ISO EXP
[Sodium Selenite results in increased abundance of Selenium] inhibits the reaction [[Vancomycin co-treated with Neomycin co-treated with Ampicillin co-treated with Metronidazole co-treated with Amphotericin B] results in increased expression of ABCC2 mRNA]; [Vancomycin co-treated with Imipenem] affects the expression of ABCC2 mRNA; [Vancomycin co-treated with Neomycin co-treated with Ampicillin co-treated with Metronidazole co-treated with Amphotericin B] results in increased expression of ABCC2 mRNA JBP 485 inhibits the reaction [Vancomycin results in decreased expression of ABCC2 mRNA]; JBP 485 inhibits the reaction [Vancomycin results in decreased expression of ABCC2 protein] Vancomycin results in decreased expression of ABCC2 mRNA; Vancomycin results in decreased expression of ABCC2 protein
CTD
PMID:24657338 PMID:29964132 PMID:36464106
NCBI chr 1:242,664,657...242,723,239
Ensembl chr 1:242,664,657...242,723,238
G
Abcc3
ATP binding cassette subfamily C member 3
multiple interactions
ISO
[Vancomycin co-treated with Imipenem] results in decreased expression of ABCC3 mRNA; [Vancomycin co-treated with Neomycin co-treated with Ampicillin co-treated with Metronidazole co-treated with Amphotericin B] results in increased expression of ABCC3 mRNA
CTD
PMID:24657338 PMID:36464106
NCBI chr10:79,296,681...79,342,749
Ensembl chr10:79,296,693...79,342,595
G
Abcd4
ATP binding cassette subfamily D member 4
increases expression
ISO
Vancomycin results in increased expression of ABCD4 mRNA
CTD
PMID:18930951
NCBI chr 6:104,246,459...104,260,965
Ensembl chr 6:104,246,468...104,280,276
G
Abcg2
ATP binding cassette subfamily G member 2
multiple interactions
ISO
[Sodium Selenite results in increased abundance of Selenium] inhibits the reaction [[Vancomycin co-treated with Neomycin co-treated with Ampicillin co-treated with Metronidazole co-treated with Amphotericin B] results in increased expression of ABCG2 mRNA]; [Vancomycin co-treated with Neomycin co-treated with Ampicillin co-treated with Metronidazole co-treated with Amphotericin B] results in increased expression of ABCG2 mRNA
CTD
PMID:36464106
NCBI chr 4:87,676,241...87,802,757
Ensembl chr 4:87,745,319...87,802,409
G
Abcg5
ATP binding cassette subfamily G member 5
multiple interactions
ISO
[Sodium Selenite results in increased abundance of Selenium] inhibits the reaction [[Vancomycin co-treated with Neomycin co-treated with Ampicillin co-treated with Metronidazole co-treated with Amphotericin B] results in decreased expression of ABCG5 mRNA]; [Vancomycin co-treated with Imipenem] affects the expression of ABCG5 mRNA; [Vancomycin co-treated with Neomycin co-treated with Ampicillin co-treated with Metronidazole co-treated with Amphotericin B] results in decreased expression of ABCG5 mRNA
CTD
PMID:24657338 PMID:36464106
NCBI chr 6:9,965,118...9,990,563
Ensembl chr 6:9,965,118...9,990,563
G
Abcg8
ATP binding cassette subfamily G member 8
multiple interactions
ISO
[Vancomycin co-treated with Imipenem] affects the expression of ABCG8 mRNA
CTD
PMID:24657338
NCBI chr 6:9,945,629...9,964,912
Ensembl chr 6:9,945,629...9,964,912
G
Abhd1
abhydrolase domain containing 1
increases expression
ISO
Vancomycin results in increased expression of ABHD1 mRNA
CTD
PMID:18930951
NCBI chr 6:25,422,526...25,427,514
Ensembl chr 6:25,422,526...25,427,514
G
Abhd14a
abhydrolase domain containing 14A
increases expression
ISO
Vancomycin results in increased expression of ABHD14A mRNA
CTD
PMID:18930951
NCBI chr 8:107,079,139...107,089,004
Ensembl chr 8:107,079,144...107,086,985
G
Abhd3
abhydrolase domain containing 3, phospholipase
increases expression
ISO
Vancomycin results in increased expression of ABHD3 mRNA
CTD
PMID:18930951
NCBI chr18:1,723,203...1,778,488
Ensembl chr18:1,720,718...1,803,428
G
Acaa2
acetyl-CoA acyltransferase 2
increases expression
ISO
Vancomycin results in increased expression of ACAA2 mRNA
CTD
PMID:18930951
NCBI chr18:68,345,136...68,373,246
Ensembl chr18:68,345,012...68,373,249
G
Acaca
acetyl-CoA carboxylase alpha
multiple interactions
ISO
[Vancomycin co-treated with Neomycin co-treated with Metronidazole co-treated with elemicin] results in increased expression of ACACA mRNA
CTD
PMID:34979169
NCBI chr10:69,014,261...69,276,453
Ensembl chr10:69,014,170...69,276,457
G
Acad10
acyl-CoA dehydrogenase family, member 10
increases expression
ISO
Vancomycin results in increased expression of ACAD10 mRNA
CTD
PMID:18930951
NCBI chr12:34,901,211...34,943,973
Ensembl chr12:34,901,219...34,982,521
G
Acad9
acyl-CoA dehydrogenase family, member 9
increases expression
ISO
Vancomycin results in increased expression of ACAD9 mRNA
CTD
PMID:18930951
NCBI chr 2:118,943,170...118,966,150
Ensembl chr 2:118,943,174...118,966,547
G
Acadsb
acyl-CoA dehydrogenase, short/branched chain
increases expression
ISO
Vancomycin results in increased expression of ACADSB mRNA
CTD
PMID:18930951
NCBI chr 1:186,188,939...186,227,796
Ensembl chr 1:186,188,987...186,230,379
G
Acat1
acetyl-CoA acetyltransferase 1
increases expression
ISO
Vancomycin results in increased expression of ACAT1 mRNA
CTD
PMID:18930951
NCBI chr 8:53,979,813...54,008,861
Ensembl chr 8:53,979,813...54,008,855
G
Acat2
acetyl-CoA acetyltransferase 2
multiple interactions
EXP
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of ACAT2 protein
CTD
PMID:30545405
NCBI chr 1:47,695,833...47,713,879
Ensembl chr 1:47,695,788...47,752,821
G
Acat2l1
acetyl-CoA acetyltransferase 2-like 1
multiple interactions
EXP
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of ACAT2L1 protein
CTD
PMID:30545405
NCBI chr 1:47,803,822...47,829,012
Ensembl chr 1:47,803,813...47,829,151
G
Ace2
angiotensin converting enzyme 2
multiple interactions
EXP
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of ACE2 protein
CTD
PMID:30545405
NCBI chr X:30,293,597...30,340,961
Ensembl chr X:30,293,589...30,340,977
G
Ache
acetylcholinesterase
affects activity multiple interactions
EXP
Vancomycin affects the activity of ACHE protein zingerone affects the reaction [Vancomycin affects the activity of ACHE protein]
CTD
PMID:31454121
NCBI chr12:19,406,133...19,413,713
Ensembl chr12:19,407,360...19,413,651
G
Acot3
acyl-CoA thioesterase 3
increases expression
ISO
Vancomycin results in increased expression of ACOT3 mRNA
CTD
PMID:18930951
NCBI chr 6:103,682,518...103,688,735
Ensembl chr 6:103,682,596...103,688,427 Ensembl chr 6:103,682,596...103,688,427
G
Acot4
acyl-CoA thioesterase 4
increases expression
ISO
Vancomycin results in increased expression of ACOT4 mRNA
CTD
PMID:18930951
NCBI chr 6:103,668,699...103,674,037
Ensembl chr 6:103,668,753...103,673,917
G
Acot9
acyl-CoA thioesterase 9
decreases expression
ISO
Vancomycin results in decreased expression of ACOT9 mRNA
CTD
PMID:18930951
NCBI chr X:40,073,197...40,123,573
Ensembl chr X:40,064,810...40,123,559
G
Acox2
acyl-CoA oxidase 2
increases expression
ISO
Vancomycin results in increased expression of ACOX2 mRNA
CTD
PMID:18930951
NCBI chr15:16,660,584...16,692,160
Ensembl chr15:16,660,272...16,692,160
G
Acsl1
acyl-CoA synthetase long-chain family member 1
increases expression
ISO
Vancomycin results in increased expression of ACSL1 mRNA
CTD
PMID:18930951
NCBI chr16:45,755,246...45,821,541
Ensembl chr16:45,755,254...45,821,541
G
Acsl4
acyl-CoA synthetase long-chain family member 4
decreases expression
ISO
Vancomycin results in decreased expression of ACSL4 mRNA
CTD
PMID:18930951
NCBI chr X:105,942,794...106,006,573
Ensembl chr X:105,942,799...106,006,427
G
Acsm1
acyl-CoA synthetase medium-chain family member 1
increases expression
ISO
Vancomycin results in increased expression of ACSM1 mRNA
CTD
PMID:18930951
NCBI chr 1:173,985,715...174,020,565
Ensembl chr 1:173,984,672...174,025,495
G
Acsm2
acyl-CoA synthetase medium-chain family member 2
increases expression
ISO
Vancomycin results in increased expression of ACSM2 mRNA
CTD
PMID:18930951
NCBI chr 1:173,916,368...173,955,116
Ensembl chr 1:173,916,368...173,955,116
G
Acsm3
acyl-CoA synthetase medium-chain family member 3
increases expression
ISO
Vancomycin results in increased expression of ACSM3 mRNA
CTD
PMID:18930951
NCBI chr 1:174,133,260...174,159,966
Ensembl chr 1:174,133,288...174,160,184
G
Acss1
acyl-CoA synthetase short-chain family member 1
increases expression
ISO
Vancomycin results in increased expression of ACSS1 mRNA
CTD
PMID:18930951
NCBI chr 3:139,450,383...139,500,325
Ensembl chr 3:139,450,383...139,500,325
G
Acss2
acyl-CoA synthetase short-chain family member 2
increases expression
ISO
Vancomycin results in increased expression of ACSS2 mRNA
CTD
PMID:18930951
NCBI chr 3:144,003,808...144,047,452
Ensembl chr 3:144,004,336...144,059,675
G
Acta2
actin alpha 2, smooth muscle
decreases expression
ISO
Vancomycin results in decreased expression of ACTA2 mRNA
CTD
PMID:18930951
NCBI chr 1:231,746,527...231,759,307
Ensembl chr 1:231,746,548...231,759,554
G
Actb
actin, beta
increases expression
ISO
Vancomycin results in increased expression of ACTB mRNA
CTD
PMID:18930951
NCBI chr12:11,663,112...11,666,697
Ensembl chr12:11,663,109...11,672,877
G
Actn1
actinin, alpha 1
decreases expression
ISO
Vancomycin results in decreased expression of ACTN1 mRNA
CTD
PMID:18930951
NCBI chr 6:98,998,553...99,093,334
Ensembl chr 6:98,998,556...99,093,251
G
Acy1
aminoacylase 1
increases expression
ISO
Vancomycin results in increased expression of ACY1 mRNA
CTD
PMID:18930951
NCBI chr 8:107,072,354...107,077,756
Ensembl chr 8:107,072,358...107,077,682
G
Acy3
aminoacylase 3
increases expression
ISO
Vancomycin results in increased expression of ACY3 mRNA
CTD
PMID:18930951
NCBI chr 1:201,279,751...201,285,803
Ensembl chr 1:201,279,851...201,283,175
G
Adamts1
ADAM metallopeptidase with thrombospondin type 1 motif, 1
decreases expression
ISO
Vancomycin results in decreased expression of ADAMTS1 mRNA
CTD
PMID:18930951
NCBI chr11:24,932,227...24,941,068
Ensembl chr11:24,931,761...24,941,103
G
Adgre5
adhesion G protein-coupled receptor E5
decreases expression
ISO
Vancomycin results in decreased expression of ADGRE5 mRNA
CTD
PMID:18930951
NCBI chr19:24,397,972...24,418,648
Ensembl chr19:24,398,689...24,418,638
G
Adhfe1
alcohol dehydrogenase, iron containing, 1
increases expression
ISO
Vancomycin results in increased expression of ADHFE1 mRNA
CTD
PMID:18930951
NCBI chr 5:9,705,966...9,732,580
Ensembl chr 5:9,705,970...9,732,517
G
Adipoq
adiponectin, C1Q and collagen domain containing
multiple interactions
ISO
[Vancomycin co-treated with Neomycin co-treated with Metronidazole co-treated with elemicin] results in increased expression of ADIPOQ mRNA
CTD
PMID:34979169
NCBI chr11:77,721,912...77,735,644
Ensembl chr11:77,721,912...77,735,564
G
Adk
adenosine kinase
increases expression
ISO
Vancomycin results in increased expression of ADK mRNA
CTD
PMID:18930951
NCBI chr15:2,863,241...3,246,453
Ensembl chr15:2,863,244...3,246,510
G
Adra2b
adrenoceptor alpha 2B
increases expression
ISO
Vancomycin results in increased expression of ADRA2B mRNA
CTD
PMID:18930951
NCBI chr 3:114,585,174...114,589,220
Ensembl chr 3:114,585,169...114,589,355
G
Aebp1
AE binding protein 1
decreases expression
ISO
Vancomycin results in decreased expression of AEBP1 mRNA
CTD
PMID:18930951
NCBI chr14:80,738,800...80,748,878
Ensembl chr14:80,738,892...80,748,877
G
Afm
afamin
increases expression
ISO
Vancomycin results in increased expression of AFM mRNA
CTD
PMID:18930951
NCBI chr14:17,531,022...17,563,868
Ensembl chr14:17,531,024...17,563,870
G
Agmat
agmatinase
increases expression
ISO
Vancomycin results in increased expression of AGMAT mRNA
CTD
PMID:18930951
NCBI chr 5:154,043,665...154,074,278
Ensembl chr 5:154,060,151...154,074,276
G
Agrn
agrin
decreases expression
ISO
Vancomycin results in decreased expression of AGRN mRNA
CTD
PMID:18930951
NCBI chr 5:166,749,306...166,782,212
Ensembl chr 5:166,749,310...166,786,003
G
Agxt2
alanine-glyoxylate aminotransferase 2
increases expression
ISO
Vancomycin results in increased expression of AGXT2 mRNA
CTD
PMID:18930951
NCBI chr 2:59,336,252...59,377,664
Ensembl chr 2:59,336,283...59,377,926
G
Ahcy
adenosylhomocysteinase
increases expression
ISO
Vancomycin results in increased expression of AHCY mRNA
CTD
PMID:18930951
NCBI chr 3:143,569,134...143,584,359
Ensembl chr 3:143,569,094...143,584,393
G
Ahnak
AHNAK nucleoprotein
decreases expression
ISO
Vancomycin results in decreased expression of AHNAK mRNA
CTD
PMID:18930951
NCBI chr 1:205,882,225...205,970,934
Ensembl chr 1:205,882,273...205,970,926
G
Ahsg
alpha-2-HS-glycoprotein
multiple interactions
EXP
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of AHSG protein
CTD
PMID:30545405
NCBI chr11:78,121,388...78,127,998
Ensembl chr11:78,117,918...78,145,999
G
Ak4
adenylate kinase 4
increases expression
ISO
Vancomycin results in increased expression of AK4 mRNA
CTD
PMID:18930951
NCBI chr 5:116,039,222...116,099,064
Ensembl chr 5:116,039,616...116,098,618
G
Akap12
A-kinase anchoring protein 12
decreases expression
ISO
Vancomycin results in decreased expression of AKAP12 mRNA
CTD
PMID:18930951
NCBI chr 1:40,730,123...40,819,863
Ensembl chr 1:40,730,123...40,819,886
G
Akr1d1
aldo-keto reductase family 1, member D1
increases expression
ISO
Vancomycin results in increased expression of AKR1D1 mRNA
CTD
PMID:18930951
NCBI chr 4:66,154,246...66,187,505
Ensembl chr 4:66,154,248...66,186,372
G
Akr7a2
aldo-keto reductase family 7, member A2
increases expression
ISO
Vancomycin results in increased expression of AKR7A5 mRNA
CTD
PMID:18930951
NCBI chr 5:151,552,375...151,560,914
Ensembl chr 5:151,552,343...151,560,909
G
Alb
albumin
increases expression
ISO
Vancomycin results in increased expression of ALB1 mRNA
CTD
PMID:18930951
NCBI chr14:17,607,397...17,622,814
Ensembl chr14:17,607,381...17,622,836
G
Aldh16a1
aldehyde dehydrogenase 16 family, member A1
increases expression
ISO
Vancomycin results in increased expression of ALDH16A1 mRNA
CTD
PMID:18930951
NCBI chr 1:95,626,727...95,639,808
Ensembl chr 1:95,613,558...95,640,131
G
Aldh1a1
aldehyde dehydrogenase 1 family, member A1
decreases expression
EXP
Vancomycin results in decreased expression of ALDH1A1 mRNA
CTD
PMID:18289764
NCBI chr 1:218,000,470...218,152,962
Ensembl chr 1:218,042,127...218,152,961
G
Aldh1a2
aldehyde dehydrogenase 1 family, member A2
decreases expression
ISO
Vancomycin results in decreased expression of ALDH1A2 mRNA
CTD
PMID:18930951
NCBI chr 8:71,877,850...71,957,107
Ensembl chr 8:71,877,850...71,957,107
G
Aldh2
aldehyde dehydrogenase 2 family member
increases expression
ISO
Vancomycin results in increased expression of ALDH2 mRNA
CTD
PMID:18930951
NCBI chr12:34,949,549...34,982,527
Ensembl chr12:34,901,219...34,982,521
G
Aldh4a1
aldehyde dehydrogenase 4 family, member A1
increases expression
ISO
Vancomycin results in increased expression of ALDH4A1 mRNA
CTD
PMID:18930951
NCBI chr 5:151,880,002...151,905,491
Ensembl chr 5:151,830,701...151,925,345
G
Aldh5a1
aldehyde dehydrogenase 5 family, member A1
increases expression
ISO
Vancomycin results in increased expression of ALDH5A1 mRNA
CTD
PMID:18930951
NCBI chr17:40,132,339...40,158,677
Ensembl chr17:40,130,883...40,158,677
G
Aldh6a1
aldehyde dehydrogenase 6 family, member A1
increases expression
ISO
Vancomycin results in increased expression of ALDH6A1 mRNA
CTD
PMID:18930951
NCBI chr 6:104,077,975...104,098,636
Ensembl chr 6:104,077,979...104,098,656
G
Aldh7a1
aldehyde dehydrogenase 7 family, member A1
increases expression
ISO
Vancomycin results in increased expression of ALDH7A1 mRNA
CTD
PMID:18930951
NCBI chr18:50,003,242...50,042,193
Ensembl chr18:50,009,934...50,042,193
G
Aldh8a1
aldehyde dehydrogenase 8 family, member A1
increases expression
ISO
Vancomycin results in increased expression of ALDH8A1 mRNA
CTD
PMID:18930951
NCBI chr 1:16,183,940...16,203,385
Ensembl chr 1:16,183,940...16,203,385
G
Aldh9a1
aldehyde dehydrogenase 9 family, member A1
increases expression
ISO
Vancomycin results in increased expression of ALDH9A1 mRNA
CTD
PMID:18930951
NCBI chr13:79,505,738...79,522,539
Ensembl chr13:79,505,695...79,540,568
G
Aldoa
aldolase, fructose-bisphosphate A
multiple interactions
EXP
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of ALDOA protein
CTD
PMID:30545405
NCBI chr 1:181,402,275...181,407,476
Ensembl chr 1:181,402,275...181,406,182
G
Aldob
aldolase, fructose-bisphosphate B
multiple interactions
EXP
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of ALDOB protein
CTD
PMID:30545405
NCBI chr 5:63,889,045...63,902,086
Ensembl chr 5:63,889,046...63,902,116
G
Aldoc
aldolase, fructose-bisphosphate C
increases expression
ISO
Vancomycin results in increased expression of ALDOC mRNA
CTD
PMID:18930951
NCBI chr10:63,217,477...63,221,066
Ensembl chr10:63,217,451...63,221,066
G
Alpl
alkaline phosphatase, biomineralization associated
increases expression
ISO
Vancomycin results in increased expression of ALPL mRNA
CTD
PMID:18930951
NCBI chr 5:149,951,397...150,006,424
Ensembl chr 5:149,951,409...150,006,446
G
Amacr
alpha-methylacyl-CoA racemase
increases expression
ISO
Vancomycin results in increased expression of AMACR mRNA
CTD
PMID:18930951
NCBI chr 2:59,946,158...59,958,255
Ensembl chr 2:59,946,153...59,958,255
G
Ampd3
adenosine monophosphate deaminase 3
decreases expression
ISO
Vancomycin results in decreased expression of AMPD3 mRNA
CTD
PMID:18930951
NCBI chr 1:164,884,823...164,929,899
Ensembl chr 1:164,885,320...164,929,887
G
Angpt1
angiopoietin 1
increases expression
ISO
Vancomycin results in increased expression of ANGPT1 mRNA
CTD
PMID:18930951
NCBI chr 7:73,528,345...73,783,953
Ensembl chr 7:73,531,486...73,784,067
G
Angptl3
angiopoietin-like 3
increases expression
ISO
Vancomycin results in increased expression of ANGPTL3 mRNA
CTD
PMID:18930951
NCBI chr 5:113,703,007...113,710,044
Ensembl chr 5:113,703,012...113,709,957
G
Angptl4
angiopoietin-like 4
decreases expression
ISO
Vancomycin results in decreased expression of ANGPTL4 mRNA
CTD
PMID:18930951
NCBI chr 7:14,550,288...14,557,797
Ensembl chr 7:14,550,311...14,556,519
G
Ankrd13c
ankyrin repeat domain 13C
increases expression
ISO
Vancomycin results in increased expression of ANKRD13C mRNA
CTD
PMID:18930951
NCBI chr 2:247,023,040...247,070,433
Ensembl chr 2:247,022,286...247,070,433
G
Ano6
anoctamin 6
decreases expression
ISO
Vancomycin results in decreased expression of ANO6 mRNA
CTD
PMID:18930951
NCBI chr 7:126,933,919...127,113,588
Ensembl chr 7:126,933,936...127,113,589
G
Anxa1
annexin A1
decreases expression
ISO
Vancomycin results in decreased expression of ANXA1 mRNA
CTD
PMID:18930951
NCBI chr 1:217,861,175...217,877,205
Ensembl chr 1:217,861,175...217,877,343
G
Anxa2
annexin A2
decreases expression
ISO
Vancomycin results in decreased expression of ANXA2 mRNA
CTD
PMID:18930951
NCBI chr 8:70,105,268...70,141,663
Ensembl chr 8:70,105,253...70,141,658
G
Anxa3
annexin A3
decreases expression
ISO
Vancomycin results in decreased expression of ANXA3 mRNA
CTD
PMID:18930951
NCBI chr14:12,727,708...12,781,717
Ensembl chr14:12,719,795...12,781,617
G
Anxa5
annexin A5
decreases expression increases expression
ISO EXP
Vancomycin results in decreased expression of ANXA5 mRNA Vancomycin results in increased expression of ANXA5 mRNA
CTD
PMID:18289764 PMID:18930951
NCBI chr 2:119,314,007...119,344,703
Ensembl chr 2:119,314,007...119,353,369
G
Aoah
acyloxyacyl hydrolase
increases expression
ISO
Vancomycin results in increased expression of AOAH mRNA
CTD
PMID:18930951
NCBI chr17:43,808,110...44,049,458
Ensembl chr17:43,809,638...44,049,148
G
Aoc1
amine oxidase, copper containing 1
decreases expression
ISO
Vancomycin results in decreased expression of AOC1 mRNA
CTD
PMID:18930951
NCBI chr 4:77,812,260...77,831,846
Ensembl chr 4:77,812,260...77,831,840
G
Apeh
acylaminoacyl-peptide hydrolase
increases expression
ISO
Vancomycin results in increased expression of APEH mRNA
CTD
PMID:18930951
NCBI chr 8:108,773,791...108,782,903
Ensembl chr 8:108,773,794...108,782,933
G
Apex1
apurinic/apyrimidinic endodeoxyribonuclease 1
decreases expression
ISO
Vancomycin results in decreased expression of APEX1 mRNA
CTD
PMID:18930951
NCBI chr15:24,144,595...24,146,785
Ensembl chr15:24,144,362...24,146,785
G
Apom
apolipoprotein M
increases expression
ISO
Vancomycin results in increased expression of APOM mRNA
CTD
PMID:18930951
NCBI chr20:3,690,950...3,693,550
Ensembl chr20:3,688,413...3,693,550
G
Aqp11
aquaporin 11
increases expression
ISO
Vancomycin results in increased expression of AQP11 mRNA
CTD
PMID:18930951
NCBI chr 1:152,046,515...152,056,675
Ensembl chr 1:152,046,517...152,056,725
G
Aqp3
aquaporin 3 (Gill blood group)
increases expression
ISO
Vancomycin results in increased expression of AQP3 mRNA
CTD
PMID:18930951
NCBI chr 5:56,239,200...56,244,718
Ensembl chr 5:56,239,201...56,244,720
G
Ar
androgen receptor
increases expression
ISO
Vancomycin results in increased expression of AR mRNA
CTD
PMID:18930951
NCBI chr X:63,104,771...63,273,934
Ensembl chr X:63,104,771...63,273,925
G
Arg2
arginase 2
decreases expression multiple interactions
ISO EXP
Vancomycin results in decreased expression of ARG2 mRNA [Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in decreased expression of ARG2 protein
CTD
PMID:18930951 PMID:30545405
NCBI chr 6:97,936,002...97,961,379
Ensembl chr 6:97,936,002...97,961,378
G
Arhgap18
Rho GTPase activating protein 18
increases expression
ISO
Vancomycin results in increased expression of ARHGAP18 mRNA
CTD
PMID:18930951
NCBI chr 1:18,403,531...18,637,306
Ensembl chr 1:18,403,537...18,637,256
G
Arhgdib
Rho GDP dissociation inhibitor beta
decreases expression
ISO
Vancomycin results in decreased expression of ARHGDIB mRNA
CTD
PMID:18930951
NCBI chr 4:169,822,951...169,841,884
Ensembl chr 4:169,822,952...169,841,658
G
Armcx3
armadillo repeat containing, X-linked 3
decreases expression
ISO
Vancomycin results in decreased expression of ARMCX3 mRNA
CTD
PMID:18930951
NCBI chr X:97,937,115...97,942,098
Ensembl chr X:97,936,999...97,942,098
G
Arpc1b
actin related protein 2/3 complex, subunit 1B
decreases expression
ISO
Vancomycin results in decreased expression of ARPC1B mRNA
CTD
PMID:18930951
NCBI chr12:9,482,176...9,495,772
Ensembl chr12:9,480,831...9,495,747
G
Arpc3
actin related protein 2/3 complex, subunit 3
multiple interactions
EXP
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of ARPC3 protein
CTD
PMID:30545405
NCBI chr12:34,172,780...34,186,651
Ensembl chr12:34,172,780...34,186,651
G
Arrb2
arrestin, beta 2
decreases expression
ISO
Vancomycin results in decreased expression of ARRB2 mRNA
CTD
PMID:18930951
NCBI chr10:55,146,887...55,154,854
Ensembl chr10:55,146,818...55,154,850
G
Asah1
N-acylsphingosine amidohydrolase 1
multiple interactions
EXP
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in decreased expression of ASAH1 protein
CTD
PMID:30545405
NCBI chr16:50,966,404...50,997,827
Ensembl chr16:50,966,229...51,008,233
G
Asl
argininosuccinate lyase
increases expression
ISO
Vancomycin results in increased expression of ASL mRNA
CTD
PMID:18930951
NCBI chr12:26,659,664...26,677,136
Ensembl chr12:26,659,565...26,679,662
G
Aspa
aspartoacylase
increases expression
ISO
Vancomycin results in increased expression of ASPA mRNA
CTD
PMID:18930951
NCBI chr10:57,891,704...57,945,267
Ensembl chr10:57,892,104...57,945,272
G
Ass1
argininosuccinate synthase 1
increases expression
ISO
Vancomycin results in increased expression of ASS1 mRNA
CTD
PMID:18930951
NCBI chr 3:14,747,355...14,796,909
Ensembl chr 3:14,747,368...14,796,903
G
Atp1a1
ATPase Na+/K+ transporting subunit alpha 1
multiple interactions
EXP
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of ATP1A1 protein
CTD
PMID:30545405
NCBI chr 2:189,020,722...189,048,826
Ensembl chr 2:189,020,722...189,048,837
G
Atp2a3
ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 3
multiple interactions
EXP
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of ATP2A3 protein
CTD
PMID:30545405
NCBI chr10:57,581,742...57,612,758
Ensembl chr10:57,582,128...57,612,748
G
Atp5mf
ATP synthase membrane subunit f
multiple interactions
EXP
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of ATP5MF protein
CTD
PMID:30545405
NCBI chr12:9,421,665...9,428,236
Ensembl chr12:9,421,579...9,428,236
G
Atp5pd
ATP synthase peripheral stalk subunit d
multiple interactions
EXP
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of ATP5PD protein
CTD
PMID:30545405
NCBI chr10:100,657,700...100,662,960
Ensembl chr10:100,657,708...100,663,479
G
Atp5pf
ATP synthase peripheral stalk subunit F6
multiple interactions
EXP
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of ATP5PF protein
CTD
PMID:30545405
NCBI chr11:23,881,594...23,889,581
Ensembl chr11:23,881,592...23,889,119
G
Atp6v1b1
ATPase H+ transporting V1 subunit B1
increases expression
ISO
Vancomycin results in increased expression of ATP6V1B1 mRNA
CTD
PMID:18930951
NCBI chr 4:116,223,799...116,242,475
Ensembl chr 4:116,223,799...116,242,475
G
Atp6v1c2
ATPase H+ transporting V1 subunit C2
increases expression
ISO
Vancomycin results in increased expression of ATP6V1C2 mRNA
CTD
PMID:18930951
NCBI chr 6:40,080,545...40,144,199
Ensembl chr 6:40,080,547...40,120,028
G
Auh
AU RNA binding methylglutaconyl-CoA hydratase
increases expression
ISO
Vancomycin results in increased expression of AUH mRNA
CTD
PMID:18930951
NCBI chr17:12,329,522...12,424,882
Ensembl chr17:12,329,524...12,424,896
G
Avpr1a
arginine vasopressin receptor 1A
increases expression
ISO
Vancomycin results in increased expression of AVPR1A mRNA
CTD
PMID:18930951
NCBI chr 7:58,114,306...58,118,230
Ensembl chr 7:58,114,284...58,122,215
G
Axl
Axl receptor tyrosine kinase
decreases expression
ISO
Vancomycin results in decreased expression of AXL mRNA
CTD
PMID:18930951
NCBI chr 1:81,265,088...81,296,278
Ensembl chr 1:81,265,088...81,296,265
G
B2m
beta-2 microglobulin
decreases expression
ISO
Vancomycin results in decreased expression of B2M mRNA
CTD
PMID:18930951
NCBI chr 3:109,095,740...109,101,764
Ensembl chr 3:109,095,729...109,101,766
G
B3galnt1
beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group)
increases expression
ISO
Vancomycin results in increased expression of B3GALNT1 mRNA
CTD
PMID:18930951
NCBI chr 2:153,847,297...153,877,371
Ensembl chr 2:153,846,474...153,877,332
G
B3galt5
Beta-1,3-galactosyltransferase 5
multiple interactions
EXP
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of B3GALT5 protein
CTD
PMID:30545405
NCBI chr11:35,584,273...35,630,922
Ensembl chr11:35,585,220...35,630,917
G
Baat
bile acid CoA:amino acid N-acyltransferase
multiple interactions
ISO
[Vancomycin co-treated with Imipenem] results in decreased expression of BAAT mRNA
CTD
PMID:24657338
NCBI chr 5:63,851,668...63,860,641
Ensembl chr 5:63,850,705...63,860,685
G
Bag2
BAG cochaperone 2
decreases expression
ISO
Vancomycin results in decreased expression of BAG2 mRNA
CTD
PMID:18930951
NCBI chr 9:35,970,033...35,980,677
Ensembl chr 9:35,970,033...35,980,721
G
Bax
BCL2 associated X, apoptosis regulator
increases expression multiple interactions
EXP
Vancomycin results in increased expression of BAX protein JBP 485 inhibits the reaction [Vancomycin results in increased expression of BAX protein]
CTD
PMID:29964132
NCBI chr 1:95,940,001...95,945,407
Ensembl chr 1:95,938,808...95,945,368
G
Bbox1
gamma-butyrobetaine hydroxylase 1
increases expression
ISO
Vancomycin results in increased expression of BBOX1 mRNA
CTD
PMID:18930951
NCBI chr 3:96,822,654...96,871,786
Ensembl chr 3:96,822,655...96,871,458
G
Bcam
basal cell adhesion molecule (Lutheran blood group)
decreases expression
ISO
Vancomycin results in decreased expression of BCAM mRNA
CTD
PMID:18930951
NCBI chr 1:79,415,016...79,429,403
Ensembl chr 1:79,415,017...79,429,403
G
Bcar3
BCAR3 adaptor protein, NSP family member
increases expression
ISO
Vancomycin results in increased expression of BCAR3 mRNA
CTD
PMID:18930951
NCBI chr 2:210,525,260...210,638,674
Ensembl chr 2:210,525,260...210,638,798
G
Bche
butyrylcholinesterase
multiple interactions affects activity
EXP
zingerone affects the reaction [Vancomycin affects the activity of BCHE protein]
CTD
PMID:31454121
NCBI chr 2:158,308,674...158,401,148
Ensembl chr 2:158,307,584...158,401,148
G
Bckdha
branched chain keto acid dehydrogenase E1 subunit alpha
increases expression
ISO
Vancomycin results in increased expression of BCKDHA mRNA
CTD
PMID:18930951
NCBI chr 1:81,138,946...81,167,765
Ensembl chr 1:81,138,947...81,167,862
G
Bckdhb
branched chain keto acid dehydrogenase E1 subunit beta
increases expression
ISO
Vancomycin results in increased expression of BCKDHB mRNA
CTD
PMID:18930951
NCBI chr 8:84,845,264...85,027,812
Ensembl chr 8:84,845,264...85,027,812
G
Bcl10
BCL10, immune signaling adaptor
decreases expression
ISO
Vancomycin results in decreased expression of BCL10 mRNA
CTD
PMID:18930951
NCBI chr 2:234,840,880...234,850,520
Ensembl chr 2:234,840,858...234,850,523
G
Bcl2
BCL2, apoptosis regulator
decreases expression multiple interactions
EXP
Vancomycin results in decreased expression of BCL2 protein JBP 485 inhibits the reaction [Vancomycin results in decreased expression of BCL2 protein]
CTD
PMID:29964132
NCBI chr13:22,689,783...22,853,920
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
G
Bdh1
3-hydroxybutyrate dehydrogenase 1
increases expression
ISO
Vancomycin results in increased expression of BDH1 mRNA
CTD
PMID:18930951
NCBI chr11:69,302,534...69,343,173
Ensembl chr11:69,302,534...69,337,671
G
Bdh2
3-hydroxybutyrate dehydrogenase 2
increases expression
ISO
Vancomycin results in increased expression of BDH2 mRNA
CTD
PMID:18930951
NCBI chr 2:223,702,410...223,723,076
Ensembl chr 2:223,702,412...223,723,072
G
Bgn
biglycan
decreases expression
ISO
Vancomycin results in decreased expression of BGN mRNA
CTD
PMID:18930951
NCBI chr X:151,197,296...151,209,458
Ensembl chr X:151,197,273...151,209,461
G
Bhmt
betaine-homocysteine S-methyltransferase
increases expression
ISO
Vancomycin results in increased expression of BHMT mRNA
CTD
PMID:18930951
NCBI chr 2:24,859,871...24,879,449
Ensembl chr 2:24,859,873...24,879,742
G
Bhmt2
betaine-homocysteine S-methyltransferase 2
increases expression
ISO
Vancomycin results in increased expression of BHMT2 mRNA
CTD
PMID:18930951
NCBI chr 2:24,895,525...24,912,475
Ensembl chr 2:24,895,533...24,912,475
G
Bicc1
BicC family RNA binding protein 1
decreases expression
ISO
Vancomycin results in decreased expression of BICC1 mRNA
CTD
PMID:18930951
NCBI chr20:17,449,639...17,686,775
Ensembl chr20:17,449,560...17,686,776
G
Birc3
baculoviral IAP repeat-containing 3
decreases expression
ISO
Vancomycin results in decreased expression of BIRC3 mRNA
CTD
PMID:18930951
NCBI chr 8:5,000,844...5,028,470
Ensembl chr 8:5,000,845...5,015,802
G
Blnk
B-cell linker
decreases expression
ISO
Vancomycin results in decreased expression of BLNK mRNA
CTD
PMID:18930951
NCBI chr 1:239,753,640...239,821,113
Ensembl chr 1:239,753,648...239,821,113
G
Bmp1
bone morphogenetic protein 1
increases expression
EXP
Vancomycin results in increased expression of BMP1 mRNA
CTD
PMID:18289764
NCBI chr15:45,551,603...45,595,862
Ensembl chr15:45,551,603...45,595,776
G
Bnip2
BCL2 interacting protein 2
decreases expression
ISO
Vancomycin results in decreased expression of BNIP2 mRNA
CTD
PMID:18930951
NCBI chr 8:70,640,436...70,661,782
Ensembl chr 8:70,640,445...70,675,590
G
Bphl
biphenyl hydrolase like
increases expression
ISO
Vancomycin results in increased expression of BPHL mRNA
CTD
PMID:18930951
NCBI chr17:30,800,939...30,837,277
Ensembl chr17:30,799,629...30,837,288
G
Bpnt1
3'(2'), 5'-bisphosphate nucleotidase 1
increases expression
ISO
Vancomycin results in increased expression of BPNT1 mRNA
CTD
PMID:18930951
NCBI chr13:96,865,634...96,893,506
Ensembl chr13:96,868,580...96,893,503
G
Bsnd
barttin CLCNK type accessory subunit beta
increases expression
ISO
Vancomycin results in increased expression of BSND mRNA
CTD
PMID:18930951
NCBI chr 5:121,251,774...121,260,571
Ensembl chr 5:121,251,774...121,260,571
G
Bspry
B-box and SPRY domain containing
decreases expression
ISO
Vancomycin results in decreased expression of BSPRY mRNA
CTD
PMID:18930951
NCBI chr 5:75,927,397...75,949,585
Ensembl chr 5:75,927,405...75,949,583
G
Bst1
bone marrow stromal cell antigen 1
decreases expression
ISO
Vancomycin results in decreased expression of BST1 mRNA
CTD
PMID:18930951
NCBI chr14:67,253,706...67,270,203
Ensembl chr14:67,252,998...67,270,180
G
Bst2
bone marrow stromal cell antigen 2
decreases expression
ISO
Vancomycin results in decreased expression of BST2 mRNA
CTD
PMID:18930951
NCBI chr16:18,216,605...18,220,979
Ensembl chr16:18,217,407...18,220,979
G
Btg2
BTG anti-proliferation factor 2
increases expression
ISO
Vancomycin results in increased expression of BTG2 mRNA
CTD
PMID:18930951
NCBI chr13:45,531,881...45,535,642
Ensembl chr13:45,531,925...45,535,628
G
C1qa
complement C1q A chain
decreases expression
ISO
Vancomycin results in decreased expression of C1QA mRNA
CTD
PMID:18930951
NCBI chr 5:149,133,635...149,136,482
Ensembl chr 5:149,133,636...149,136,534
G
C1qb
complement C1q B chain
decreases expression
ISO
Vancomycin results in decreased expression of C1QB mRNA
CTD
PMID:18930951
NCBI chr 5:149,118,843...149,124,394
Ensembl chr 5:149,118,846...149,124,407
G
C1ql3
complement C1q like 3
increases expression
ISO
Vancomycin results in increased expression of C1QL3 mRNA
CTD
PMID:18930951
NCBI chr17:76,119,344...76,129,170
Ensembl chr17:76,119,447...76,128,530
G
C1qtnf12
C1q and TNF related 12
increases expression
ISO
Vancomycin results in increased expression of C1QTNF12 mRNA
CTD
PMID:18930951
NCBI chr 5:166,551,628...166,556,003
Ensembl chr 5:166,551,628...166,556,003
G
C1qtnf3
C1q and TNF related 3
increases expression
ISO
Vancomycin results in increased expression of C1QTNF3 mRNA
CTD
PMID:18930951
NCBI chr 2:59,917,099...59,939,519
Ensembl chr 2:59,917,188...59,939,433
G
C1r
complement C1r
decreases expression
ISO
Vancomycin results in decreased expression of C1R mRNA
CTD
PMID:18930951
NCBI chr 4:157,412,718...157,423,483
Ensembl chr 4:157,412,692...157,423,484
G
C1s
complement C1s
decreases expression
ISO
Vancomycin results in decreased expression of C1S mRNA
CTD
PMID:18930951
NCBI chr 4:157,430,249...157,442,438
Ensembl chr 4:157,430,117...157,442,303
G
C2cd2l
C2CD2-like
increases expression
ISO
Vancomycin results in increased expression of C2CD2L mRNA
CTD
PMID:18930951
NCBI chr 8:44,648,074...44,658,856
Ensembl chr 8:44,648,079...44,658,340
G
C3
complement C3
decreases expression
ISO
Vancomycin results in decreased expression of C3 mRNA
CTD
PMID:18930951
NCBI chr 9:2,087,437...2,114,366
Ensembl chr 9:2,087,437...2,114,429
G
C4b
complement C4B
increases expression decreases expression
ISO
Vancomycin results in increased expression of C4B mRNA Vancomycin results in decreased expression of C4B mRNA
CTD
PMID:18930951
NCBI chr20:4,197,371...4,211,684
Ensembl chr20:4,197,366...4,211,681
G
C8a
complement C8 alpha chain
increases expression
ISO
Vancomycin results in increased expression of C8A mRNA
CTD
PMID:18930951
NCBI chr 5:119,583,168...119,637,675
Ensembl chr 5:119,583,174...119,637,754
G
Calb1
calbindin 1
increases expression decreases expression
ISO EXP
Vancomycin results in increased expression of CALB1 mRNA Vancomycin results in decreased expression of CALB1 mRNA
CTD
PMID:18289764 PMID:18930951
NCBI chr 5:29,375,624...29,402,532
Ensembl chr 5:29,375,642...29,402,431
G
Cald1
caldesmon 1
decreases expression
ISO
Vancomycin results in decreased expression of CALD1 mRNA
CTD
PMID:18930951
NCBI chr 4:63,265,781...63,446,938
Ensembl chr 4:63,265,942...63,446,932
G
Capg
capping actin protein, gelsolin like
decreases expression
ISO
Vancomycin results in decreased expression of CAPG mRNA
CTD
PMID:18930951
NCBI chr 4:104,594,743...104,611,856
Ensembl chr 4:104,594,753...104,611,856
G
Capn2
calpain 2
decreases expression
ISO
Vancomycin results in decreased expression of CAPN2 mRNA
CTD
PMID:18930951
NCBI chr13:94,150,244...94,200,969
Ensembl chr13:94,150,240...94,200,969
G
Car12
carbonic anhydrase 12
increases expression
ISO
Vancomycin results in increased expression of CAR12 mRNA
CTD
PMID:18930951
NCBI chr 8:67,274,739...67,330,428
Ensembl chr 8:67,274,359...67,330,440
G
Car14
carbonic anhydrase 14
increases expression
ISO
Vancomycin results in increased expression of CAR14 mRNA
CTD
PMID:18930951
NCBI chr 2:183,442,263...183,449,231
Ensembl chr 2:183,441,667...183,449,693
G
Car5a
carbonic anhydrase 5A
increases expression
ISO
Vancomycin results in increased expression of CAR5A mRNA
CTD
PMID:18930951
NCBI chr19:49,973,092...50,002,948
Ensembl chr19:49,973,107...50,002,906
G
Casp3
caspase 3
multiple interactions increases cleavage
EXP
JBP 485 inhibits the reaction [Vancomycin results in increased cleavage of CASP3 protein]
CTD
PMID:29964132
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
G
Casr
calcium-sensing receptor
increases expression
ISO
Vancomycin results in increased expression of CASR mRNA
CTD
PMID:18930951
NCBI chr11:64,235,251...64,304,811
Ensembl chr11:64,235,251...64,304,811
G
Cat
catalase
decreases expression increases expression
ISO EXP
Vancomycin results in decreased expression of CAT protein Vancomycin results in increased expression of CAT mRNA Vancomycin results in decreased expression of CAT mRNA
CTD
PMID:18289764 PMID:18930951 PMID:19442074
NCBI chr 3:89,842,393...89,874,577
Ensembl chr 3:89,842,399...89,874,478
G
Cavin2
caveolae associated protein 2
increases expression
ISO
Vancomycin results in increased expression of CAVIN2 mRNA
CTD
PMID:18930951
NCBI chr 9:50,302,079...50,314,096
Ensembl chr 9:50,301,206...50,314,147
G
Cavin3
caveolae associated protein 3
decreases expression
ISO
Vancomycin results in decreased expression of CAVIN3 mRNA
CTD
PMID:18930951
NCBI chr 1:159,826,549...159,828,138
Ensembl chr 1:159,826,549...159,828,161
G
Cbfb
core-binding factor subunit beta
decreases expression
ISO
Vancomycin results in decreased expression of CBFB mRNA
CTD
PMID:18930951
NCBI chr19:33,049,162...33,092,752
Ensembl chr19:33,049,172...33,092,751
G
Cbr1
carbonyl reductase 1
increases expression
ISO
Vancomycin results in increased expression of CBR1 mRNA
CTD
PMID:18930951
NCBI chr11:32,860,571...32,862,981
Ensembl chr11:32,908,950...32,911,393 Ensembl chr11:32,908,950...32,911,393
G
Cbr2
carbonyl reductase 2
increases expression
ISO
Vancomycin results in increased expression of CBR2 mRNA
CTD
PMID:18930951
NCBI chr10:106,008,535...106,012,838
Ensembl chr10:105,991,589...106,013,001
G
Cbs
cystathionine beta synthase
increases expression
ISO
Vancomycin results in increased expression of CBS mRNA
CTD
PMID:18930951
NCBI chr20:9,708,089...9,732,623
Ensembl chr20:9,708,090...9,732,764
G
Ccn1
cellular communication network factor 1
decreases expression
EXP
Vancomycin results in decreased expression of CCN1 mRNA
CTD
PMID:18289764
NCBI chr 2:234,562,410...234,565,370
Ensembl chr 2:234,562,408...234,565,484
G
Ccn4
cellular communication network factor 4
decreases expression
ISO
Vancomycin results in decreased expression of CCN4 mRNA
CTD
PMID:18930951
NCBI chr 7:98,645,238...98,677,253
Ensembl chr 7:98,645,182...98,677,248
G
Ccng1
cyclin G1
decreases expression
EXP
Vancomycin results in decreased expression of CCNG1 mRNA
CTD
PMID:18289764
NCBI chr10:25,176,231...25,182,604
Ensembl chr10:25,176,234...25,181,641
G
Ccs
copper chaperone for superoxide dismutase
increases expression
ISO
Vancomycin results in increased expression of CCS mRNA
CTD
PMID:18930951
NCBI chr 1:202,113,792...202,134,931
Ensembl chr 1:202,113,804...202,134,915
G
Ccser2
coiled-coil serine-rich protein 2
increases expression
ISO
Vancomycin results in increased expression of CCSER2 mRNA
CTD
PMID:18930951
NCBI chr16:12,613,103...12,725,764
Ensembl chr16:12,613,103...12,725,738
G
Cd14
CD14 molecule
decreases expression
ISO
Vancomycin results in decreased expression of CD14 mRNA
CTD
PMID:18930951
NCBI chr18:28,335,522...28,337,383
Ensembl chr18:28,335,340...28,337,261
G
Cd151
CD151 molecule (Raph blood group)
decreases expression
ISO
Vancomycin results in decreased expression of CD151 mRNA
CTD
PMID:18930951
NCBI chr 1:196,564,744...196,568,753
Ensembl chr 1:196,565,181...196,568,753
G
Cd24
CD24 molecule
increases expression decreases expression
EXP ISO
Vancomycin results in increased expression of CD24 mRNA Vancomycin results in decreased expression of CD24A mRNA
CTD
PMID:18289764 PMID:18930951
NCBI chr20:47,074,353...47,079,662
Ensembl chr20:47,073,512...47,079,662
G
Cd44
CD44 molecule
increases expression
EXP
Vancomycin results in increased expression of CD44 mRNA
CTD
PMID:18289764
NCBI chr 3:89,155,850...89,244,615
Ensembl chr 3:89,157,058...89,244,620
G
Cd47
Cd47 molecule
decreases expression
ISO
Vancomycin results in decreased expression of CD47 mRNA
CTD
PMID:18930951
NCBI chr11:50,906,052...50,970,000
Ensembl chr11:50,906,177...50,969,425
G
Cd52
CD52 molecule
decreases expression
ISO
Vancomycin results in decreased expression of CD52 mRNA
CTD
PMID:18930951
NCBI chr 5:146,319,789...146,321,348
Ensembl chr 5:146,319,969...146,321,348
G
Cd74
CD74 molecule
decreases expression
ISO
Vancomycin results in decreased expression of CD74 mRNA
CTD
PMID:18930951
NCBI chr18:54,256,757...54,266,003
Ensembl chr18:54,256,778...54,266,003
G
Cd9
CD9 molecule
decreases expression
ISO
Vancomycin results in decreased expression of CD9 mRNA
CTD
PMID:18930951
NCBI chr 4:158,256,328...158,289,136
Ensembl chr 4:158,256,328...158,289,222
G
Cdh11
cadherin 11
decreases expression
ISO
Vancomycin results in decreased expression of CDH11 mRNA
CTD
PMID:18930951
NCBI chr19:2,148,447...2,305,754
Ensembl chr19:2,148,458...2,304,272
G
Cdk6
cyclin-dependent kinase 6
decreases expression
ISO
Vancomycin results in decreased expression of CDK6 mRNA
CTD
PMID:18930951
NCBI chr 4:30,637,650...30,829,688
Ensembl chr 4:30,646,460...30,829,634
G
Cdkl1
cyclin dependent kinase like 1
increases expression
ISO
Vancomycin results in increased expression of CDKL1 mRNA
CTD
PMID:18930951
NCBI chr 6:88,224,154...88,273,434
Ensembl chr 6:88,224,143...88,270,276
G
Cdkn1a
cyclin-dependent kinase inhibitor 1A
decreases expression
ISO
Vancomycin results in decreased expression of CDKN1A mRNA
CTD
PMID:18930951
NCBI chr20:7,149,177...7,159,727
Ensembl chr20:7,149,217...7,159,585
G
Cdkn2d
cyclin dependent kinase inhibitor 2D
decreases expression
ISO
Vancomycin results in decreased expression of CDKN2D mRNA
CTD
PMID:18930951
NCBI chr 8:19,831,874...19,834,640
Ensembl chr 8:19,831,866...19,834,674
G
Cdt1
chromatin licensing and DNA replication factor 1
decreases expression
ISO
Vancomycin results in decreased expression of CDT1 mRNA
CTD
PMID:18930951
NCBI chr19:50,620,713...50,625,659
Ensembl chr19:50,620,713...50,625,659
G
Ceacam1
CEA cell adhesion molecule 1
increases expression
ISO
Vancomycin results in increased expression of CEACAM1 mRNA
CTD
PMID:18930951
NCBI chr 1:81,043,595...81,060,050
Ensembl chr 1:81,043,595...81,059,992
G
Cela1
chymotrypsin like elastase 1
increases expression
ISO
Vancomycin results in increased expression of CELA1 mRNA
CTD
PMID:18930951
NCBI chr 7:131,773,161...131,786,300
Ensembl chr 7:131,742,002...131,786,285
G
Ces3a
carboxylesterase 3a
increases expression
ISO
Vancomycin results in increased expression of CES3 mRNA
CTD
PMID:18930951
NCBI chr19:32,992,386...33,000,562
G
Cfh
complement factor H
decreases expression
ISO
Vancomycin results in decreased expression of CFH mRNA
CTD
PMID:18930951
NCBI chr13:51,512,376...51,613,829
Ensembl chr13:51,511,828...51,613,838
G
Cfi
complement factor I
decreases expression
ISO
Vancomycin results in decreased expression of CFI mRNA
CTD
PMID:18930951
NCBI chr 2:218,389,079...218,430,565
Ensembl chr 2:218,387,990...218,430,561
G
Cgn
cingulin
decreases expression
ISO
Vancomycin results in decreased expression of CGN mRNA
CTD
PMID:18930951
NCBI chr 2:182,308,389...182,335,747
Ensembl chr 2:182,308,714...182,334,645
G
Cgref1
cell growth regulator with EF hand domain 1
increases expression
ISO
Vancomycin results in increased expression of CGREF1 mRNA
CTD
PMID:18930951
NCBI chr 6:25,431,846...25,443,853
Ensembl chr 6:25,431,799...25,443,852
G
Chpt1
choline phosphotransferase 1
increases expression
ISO
Vancomycin results in increased expression of CHPT1 mRNA
CTD
PMID:18930951
NCBI chr 7:22,866,455...22,915,111
Ensembl chr 7:22,863,027...22,915,103
G
Chrna4
cholinergic receptor nicotinic alpha 4 subunit
increases expression
ISO
Vancomycin results in increased expression of CHRNA4 mRNA
CTD
PMID:18930951
NCBI chr 3:168,136,246...168,157,839
Ensembl chr 3:168,136,266...168,156,957
G
Cklf
chemokine-like factor
decreases expression
ISO
Vancomycin results in decreased expression of CKLF mRNA
CTD
PMID:18930951
NCBI chr19:698,097...706,570
Ensembl chr19:698,033...706,570
G
Cks1b
CDC28 protein kinase regulatory subunit 1B
decreases expression
ISO
Vancomycin results in decreased expression of CKS1B mRNA
CTD
PMID:18930951
NCBI chr 2:174,833,025...174,837,614
Ensembl chr 2:174,833,050...174,837,636
G
Clca1
chloride channel accessory 1
decreases expression
ISO
Vancomycin results in decreased expression of CLCA1 mRNA
CTD
PMID:18930951
NCBI chr 2:233,938,677...233,964,369
Ensembl chr 2:233,938,677...233,964,369
G
Clca4
chloride channel accessory 4
multiple interactions
EXP
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of CLCA4 protein
CTD
PMID:30545405
NCBI chr 2:233,883,625...233,904,993
Ensembl chr 2:233,883,851...233,903,089
G
Clcnkb
chloride voltage-gated channel Kb
increases expression
ISO
Vancomycin results in increased expression of CLCNKB mRNA
CTD
PMID:18930951
NCBI chr 5:153,710,086...153,733,162
Ensembl chr 5:153,710,094...153,732,153
G
Cldn1
claudin 1
decreases expression
ISO
Vancomycin results in decreased expression of CLDN1 mRNA
CTD
PMID:18930951
NCBI chr11:74,421,569...74,436,728
Ensembl chr11:74,421,569...74,436,724
G
Cldn3
claudin 3
decreases expression
ISO
Vancomycin results in decreased expression of CLDN3 mRNA
CTD
PMID:18930951
NCBI chr12:21,708,538...21,710,010
Ensembl chr12:21,708,398...21,711,001
G
Cldn5
claudin 5
multiple interactions
ISO
[Neomycin co-treated with Metronidazole co-treated with Ampicillin co-treated with Vancomycin] inhibits the reaction [Methamphetamine results in decreased expression of CLDN5 mRNA]; [Neomycin co-treated with Metronidazole co-treated with Ampicillin co-treated with Vancomycin] inhibits the reaction [Methamphetamine results in decreased expression of CLDN5 protein]
CTD
PMID:35390362
NCBI chr11:82,212,822...82,214,248
Ensembl chr11:82,211,475...82,214,992
G
Cldn7
claudin 7
decreases expression multiple interactions
ISO EXP
Vancomycin results in decreased expression of CLDN7 mRNA [Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of CLDN7 protein
CTD
PMID:18930951 PMID:30545405
NCBI chr10:54,689,684...54,692,177
Ensembl chr10:54,689,987...54,692,171
G
Clic1
chloride intracellular channel 1
decreases expression
ISO
Vancomycin results in decreased expression of CLIC1 mRNA
CTD
PMID:18930951
NCBI chr20:3,764,867...3,773,711
Ensembl chr20:3,761,461...3,773,712
G
Clu
clusterin
increases expression decreases expression
EXP ISO
Vancomycin results in increased expression of CLU mRNA Vancomycin results in decreased expression of CLU mRNA
CTD
PMID:18289764 PMID:18930951
NCBI chr15:40,161,068...40,200,315
Ensembl chr15:40,174,617...40,200,315
G
Cmbl
carboxymethylenebutenolidase homolog
multiple interactions
EXP
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in decreased expression of CMBL protein
CTD
PMID:30545405
NCBI chr 2:82,569,257...82,591,007
Ensembl chr 2:82,571,888...82,591,009
G
Cmtm3
CKLF-like MARVEL transmembrane domain containing 3
decreases expression
ISO
Vancomycin results in decreased expression of CMTM3 mRNA
CTD
PMID:18930951
NCBI chr19:622,563...630,721
Ensembl chr19:604,458...629,790
G
Cndp1
carnosine dipeptidase 1
increases expression
ISO
Vancomycin results in increased expression of CNDP1 mRNA
CTD
PMID:18930951
NCBI chr18:77,984,886...78,030,837
Ensembl chr18:77,984,907...78,007,765
G
Cndp2
carnosine dipeptidase 2
multiple interactions
EXP
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of CNDP2 protein
CTD
PMID:30545405
NCBI chr18:78,039,924...78,057,030
Ensembl chr18:78,039,932...78,056,922
G
Cnn2
calponin 2
decreases expression
ISO
Vancomycin results in decreased expression of CNN2 mRNA
CTD
PMID:18930951
NCBI chr 7:9,712,505...9,719,678
Ensembl chr 7:9,712,516...9,719,656
G
Cnp
2',3'-cyclic nucleotide 3' phosphodiesterase
decreases expression
ISO
Vancomycin results in decreased expression of CNP1 mRNA
CTD
PMID:18930951
NCBI chr10:85,511,164...85,517,723
Ensembl chr10:85,511,160...85,517,720
G
Coasy
Coenzyme A synthase
increases expression
ISO
Vancomycin results in increased expression of COASY mRNA
CTD
PMID:18930951
NCBI chr10:86,014,566...86,018,849
Ensembl chr10:86,014,597...86,018,841
G
Col18a1
collagen type XVIII alpha 1 chain
decreases expression
ISO
Vancomycin results in decreased expression of COL18A1 mRNA
CTD
PMID:18930951
NCBI chr20:11,474,104...11,582,593
Ensembl chr20:11,474,104...11,582,593
G
Col1a2
collagen type I alpha 2 chain
decreases expression
ISO
Vancomycin results in decreased expression of COL1A2 mRNA
CTD
PMID:18930951
NCBI chr 4:32,563,938...32,598,868
Ensembl chr 4:32,563,381...32,598,867
G
Col3a1
collagen type III alpha 1 chain
decreases expression
ISO
Vancomycin results in decreased expression of COL3A1 mRNA
CTD
PMID:18930951
NCBI chr 9:47,374,611...47,410,547
Ensembl chr 9:47,374,593...47,410,547
G
Col4a1
collagen type IV alpha 1 chain
decreases expression
ISO
Vancomycin results in decreased expression of COL4A1 mRNA
CTD
PMID:18930951
NCBI chr16:78,183,533...78,294,412
Ensembl chr16:78,183,533...78,294,412
G
Col4a2
collagen type IV alpha 2 chain
decreases expression
ISO
Vancomycin results in decreased expression of COL4A2 mRNA
CTD
PMID:18930951
NCBI chr16:78,047,591...78,183,360
Ensembl chr16:78,047,602...78,183,839
G
Col5a2
collagen type V alpha 2 chain
decreases expression
ISO
Vancomycin results in decreased expression of COL5A2 mRNA
CTD
PMID:18930951
NCBI chr 9:47,448,741...47,598,134
Ensembl chr 9:47,448,736...47,598,154
G
Col6a1
collagen type VI alpha 1 chain
decreases expression
ISO
Vancomycin results in decreased expression of COL6A1 mRNA
CTD
PMID:18930951
NCBI chr20:11,906,105...11,924,599
Ensembl chr20:11,905,957...11,924,597
G
Col6a3
collagen type VI alpha 3 chain
decreases expression
ISO
Vancomycin results in decreased expression of COL6A3 mRNA
CTD
PMID:18930951
NCBI chr 9:91,361,578...91,439,434
Ensembl chr 9:91,361,583...91,439,471
G
Col8a1
collagen type VIII alpha 1 chain
decreases expression
ISO
Vancomycin results in decreased expression of COL8A1 mRNA
CTD
PMID:18930951
NCBI chr11:42,776,851...42,906,432
Ensembl chr11:42,777,628...42,906,424
G
Coq8a
coenzyme Q8A
increases expression
ISO
Vancomycin results in increased expression of COQ8A mRNA
CTD
PMID:18930951
NCBI chr13:91,904,731...91,933,588
Ensembl chr13:91,904,739...91,931,431
G
Coro1c
coronin 1C
decreases expression
ISO
Vancomycin results in decreased expression of CORO1C mRNA
CTD
PMID:18930951
NCBI chr12:42,713,024...42,785,179
Ensembl chr12:42,712,991...42,785,179
G
Cox5a
cytochrome c oxidase subunit 5A
multiple interactions
EXP
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of COX5A protein
CTD
PMID:30545405
NCBI chr 8:57,922,374...57,933,781
Ensembl chr 8:57,922,290...57,933,781
G
Cox6b1
cytochrome c oxidase subunit 6B1
multiple interactions
EXP
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of COX6B1 protein
CTD
PMID:30545405
NCBI chr 1:85,875,080...85,884,081
Ensembl chr 1:85,875,109...85,884,001 Ensembl chr 2:85,875,109...85,884,001
G
Cox7a1
cytochrome c oxidase subunit 7A1
increases expression
ISO
Vancomycin results in increased expression of COX7A1 mRNA
CTD
PMID:18930951
NCBI chr 1:85,422,162...85,447,530
Ensembl chr 1:85,441,871...85,445,151
G
Cox7a2
cytochrome c oxidase subunit 7A2
multiple interactions
EXP
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of COX7A2 protein
CTD
PMID:30545405
NCBI chr 8:80,716,824...80,720,922
Ensembl chr14:51,301,168...51,301,633 Ensembl chr 8:51,301,168...51,301,633
G
Cp
ceruloplasmin
decreases expression increases expression
ISO EXP
Vancomycin results in decreased expression of CP mRNA Vancomycin results in increased expression of CP mRNA
CTD
PMID:18289764 PMID:18930951
NCBI chr 2:102,439,433...102,498,075
Ensembl chr 2:102,439,624...102,498,075
G
Cpe
carboxypeptidase E
decreases expression
ISO
Vancomycin results in decreased expression of CPE mRNA
CTD
PMID:18930951
NCBI chr16:25,030,276...25,142,231
Ensembl chr16:25,030,276...25,142,233
G
Cpeb3
cytoplasmic polyadenylation element binding protein 3
increases expression
ISO
Vancomycin results in increased expression of CPEB3 mRNA
CTD
PMID:18930951
NCBI chr 1:234,749,138...234,931,219
Ensembl chr 1:234,751,733...234,931,560
G
Crem
cAMP responsive element modulator
decreases expression
ISO
Vancomycin results in decreased expression of CREM mRNA
CTD
PMID:18930951
NCBI chr17:54,238,889...54,305,989
Ensembl chr17:54,239,030...54,305,989
G
Crip1
cysteine rich protein 1
decreases expression
ISO
Vancomycin results in decreased expression of CRIP1 mRNA
CTD
PMID:18930951
NCBI chr 6:132,226,746...132,234,620
Ensembl chr 6:132,226,746...132,234,620
G
Crp
C-reactive protein
decreases expression
ISO
Vancomycin results in decreased expression of CRP protein
CTD
PMID:12680319
NCBI chr13:85,135,384...85,175,178
Ensembl chr13:85,124,977...85,175,178
G
Cryl1
crystallin, lambda 1
increases expression
ISO
Vancomycin results in increased expression of CRYL1 mRNA
CTD
PMID:18930951
NCBI chr15:31,427,011...31,545,997
Ensembl chr15:31,427,054...31,545,997
G
Csad
cysteine sulfinic acid decarboxylase
increases expression
ISO
Vancomycin results in increased expression of CSAD mRNA
CTD
PMID:18930951
NCBI chr 7:133,308,571...133,337,914
Ensembl chr 7:133,308,574...133,337,615
G
Csf2
colony stimulating factor 2
multiple interactions
ISO
[Ampicillin co-treated with Vancomycin co-treated with Neomycin co-treated with Metronidazole] inhibits the reaction [Dextran Sulfate results in increased expression of CSF2 protein]; [Ampicillin co-treated with Vancomycin co-treated with Neomycin co-treated with Metronidazole] results in decreased expression of CSF2 protein
CTD
PMID:31442584
NCBI chr10:38,386,945...38,388,926
Ensembl chr10:38,386,945...38,389,199
G
Csf2ra
colony stimulating factor 2 receptor subunit alpha
decreases expression
ISO
Vancomycin results in decreased expression of CSF2RA mRNA
CTD
PMID:18930951
NCBI chr14:98,089...103,261
Ensembl chr14:89,172...103,128
G
Csnk1e
casein kinase 1, epsilon
decreases expression
ISO
Vancomycin results in decreased expression of CSNK1E mRNA
CTD
PMID:18930951
NCBI chr 7:110,983,322...111,006,926
Ensembl chr 7:110,983,318...111,006,794
G
Csrp1
cysteine and glycine-rich protein 1
decreases expression
ISO
Vancomycin results in decreased expression of CSRP1 mRNA
CTD
PMID:18930951
NCBI chr13:47,158,171...47,179,388
Ensembl chr13:47,167,789...47,179,384
G
Cstb
cystatin B
decreases expression
ISO
Vancomycin results in decreased expression of CSTB mRNA
CTD
PMID:18930951
NCBI chr20:10,245,462...10,247,505
Ensembl chr20:10,245,462...10,247,526
G
Cth
cystathionine gamma-lyase
increases expression
ISO
Vancomycin results in increased expression of CTH mRNA
CTD
PMID:18930951
NCBI chr 2:246,975,888...247,002,234
Ensembl chr 2:246,975,894...247,002,234
G
Ctps1
CTP synthase 1
decreases expression
ISO
Vancomycin results in decreased expression of CTPS1 mRNA
CTD
PMID:18930951
NCBI chr 5:134,125,022...134,154,155
Ensembl chr 5:134,125,025...134,154,180
G
Ctsa
cathepsin A
multiple interactions
EXP
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in decreased expression of CTSA protein
CTD
PMID:30545405
NCBI chr 3:153,569,106...153,574,983
Ensembl chr 3:153,568,381...153,576,215
G
Ctsc
cathepsin C
decreases expression
ISO
Vancomycin results in decreased expression of CTSC mRNA
CTD
PMID:18930951
NCBI chr 1:142,028,386...142,059,841
Ensembl chr 1:142,028,392...142,060,387
G
Ctsd
cathepsin D
decreases expression
ISO
Vancomycin results in decreased expression of CTSD mRNA
CTD
PMID:18930951
NCBI chr 1:197,527,467...197,539,343
Ensembl chr 1:197,527,467...197,539,488
G
Ctsl
cathepsin L
decreases expression
ISO
Vancomycin results in decreased expression of CTSL mRNA
CTD
PMID:18930951
NCBI chr17:764,370...770,533
Ensembl chr17:764,309...770,548
G
Ctss
cathepsin S
decreases expression increases expression
ISO EXP
Vancomycin results in decreased expression of CTSS mRNA Vancomycin results in increased expression of CTSS mRNA
CTD
PMID:18289764 PMID:18930951
NCBI chr 2:183,086,437...183,114,483
Ensembl chr 2:183,086,437...183,114,483
G
Cttnbp2nl
CTTNBP2 N-terminal like
decreases expression
ISO
Vancomycin results in decreased expression of CTTNBP2NL mRNA
CTD
PMID:18930951
NCBI chr 2:192,507,963...192,554,548
Ensembl chr 2:192,507,963...192,541,101
G
Cubn
cubilin
increases expression
ISO
Vancomycin results in increased expression of CUBN mRNA
CTD
PMID:18930951
NCBI chr17:76,385,046...76,593,133
Ensembl chr17:76,385,060...76,593,231
G
Cul3
cullin 3
increases expression
ISO
Vancomycin results in increased expression of CUL3 mRNA
CTD
PMID:18930951
NCBI chr 9:81,592,641...81,670,428
Ensembl chr 9:81,592,641...81,670,462
G
Cx3cl1
C-X3-C motif chemokine ligand 1
decreases expression
ISO
Vancomycin results in decreased expression of CX3CL1 mRNA
CTD
PMID:18930951
NCBI chr19:10,227,337...10,237,826
Ensembl chr19:10,227,340...10,236,833
G
Cxadr
CXADR, Ig-like cell adhesion molecule
decreases expression
ISO
Vancomycin results in decreased expression of CXADR mRNA
CTD
PMID:18930951
NCBI chr11:16,982,864...17,030,078
Ensembl chr11:16,982,860...17,030,046
G
Cxcl12
C-X-C motif chemokine ligand 12
increases expression
ISO
Vancomycin results in increased expression of CXCL12 mRNA
CTD
PMID:18930951
NCBI chr 4:150,388,326...150,401,173
Ensembl chr 4:150,388,325...150,401,168
G
Cxcl16
C-X-C motif chemokine ligand 16
decreases expression
ISO
Vancomycin results in decreased expression of CXCL16 mRNA
CTD
PMID:18930951
NCBI chr10:55,166,721...55,171,316
Ensembl chr10:55,166,723...55,171,592
G
Cxcl3
C-X-C motif chemokine ligand 3
increases expression
ISO
Vancomycin results in increased expression of CXCL1 mRNA
CTD
PMID:18930951
NCBI chr14:17,287,727...17,289,451
Ensembl chr14:17,270,146...17,289,511
G
Cxcl9
C-X-C motif chemokine ligand 9
multiple interactions
ISO
[Vancomycin co-treated with Neomycin co-treated with Cilastatin, Imipenem Drug Combination] inhibits the reaction [Doxorubicin results in increased expression of CXCL9 mRNA]; [Vancomycin co-treated with Neomycin co-treated with Cilastatin, Imipenem Drug Combination] inhibits the reaction [Nanotubes, Carbon promotes the reaction [Doxorubicin results in increased expression of CXCL9 mRNA]]
CTD
PMID:32068018
NCBI chr14:15,722,868...15,727,779
Ensembl chr14:15,722,908...15,728,435
G
Cyb561
cytochrome b-561
decreases expression
ISO
Vancomycin results in decreased expression of CYB561 mRNA
CTD
PMID:18930951
NCBI chr10:90,878,052...90,888,734
Ensembl chr10:90,878,054...90,884,787
G
Cyfip2
cytoplasmic FMR1 interacting protein 2
increases expression
ISO
Vancomycin results in increased expression of CYFIP2 mRNA
CTD
PMID:18930951
NCBI chr10:30,621,318...30,741,113
Ensembl chr10:30,621,318...30,741,113
G
Cyp1a2
cytochrome P450, family 1, subfamily a, polypeptide 2
multiple interactions
EXP
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in decreased expression of CYP1A2 mRNA
CTD
PMID:30545405
NCBI chr 8:58,075,367...58,082,255
Ensembl chr 8:58,075,367...58,082,312
G
Cyp1b1
cytochrome P450, family 1, subfamily b, polypeptide 1
decreases expression
ISO
Vancomycin results in decreased expression of CYP1B1 mRNA
CTD
PMID:18930951
NCBI chr 6:15,342,312...15,350,886
Ensembl chr 6:15,342,344...15,350,917
G
Cyp27a1
cytochrome P450, family 27, subfamily a, polypeptide 1
increases expression multiple interactions
ISO
Vancomycin results in increased expression of CYP27A1 mRNA [Sodium Selenite results in increased abundance of Selenium] inhibits the reaction [[Vancomycin co-treated with Neomycin co-treated with Ampicillin co-treated with Metronidazole co-treated with Amphotericin B] results in decreased expression of CYP27A1 mRNA]; [Vancomycin co-treated with Neomycin co-treated with Ampicillin co-treated with Metronidazole co-treated with Amphotericin B] results in decreased expression of CYP27A1 mRNA
CTD
PMID:18930951 PMID:36464106
NCBI chr 9:76,264,655...76,294,551
Ensembl chr 9:76,264,860...76,294,551
G
Cyp27b1
cytochrome P450, family 27, subfamily b, polypeptide 1
decreases expression
ISO
Vancomycin results in decreased expression of CYP27B1 mRNA
CTD
PMID:18930951
NCBI chr 7:62,869,340...62,876,242
Ensembl chr 7:62,871,297...62,876,241
G
Cyp2c11
cytochrome P450, subfamily 2, polypeptide 11
multiple interactions
EXP
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in decreased expression of CYP2C11 mRNA
CTD
PMID:30545405
NCBI chr 1:236,762,719...236,799,069
Ensembl chr 1:236,762,842...236,799,066
G
Cyp2d2
cytochrome P450, family 2, subfamily d, polypeptide 2
multiple interactions
EXP
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in decreased expression of CYP2D2 mRNA
CTD
PMID:30545405
NCBI chr 7:113,935,138...113,939,209
Ensembl chr 7:113,935,138...113,939,209
G
Cyp2d4
cytochrome P450, family 2, subfamily d, polypeptide 4
increases expression
ISO
Vancomycin results in increased expression of CYP2D22 mRNA
CTD
PMID:18930951
NCBI chr 7:113,882,584...113,891,754
Ensembl chr 7:113,881,618...113,891,759
G
Cyp2e1
cytochrome P450, family 2, subfamily e, polypeptide 1
multiple interactions
EXP
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in decreased expression of CYP2E1 mRNA
CTD
PMID:30545405
NCBI chr 1:195,840,330...195,850,728
Ensembl chr 1:195,840,058...195,864,023
G
Cyp3a2
cytochrome P450, family 3, subfamily a, polypeptide 2
multiple interactions
EXP
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in decreased expression of CYP3A2 mRNA
CTD
PMID:30545405
NCBI chr12:9,207,978...9,230,064
Ensembl chr12:9,015,383...9,285,008
G
Cyp51
cytochrome P450, family 51
increases expression
ISO
Vancomycin results in increased expression of CYP51 mRNA
CTD
PMID:18930951
NCBI chr 4:30,036,956...30,055,410
Ensembl chr 4:30,036,865...30,055,410
G
Cyp7a1
cytochrome P450 family 7 subfamily A member 1
multiple interactions
ISO
[Sodium Selenite results in increased abundance of Selenium] inhibits the reaction [[Vancomycin co-treated with Neomycin co-treated with Ampicillin co-treated with Metronidazole co-treated with Amphotericin B] results in decreased expression of CYP7A1 mRNA]; [Vancomycin co-treated with Imipenem] results in decreased expression of CYP7A1 mRNA; [Vancomycin co-treated with Neomycin co-treated with Ampicillin co-treated with Metronidazole co-treated with Amphotericin B] results in decreased expression of CYP7A1 mRNA
CTD
PMID:24657338 PMID:36464106
NCBI chr 5:19,376,979...19,386,676
Ensembl chr 5:19,376,974...19,386,688
G
Cyp7b1
cytochrome P450 family 7 subfamily B member 1
multiple interactions
ISO
[Vancomycin co-treated with Neomycin co-treated with Ampicillin co-treated with Metronidazole co-treated with Amphotericin B] results in decreased expression of CYP7B1 mRNA
CTD
PMID:36464106
NCBI chr 2:100,502,791...100,669,713
Ensembl chr 2:100,502,791...100,669,698
G
Cyp8b1
cytochrome P450 family 8 subfamily B member 1
multiple interactions
ISO
[Sodium Selenite results in increased abundance of Selenium] inhibits the reaction [[Vancomycin co-treated with Neomycin co-treated with Ampicillin co-treated with Metronidazole co-treated with Amphotericin B] results in decreased expression of CYP8B1 mRNA]; [Vancomycin co-treated with Imipenem] results in decreased expression of CYP8B1 mRNA; [Vancomycin co-treated with Neomycin co-treated with Ampicillin co-treated with Metronidazole co-treated with Amphotericin B] results in decreased expression of CYP8B1 mRNA
CTD
PMID:24657338 PMID:36464106
NCBI chr 8:121,578,123...121,580,093
Ensembl chr 8:121,557,062...121,580,166
G
Dap
death-associated protein
decreases expression
ISO
Vancomycin results in decreased expression of DAP mRNA
CTD
PMID:18930951
NCBI chr 2:82,199,206...82,251,771
Ensembl chr 2:82,199,280...82,251,752
G
Dbt
dihydrolipoamide branched chain transacylase E2
increases expression
ISO
Vancomycin results in increased expression of DBT mRNA
CTD
PMID:18930951
NCBI chr 2:204,481,744...204,510,612
Ensembl chr 2:204,481,737...204,510,609
G
Dcxr
dicarbonyl and L-xylulose reductase
increases expression
ISO
Vancomycin results in increased expression of DCXR mRNA
CTD
PMID:18930951
NCBI chr10:106,006,404...106,008,293
G
Ddah2
DDAH family member 2, ADMA-independent
decreases expression
ISO
Vancomycin results in decreased expression of DDAH2 mRNA
CTD
PMID:18930951
NCBI chr20:3,761,460...3,764,718
Ensembl chr20:3,761,465...3,764,511
G
Ddc
dopa decarboxylase
increases expression
ISO
Vancomycin results in increased expression of DDC mRNA
CTD
PMID:18930951
NCBI chr14:86,378,685...86,469,189
Ensembl chr14:86,378,685...86,469,208
G
Ddit4
DNA-damage-inducible transcript 4
increases expression
ISO
Vancomycin results in increased expression of DDIT4 mRNA
CTD
PMID:18930951
NCBI chr20:27,891,989...27,894,088
Ensembl chr20:27,891,998...27,894,105
G
Ddt
D-dopachrome tautomerase
increases expression
ISO
Vancomycin results in increased expression of DDT mRNA
CTD
PMID:18930951
NCBI chr20:12,884,216...12,886,687
Ensembl chr20:12,884,243...12,888,482
G
Decr2
2,4-dienoyl-CoA reductase 2
increases expression
ISO
Vancomycin results in increased expression of DECR2 mRNA
CTD
PMID:18930951
NCBI chr10:15,104,907...15,113,281
Ensembl chr10:15,002,926...15,118,479
G
Dgat2
diacylglycerol O-acyltransferase 2
increases expression
ISO
Vancomycin results in increased expression of DGAT2 mRNA
CTD
PMID:18930951
NCBI chr 1:153,454,078...153,484,432
Ensembl chr 1:153,454,080...153,484,428
G
Dhrs3
dehydrogenase/reductase 3
increases expression
ISO
Vancomycin results in increased expression of DHRS3 mRNA
CTD
PMID:18930951
NCBI chr 5:156,747,939...156,782,420
Ensembl chr 5:156,747,962...156,782,417
G
Dhtkd1
dehydrogenase E1 and transketolase domain containing 1
increases expression
ISO
Vancomycin results in increased expression of DHTKD1 mRNA
CTD
PMID:18930951
NCBI chr17:72,355,201...72,406,725
Ensembl chr17:72,355,201...72,406,723
G
Dio1
iodothyronine deiodinase 1
increases expression
ISO
Vancomycin results in increased expression of DIO1 mRNA
CTD
PMID:18930951
NCBI chr 5:122,074,285...122,090,983
Ensembl chr 5:122,074,279...122,090,970
G
Dmgdh
dimethylglycine dehydrogenase
increases expression
ISO
Vancomycin results in increased expression of DMGDH mRNA
CTD
PMID:18930951
NCBI chr 2:24,912,600...24,987,533
Ensembl chr 2:24,912,578...24,987,528
G
Dmtn
dematin actin binding protein
increases expression
ISO
Vancomycin results in increased expression of DMTN mRNA
CTD
PMID:18930951
NCBI chr15:45,677,974...45,702,261
Ensembl chr15:45,677,977...45,705,601
G
Dnajc12
DnaJ heat shock protein family (Hsp40) member C12
increases expression
ISO
Vancomycin results in increased expression of DNAJC12 mRNA
CTD
PMID:18930951
NCBI chr20:25,246,744...25,267,508
Ensembl chr20:25,223,144...25,267,521
G
Dnajc28
DnaJ heat shock protein family (Hsp40) member C28
increases expression
ISO
Vancomycin results in increased expression of DNAJC28 mRNA
CTD
PMID:18930951
NCBI chr11:30,855,566...30,858,386
Ensembl chr11:30,853,526...30,858,441
G
Dnajc6
DnaJ heat shock protein family (Hsp40) member C6
increases expression
ISO
Vancomycin results in increased expression of DNAJC6 mRNA
CTD
PMID:18930951
NCBI chr 5:116,120,069...116,283,448
Ensembl chr 5:116,119,676...116,283,448
G
Dnase1
deoxyribonuclease 1
increases expression
ISO
Vancomycin results in increased expression of DNASE1 mRNA
CTD
PMID:18930951
NCBI chr10:11,498,930...11,505,151
Ensembl chr10:11,498,931...11,501,869
G
Dnmt1
DNA methyltransferase 1
decreases expression
ISO
Vancomycin results in decreased expression of DNMT1 mRNA
CTD
PMID:18930951
NCBI chr 8:19,440,611...19,486,659
Ensembl chr 8:19,440,611...19,486,659
G
Dock9
dedicator of cytokinesis 9
increases expression
ISO
Vancomycin results in increased expression of DOCK9 mRNA
CTD
PMID:18930951
NCBI chr15:98,611,518...98,883,306
Ensembl chr15:98,618,084...98,883,153
G
Dpep1
dipeptidase 1
increases expression
ISO
Vancomycin results in increased expression of DPEP1 mRNA
CTD
PMID:18930951
NCBI chr19:51,209,831...51,237,004
Ensembl chr19:51,219,660...51,235,257
G
Dpp4
dipeptidylpeptidase 4
increases expression
ISO
Vancomycin results in increased expression of DPP4 mRNA
CTD
PMID:18930951
NCBI chr 3:46,962,233...47,043,870
Ensembl chr 3:46,962,243...47,043,901
G
Dpyd
dihydropyrimidine dehydrogenase
increases expression
ISO
Vancomycin results in increased expression of DPYD mRNA
CTD
PMID:18930951
NCBI chr 2:206,609,043...207,474,982
Ensembl chr 2:206,609,122...207,474,982
G
Dpys
dihydropyrimidinase
increases expression
ISO
Vancomycin results in increased expression of DPYS mRNA
CTD
PMID:18930951
NCBI chr 7:70,822,648...70,929,255
Ensembl chr 7:70,835,789...70,929,231
G
Dtx3l
deltex E3 ubiquitin ligase 3L
decreases expression
ISO
Vancomycin results in decreased expression of DTX3L mRNA
CTD
PMID:18930951
NCBI chr11:64,814,926...64,824,539
Ensembl chr11:64,814,926...64,824,538
G
Dtx4
deltex E3 ubiquitin ligase 4
decreases expression
ISO
Vancomycin results in decreased expression of DTX4 mRNA
CTD
PMID:18930951
NCBI chr 1:209,457,719...209,545,163
Ensembl chr 1:209,460,735...209,492,818
G
Dym
dymeclin
increases expression
ISO
Vancomycin results in increased expression of DYM mRNA
CTD
PMID:18930951
NCBI chr18:68,605,131...68,900,905
Ensembl chr18:68,605,185...68,900,903
G
Dynll1
dynein light chain LC8-type 1
decreases expression
ISO
Vancomycin results in decreased expression of DYNLL1 mRNA
CTD
PMID:18930951
NCBI chr12:41,312,365...41,316,157
Ensembl chr12:41,312,367...41,314,741
G
Echdc3
enoyl CoA hydratase domain containing 3
increases expression
ISO
Vancomycin results in increased expression of ECHDC3 mRNA
CTD
PMID:18930951
NCBI chr17:72,070,697...72,093,519
Ensembl chr17:72,070,668...72,093,516
G
Efemp1
EGF containing fibulin extracellular matrix protein 1
decreases expression
ISO
Vancomycin results in decreased expression of EFEMP1 mRNA
CTD
PMID:18930951
NCBI chr14:102,610,813...102,690,027
Ensembl chr14:102,610,908...102,690,018
G
Efemp2
EGF containing fibulin extracellular matrix protein 2
decreases expression
ISO
Vancomycin results in decreased expression of EFEMP2 mRNA
CTD
PMID:18930951
NCBI chr 1:202,781,692...202,789,784
Ensembl chr 1:202,781,665...202,789,414
G
Efhd1
EF-hand domain family, member D1
increases expression
ISO
Vancomycin results in increased expression of EFHD1 mRNA
CTD
PMID:18930951
NCBI chr 9:87,938,259...87,984,917
Ensembl chr 9:87,938,284...87,984,917
G
Efhd2
EF-hand domain family, member D2
decreases expression
ISO
Vancomycin results in decreased expression of EFHD2 mRNA
CTD
PMID:18930951
NCBI chr 5:154,160,945...154,176,980
Ensembl chr 5:154,160,946...154,176,980
G
Egf
epidermal growth factor
decreases expression increases expression
EXP ISO
Vancomycin results in decreased expression of EGF mRNA Vancomycin results in increased expression of EGF mRNA
CTD
PMID:18289764 PMID:18930951
NCBI chr 2:218,219,408...218,302,359
Ensembl chr 2:218,219,415...218,302,064
G
Egfl6
EGF-like-domain, multiple 6
increases expression
ISO
Vancomycin results in increased expression of EGFL6 mRNA
CTD
PMID:18930951
NCBI chr X:27,884,087...27,942,044
Ensembl chr X:27,884,125...27,942,044
G
Egr1
early growth response 1
increases expression
ISO
Vancomycin results in increased expression of EGR1 mRNA
CTD
PMID:18930951
NCBI chr18:26,462,967...26,466,766
Ensembl chr18:26,462,981...26,466,766
G
Ehd4
EH-domain containing 4
decreases expression
ISO
Vancomycin results in decreased expression of EHD4 mRNA
CTD
PMID:18930951
NCBI chr 3:107,058,191...107,121,985
Ensembl chr 3:107,058,958...107,122,002
G
Ehhadh
enoyl-CoA hydratase and 3-hydroxyacyl CoA dehydrogenase
increases expression
ISO
Vancomycin results in increased expression of EHHADH mRNA
CTD
PMID:18930951
NCBI chr11:79,241,927...79,275,173
Ensembl chr11:79,241,938...79,275,188
G
Eif1a
eukaryotic translation initiation factor 1A
decreases expression
ISO
Vancomycin results in decreased expression of EIF1A mRNA
CTD
PMID:18930951
NCBI chr18:39,325,695...39,338,043
Ensembl chr18:39,325,202...39,338,696
G
Eif2ak2
eukaryotic translation initiation factor 2-alpha kinase 2
decreases expression
ISO
Vancomycin results in decreased expression of EIF2AK2 mRNA
CTD
PMID:18930951
NCBI chr 6:16,189,000...16,224,972
Ensembl chr 6:16,188,979...16,224,971
G
Eif4a1
eukaryotic translation initiation factor 4A1
decreases expression
ISO
Vancomycin results in decreased expression of EIF4A1 mRNA
CTD
PMID:18930951
NCBI chr10:54,384,345...54,389,855
Ensembl chr10:54,384,347...54,389,858
G
Eif4ebp1
eukaryotic translation initiation factor 4E binding protein 1
decreases expression
ISO
Vancomycin results in decreased expression of EIF4EBP1 mRNA
CTD
PMID:18930951
NCBI chr16:64,792,595...64,805,984
Ensembl chr16:64,790,226...64,805,984
G
Eif6
eukaryotic translation initiation factor 6
decreases expression
ISO
Vancomycin results in decreased expression of EIF6 mRNA
CTD
PMID:18930951
NCBI chr 3:144,325,038...144,331,396
Ensembl chr 3:144,325,036...144,331,401
G
Elf3
E74 like ETS transcription factor 3
decreases expression
ISO
Vancomycin results in decreased expression of ELF3 mRNA
CTD
PMID:18930951
NCBI chr13:46,690,460...46,695,394
Ensembl chr13:46,690,466...46,695,481
G
Ell3
elongation factor for RNA polymerase II 3
increases expression
ISO
Vancomycin results in increased expression of ELL3 mRNA
CTD
PMID:18930951
NCBI chr 3:108,413,035...108,417,181
Ensembl chr 3:108,410,448...108,417,132
G
Elovl6
ELOVL fatty acid elongase 6
increases expression
ISO
Vancomycin results in increased expression of ELOVL6 mRNA
CTD
PMID:18930951
NCBI chr 2:218,063,682...218,174,767
Ensembl chr 2:218,063,804...218,171,186
G
Emilin1
elastin microfibril interfacer 1
decreases expression
ISO
Vancomycin results in decreased expression of EMILIN1 mRNA
CTD
PMID:18930951
NCBI chr 6:25,455,974...25,463,713
Ensembl chr 6:25,445,298...25,463,698
G
Emp1
epithelial membrane protein 1
decreases expression
ISO
Vancomycin results in decreased expression of EMP1 mRNA
CTD
PMID:18930951
NCBI chr 4:168,212,901...168,233,039
Ensembl chr 4:168,212,861...168,232,904
G
Emp2
epithelial membrane protein 2
decreases expression
ISO
Vancomycin results in decreased expression of EMP2 mRNA
CTD
PMID:18930951
NCBI chr10:5,360,073...5,394,734
Ensembl chr10:5,360,073...5,394,733
G
Emp3
epithelial membrane protein 3
decreases expression
ISO
Vancomycin results in decreased expression of EMP3 mRNA
CTD
PMID:18930951
NCBI chr 1:96,388,651...96,391,946
Ensembl chr 1:96,388,652...96,391,988
G
Enc1
ectodermal-neural cortex 1
decreases expression
ISO
Vancomycin results in decreased expression of ENC1 mRNA
CTD
PMID:18930951
NCBI chr 2:28,550,670...28,562,591
Ensembl chr 2:28,550,464...28,562,713
G
Enpp2
ectonucleotide pyrophosphatase/phosphodiesterase 2
increases expression
ISO
Vancomycin results in increased expression of ENPP2 mRNA
CTD
PMID:18930951
NCBI chr 7:86,202,345...86,325,050
Ensembl chr 7:86,202,350...86,324,827
G
Entpd5
ectonucleoside triphosphate diphosphohydrolase 5
increases expression
ISO
Vancomycin results in increased expression of ENTPD5 mRNA
CTD
PMID:18930951
NCBI chr 6:104,019,095...104,055,311
Ensembl chr 6:104,019,185...104,055,530
G
Epcam
epithelial cell adhesion molecule
multiple interactions
EXP
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of EPCAM protein
CTD
PMID:30545405
NCBI chr 6:6,880,142...6,896,103
Ensembl chr 6:6,878,237...6,896,127
G
Ercc1
ERCC excision repair 1, endonuclease non-catalytic subunit
decreases expression
ISO
Vancomycin results in decreased expression of ERCC1 mRNA
CTD
PMID:18930951
NCBI chr 1:78,971,310...79,007,963
Ensembl chr 1:78,996,390...79,007,963
G
Erh
ERH, mRNA splicing and mitosis factor
decreases expression
ISO
Vancomycin results in decreased expression of ERH mRNA
CTD
PMID:18930951
NCBI chr 6:100,280,933...100,291,200
Ensembl chr 6:100,280,930...100,291,210
G
Errfi1
ERBB receptor feedback inhibitor 1
increases expression
ISO
Vancomycin results in increased expression of ERRFI1 mRNA
CTD
PMID:18930951
NCBI chr 5:161,323,981...161,337,289
Ensembl chr 5:161,323,998...161,337,282
G
Esrrb
estrogen-related receptor beta
increases expression
ISO
Vancomycin results in increased expression of ESRRB mRNA
CTD
PMID:18930951
NCBI chr 6:106,007,701...106,163,136
Ensembl chr 6:106,008,095...106,160,791
G
Esyt1
extended synaptotagmin 1
decreases expression
ISO
Vancomycin results in decreased expression of ESYT1 mRNA
CTD
PMID:18930951
NCBI chr 7:928,848...946,199
Ensembl chr 7:928,848...946,199
G
Etfa
electron transfer flavoprotein subunit alpha
multiple interactions
EXP
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of ETFA protein
CTD
PMID:30545405
NCBI chr 8:55,835,115...55,891,890
Ensembl chr 8:55,835,134...55,891,969
G
Etnk1
ethanolamine kinase 1
increases expression
ISO
Vancomycin results in increased expression of ETNK1 mRNA
CTD
PMID:18930951
NCBI chr 4:176,126,056...176,170,325
Ensembl chr 4:176,126,180...176,193,770
G
Ets2
ETS proto-oncogene 2, transcription factor
decreases expression
ISO
Vancomycin results in decreased expression of ETS2 mRNA
CTD
PMID:18930951
NCBI chr11:35,021,536...35,038,322
Ensembl chr11:35,021,596...35,038,319
G
Evc
EvC ciliary complex subunit 1
increases expression
ISO
Vancomycin results in increased expression of EVC mRNA
CTD
PMID:18930951
NCBI chr14:73,456,181...73,498,955
Ensembl chr14:73,456,222...73,498,099
G
Evl
Enah/Vasp-like
decreases expression
ISO
Vancomycin results in decreased expression of EVL mRNA
CTD
PMID:18930951
NCBI chr 6:127,473,119...127,594,342
Ensembl chr 6:127,474,543...127,594,344
G
Exoc6
exocyst complex component 6
decreases expression
ISO
Vancomycin results in decreased expression of EXOC6 mRNA
CTD
PMID:18930951
NCBI chr 1:235,314,612...235,457,824
Ensembl chr 1:235,300,369...235,457,015
G
Ezr
ezrin
multiple interactions
EXP
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of EZR protein
CTD
PMID:30545405
NCBI chr 1:46,967,961...47,011,505
Ensembl chr 1:46,967,658...47,011,505
G
F13b
coagulation factor XIII B chain
increases expression
ISO
Vancomycin results in increased expression of F13B mRNA
CTD
PMID:18930951
NCBI chr13:51,130,908...51,156,383
Ensembl chr13:51,130,920...51,156,381
G
F2r
coagulation factor II (thrombin) receptor
decreases expression
ISO
Vancomycin results in decreased expression of F2R mRNA
CTD
PMID:18930951
NCBI chr 2:26,869,343...26,885,856
Ensembl chr 2:26,868,404...26,885,870
G
F2rl1
F2R like trypsin receptor 1
decreases expression
ISO
Vancomycin results in decreased expression of F2RL1 mRNA
CTD
PMID:18930951
NCBI chr 2:26,772,274...26,785,226
Ensembl chr 2:26,772,278...26,785,226
G
F3
coagulation factor III, tissue factor
decreases expression
ISO
Vancomycin results in decreased expression of F3 mRNA
CTD
PMID:18930951
NCBI chr 2:209,827,061...209,838,666
Ensembl chr 2:209,826,959...209,838,668
G
Faah
fatty acid amide hydrolase
increases expression
ISO
Vancomycin results in increased expression of FAAH mRNA
CTD
PMID:18930951
NCBI chr 5:129,479,774...129,499,018
Ensembl chr 5:129,479,824...129,498,677
G
Fabp7
fatty acid binding protein 7
increases expression
ISO
Vancomycin results in increased expression of FABP7 mRNA
CTD
PMID:18930951
NCBI chr20:37,123,193...37,126,725
Ensembl chr20:37,123,193...37,126,880
G
Fads6
fatty acid desaturase 6
increases expression
ISO
Vancomycin results in increased expression of FADS6 mRNA
CTD
PMID:18930951
NCBI chr10:100,522,981...100,538,181
Ensembl chr10:100,522,981...100,538,181
G
Fah
fumarylacetoacetate hydrolase
increases expression
ISO
Vancomycin results in increased expression of FAH mRNA
CTD
PMID:18930951
NCBI chr 1:138,548,830...138,571,599
Ensembl chr 1:138,548,834...138,571,505
G
Fahd1
fumarylacetoacetate hydrolase domain containing 1
increases expression
ISO
Vancomycin results in increased expression of FAHD1 mRNA
CTD
PMID:18930951
NCBI chr10:13,873,539...13,874,978
Ensembl chr10:13,873,527...13,875,012
G
Fasn
fatty acid synthase
multiple interactions
ISO
[Sodium Selenite results in increased abundance of Selenium] inhibits the reaction [[Vancomycin co-treated with Neomycin co-treated with Ampicillin co-treated with Metronidazole co-treated with Amphotericin B] results in increased expression of FASN mRNA]; [Vancomycin co-treated with Neomycin co-treated with Ampicillin co-treated with Metronidazole co-treated with Amphotericin B] results in increased expression of FASN mRNA; [Vancomycin co-treated with Neomycin co-treated with Metronidazole] inhibits the reaction [elemicin results in increased expression of FASN mRNA]
CTD
PMID:34979169 PMID:36464106
NCBI chr10:106,072,093...106,090,259
Ensembl chr10:106,072,091...106,090,261
G
Fbn1
fibrillin 1
decreases expression
ISO
Vancomycin results in decreased expression of FBN1 mRNA
CTD
PMID:18930951
NCBI chr 3:112,554,257...112,750,835
Ensembl chr 3:112,554,925...112,750,889
G
Fbp1
fructose-bisphosphatase 1
increases expression
ISO
Vancomycin results in increased expression of FBP1 mRNA
CTD
PMID:18930951
NCBI chr17:2,207,271...2,230,076
Ensembl chr17:2,208,031...2,230,071
G
Fbxo39
F-box protein 39
decreases expression
ISO
Vancomycin results in decreased expression of FBXO39 mRNA
CTD
PMID:18930951
NCBI chr10:56,929,699...56,934,911
Ensembl chr10:56,932,297...56,934,906
G
Fbxo7
F-box protein 7
increases expression
ISO
Vancomycin results in increased expression of FBXO7 mRNA
CTD
PMID:18930951
NCBI chr 7:17,809,224...17,837,549
Ensembl chr 7:17,809,231...17,837,530
G
Fga
fibrinogen alpha chain
decreases expression
ISO
Vancomycin results in decreased expression of FGA mRNA
CTD
PMID:18930951
NCBI chr 2:168,374,120...168,381,523
Ensembl chr 2:168,374,120...168,381,528
G
Fgf9
fibroblast growth factor 9
increases expression
ISO
Vancomycin results in increased expression of FGF9 mRNA
CTD
PMID:18930951
NCBI chr15:32,208,993...32,254,952
Ensembl chr15:32,210,074...32,253,309
G
Fgfr3
fibroblast growth factor receptor 3
increases expression
ISO
Vancomycin results in increased expression of FGFR3 mRNA
CTD
PMID:18930951
NCBI chr14:76,987,242...77,002,671
Ensembl chr14:76,987,993...77,003,341
G
Flna
filamin A
decreases expression
ISO
Vancomycin results in decreased expression of FLNA mRNA
CTD
PMID:18930951
NCBI chr X:152,007,758...152,034,266
Ensembl chr X:152,007,758...152,031,052
G
Flot1
flotillin 1
decreases expression
ISO
Vancomycin results in decreased expression of FLOT1 mRNA
CTD
PMID:18930951
NCBI chr20:2,917,864...2,927,993
Ensembl chr20:2,917,137...2,927,978
G
Fmo2
flavin containing dimethylaniline monoxygenase 2
increases expression
ISO
Vancomycin results in increased expression of FMO2 mRNA
CTD
PMID:18930951
NCBI chr13:75,221,149...75,244,377
Ensembl chr13:75,224,402...75,244,308
G
Fn1
fibronectin 1
increases expression decreases expression
EXP ISO
Vancomycin results in increased expression of FN1 mRNA Vancomycin results in decreased expression of FN1 mRNA
CTD
PMID:18289764 PMID:18930951
NCBI chr 9:73,196,044...73,264,695
Ensembl chr 9:73,196,044...73,264,678
G
Fn3k
fructosamine 3 kinase
increases expression
ISO
Vancomycin results in increased expression of FN3K mRNA
CTD
PMID:18930951
NCBI chr10:106,700,670...106,715,903
Ensembl chr10:106,700,670...106,715,895
G
Fos
Fos proto-oncogene, AP-1 transcription factor subunit
increases expression
ISO
Vancomycin results in increased expression of FOS mRNA
CTD
PMID:18930951
NCBI chr 6:105,121,170...105,124,036
Ensembl chr 6:105,121,170...105,124,036
G
Fosl2
FOS like 2, AP-1 transcription factor subunit
decreases expression
ISO
Vancomycin results in decreased expression of FOSL2 mRNA
CTD
PMID:18930951
NCBI chr 6:24,297,898...24,319,219
Ensembl chr 6:24,300,956...24,320,034
G
Foxq1
forkhead box Q1
increases expression
ISO
Vancomycin results in increased expression of FOXQ1 mRNA
CTD
PMID:18930951
NCBI chr17:32,912,744...32,915,377
Ensembl chr17:32,912,744...32,915,377 Ensembl chr17:32,912,744...32,915,377
G
Frk
fyn-related Src family tyrosine kinase
decreases expression
ISO
Vancomycin results in decreased expression of FRK mRNA
CTD
PMID:18930951
NCBI chr20:38,265,416...38,371,038
Ensembl chr20:38,265,280...38,371,114
G
Fscn1
fascin actin-bundling protein 1
decreases expression
ISO
Vancomycin results in decreased expression of FSCN1 mRNA
CTD
PMID:18930951
NCBI chr12:11,597,042...11,610,183
Ensembl chr12:11,597,048...11,610,211
G
Fst
follistatin
decreases expression
ISO
Vancomycin results in decreased expression of FST mRNA
CTD
PMID:18930951
NCBI chr 2:46,123,260...46,130,584
Ensembl chr 2:46,123,439...46,130,571
G
Fstl1
follistatin-like 1
decreases expression
ISO
Vancomycin results in decreased expression of FSTL1 mRNA
CTD
PMID:18930951
NCBI chr11:62,895,391...62,948,581
Ensembl chr11:62,779,783...62,948,677
G
Fut9
fucosyltransferase 9
increases expression
ISO
Vancomycin results in increased expression of FUT9 mRNA
CTD
PMID:18930951
NCBI chr 5:39,351,815...39,565,256
Ensembl chr 5:39,351,819...39,565,130
G
Fxyd5
FXYD domain-containing ion transport regulator 5
decreases expression
ISO
Vancomycin results in decreased expression of FXYD5 mRNA
CTD
PMID:18930951
NCBI chr 1:86,267,937...86,277,329
Ensembl chr 1:86,267,406...86,277,519
G
G6pc1
glucose-6-phosphatase catalytic subunit 1
decreases expression increases expression
EXP ISO
Vancomycin results in decreased expression of G6PC1 mRNA Vancomycin results in increased expression of G6PC1 mRNA
CTD
PMID:18289764 PMID:18930951
NCBI chr10:86,307,400...86,318,766
Ensembl chr10:86,257,668...86,333,804
G
Gabrb3
gamma-aminobutyric acid type A receptor subunit beta 3
increases expression
ISO
Vancomycin results in increased expression of GABRB3 mRNA
CTD
PMID:18930951
NCBI chr 1:108,467,047...108,702,522
Ensembl chr 1:108,296,124...108,698,961
G
Gadd45a
growth arrest and DNA-damage-inducible, alpha
decreases expression
EXP
Vancomycin results in decreased expression of GADD45A mRNA
CTD
PMID:18289764
NCBI chr 4:96,154,789...96,157,091
Ensembl chr 4:96,154,789...96,157,115
G
Galm
galactose mutarotase
increases expression
ISO
Vancomycin results in increased expression of GALM mRNA
CTD
PMID:18930951
NCBI chr 6:14,837,540...14,889,484
Ensembl chr 6:14,837,548...14,889,310
G
Galnt11
polypeptide N-acetylgalactosaminyltransferase 11
increases expression
ISO
Vancomycin results in increased expression of GALNT11 mRNA
CTD
PMID:18930951
NCBI chr 4:9,837,629...9,871,141
Ensembl chr 4:9,837,629...9,871,140
G
Gamt
guanidinoacetate N-methyltransferase
increases expression
ISO
Vancomycin results in increased expression of GAMT mRNA
CTD
PMID:18930951
NCBI chr 7:9,448,590...9,451,413
Ensembl chr 7:9,448,628...9,451,778
G
Gas2
growth arrest-specific 2
increases expression
ISO
Vancomycin results in increased expression of GAS2 mRNA
CTD
PMID:18930951
NCBI chr 1:101,452,361...101,582,619
Ensembl chr 1:101,482,591...101,582,619
G
Gas5
growth arrest specific 5
decreases expression
ISO
Vancomycin results in decreased expression of GAS5 mRNA
CTD
PMID:18930951
NCBI chr13:73,303,611...73,306,932
G
Gatm
glycine amidinotransferase
increases expression
ISO
Vancomycin results in increased expression of GATM mRNA
CTD
PMID:18930951
NCBI chr 3:109,658,919...109,675,508
Ensembl chr 3:109,658,951...109,684,129
G
Gbp2
guanylate binding protein 2
decreases expression
ISO
Vancomycin results in decreased expression of GBP2 mRNA
CTD
PMID:18930951
NCBI chr 2:231,332,488...231,348,573
Ensembl chr 2:231,332,284...231,348,571
G
Gbp6
guanylate binding protein family member 6
decreases expression
ISO
Vancomycin results in decreased expression of GBP6 mRNA
CTD
PMID:18930951
NCBI chr14:4,730,286...4,756,508
Ensembl chr14:4,730,453...4,839,062 Ensembl chr14:4,730,453...4,839,062
G
Gcat
glycine C-acetyltransferase
increases expression
ISO
Vancomycin results in increased expression of GCAT mRNA
CTD
PMID:18930951
NCBI chr 7:110,595,126...110,601,474
Ensembl chr 7:110,595,091...110,601,473
G
Gcdh
glutaryl-CoA dehydrogenase
increases expression
ISO
Vancomycin results in increased expression of GCDH mRNA
CTD
PMID:18930951
NCBI chr19:23,263,215...23,269,689
Ensembl chr19:23,263,264...23,269,681
G
Gcgr
glucagon receptor
increases expression
ISO
Vancomycin results in increased expression of GCGR mRNA
CTD
PMID:18930951
NCBI chr10:105,808,474...105,816,641
Ensembl chr10:105,808,473...105,816,640
G
Gchfr
GTP cyclohydrolase I feedback regulator
increases expression
ISO
Vancomycin results in increased expression of GCHFR mRNA
CTD
PMID:18930951
NCBI chr 3:106,158,046...106,162,080
Ensembl chr 3:106,159,394...106,162,080
G
Gclm
glutamate cysteine ligase, modifier subunit
multiple interactions
ISO
[Vancomycin co-treated with Neomycin co-treated with Metronidazole] promotes the reaction [Zinc Oxide analog results in increased expression of GCLM protein]
CTD
PMID:36535435
NCBI chr 2:210,347,482...210,367,537
Ensembl chr 2:210,347,482...210,367,535
G
Gcsh
glycine cleavage system protein H
increases expression
ISO
Vancomycin results in increased expression of GCSH mRNA
CTD
PMID:18930951
NCBI chr19:45,036,013...45,046,770
Ensembl chr19:45,036,011...45,046,792
G
Gda
guanine deaminase
decreases expression
ISO
Vancomycin results in decreased expression of GDA mRNA
CTD
PMID:18930951
NCBI chr 1:218,903,045...218,982,360
Ensembl chr 1:218,906,815...218,982,416
G
Gfpt2
glutamine-fructose-6-phosphate transaminase 2
multiple interactions
EXP
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of GFPT2 protein
CTD
PMID:30545405
NCBI chr10:34,115,005...34,161,329
Ensembl chr10:34,115,052...34,161,329
G
Ggt1
gamma-glutamyltransferase 1
increases expression
ISO
Vancomycin results in increased expression of GGT1 mRNA
CTD
PMID:18930951
NCBI chr20:13,074,695...13,104,095
Ensembl chr20:13,074,700...13,108,442
G
Gipc2
GIPC PDZ domain containing family, member 2
multiple interactions
EXP
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of GIPC2 protein
CTD
PMID:30545405
NCBI chr 2:241,030,764...241,110,236
Ensembl chr 2:241,030,770...241,110,236
G
Gjb1
gap junction protein, beta 1
increases expression
ISO
Vancomycin results in increased expression of GJB1 mRNA
CTD
PMID:18930951
NCBI chr X:66,501,848...66,509,783
Ensembl chr X:66,501,820...66,509,925
G
Gjb2
gap junction protein, beta 2
increases expression
ISO
Vancomycin results in increased expression of GJB2 mRNA
CTD
PMID:18930951
NCBI chr15:31,260,390...31,278,222
Ensembl chr15:31,260,357...31,278,177
G
Gk
glycerol kinase
increases expression
ISO
Vancomycin results in increased expression of GK mRNA
CTD
PMID:18930951
NCBI chr X:50,162,089...50,238,707
Ensembl chr X:50,163,123...50,238,631
G
Glul
glutamate-ammonia ligase
increases expression
ISO EXP
Vancomycin results in increased expression of GLUL mRNA
CTD
PMID:18289764 PMID:18930951
NCBI chr13:65,969,053...66,035,121
Ensembl chr13:66,025,630...66,035,108
G
Glyat
glycine-N-acyltransferase
increases expression
ISO
Vancomycin results in increased expression of GLYAT mRNA
CTD
PMID:18930951
NCBI chr 1:209,704,213...209,724,949
Ensembl chr 1:209,704,268...209,724,942
G
Gm2a
ganglioside GM2 activator
increases expression
ISO
Vancomycin results in increased expression of GM2A mRNA
CTD
PMID:18930951
NCBI chr10:39,219,221...39,231,756
Ensembl chr10:39,219,243...39,231,757
G
Gmds
GDP-mannose 4, 6-dehydratase
decreases expression
ISO
Vancomycin results in decreased expression of GMDS mRNA
CTD
PMID:18930951
NCBI chr17:32,095,315...32,621,975
Ensembl chr17:32,095,386...32,621,961
G
Gnai2
G protein subunit alpha i2
decreases expression
ISO
Vancomycin results in decreased expression of GNAI2 mRNA
CTD
PMID:18930951
NCBI chr 8:108,288,401...108,309,009
Ensembl chr 8:108,288,401...108,308,979
G
Gnb1
G protein subunit beta 1
decreases expression
ISO
Vancomycin results in decreased expression of GNB1 mRNA
CTD
PMID:18930951
NCBI chr 5:166,075,508...166,142,223
Ensembl chr 5:166,075,629...166,142,124
G
Gng10
G protein subunit gamma 10
decreases expression
ISO
Vancomycin results in decreased expression of GNG10 mRNA
CTD
PMID:18930951
NCBI chr 5:73,856,124...73,863,017
Ensembl chr 5:73,856,164...73,863,012 Ensembl chr 5:73,856,164...73,863,012
G
Gng12
G protein subunit gamma 12
multiple interactions
EXP
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of GNG12 protein
CTD
PMID:30545405
NCBI chr 4:96,011,118...96,134,767
Ensembl chr 4:96,010,952...96,134,712
G
Gnmt
glycine N-methyltransferase
increases expression
ISO
Vancomycin results in increased expression of GNMT mRNA
CTD
PMID:18930951
NCBI chr 9:14,254,675...14,258,028
Ensembl chr 9:14,254,675...14,258,434
G
Golm1
golgi membrane protein 1
decreases expression
ISO
Vancomycin results in decreased expression of GOLM1 mRNA
CTD
PMID:18930951
NCBI chr17:4,995,925...5,044,329
Ensembl chr17:4,996,104...5,034,057
G
Gpc3
glypican 3
decreases expression
ISO
Vancomycin results in decreased expression of GPC3 mRNA
CTD
PMID:18930951
NCBI chr X:131,868,986...132,236,824
Ensembl chr X:131,868,990...132,236,798
G
Gpd1
glycerol-3-phosphate dehydrogenase 1
increases expression
ISO
Vancomycin results in increased expression of GPD1 mRNA
CTD
PMID:18930951
NCBI chr 7:130,842,526...130,851,530
Ensembl chr 7:130,844,138...130,851,529
G
Gpm6a
glycoprotein m6a
increases expression
ISO
Vancomycin results in increased expression of GPM6A mRNA
CTD
PMID:18930951
NCBI chr16:36,641,282...36,973,377
Ensembl chr16:36,641,284...36,973,475
G
Gpm6b
glycoprotein m6b
decreases expression
ISO
Vancomycin results in decreased expression of GPM6B mRNA
CTD
PMID:18930951
NCBI chr X:28,057,788...28,204,409
Ensembl chr X:28,059,450...28,204,211
G
Gpsm3
G-protein signaling modulator 3
decreases expression
ISO
Vancomycin results in decreased expression of GPSM3 mRNA
CTD
PMID:18930951
NCBI chr20:4,157,123...4,158,984
Ensembl chr20:4,157,123...4,159,035
G
Gpt
glutamic--pyruvic transaminase
increases expression multiple interactions
ISO
Vancomycin results in increased expression of GPT mRNA [Sodium Selenite results in increased abundance of Selenium] inhibits the reaction [[Vancomycin co-treated with Neomycin co-treated with Ampicillin co-treated with Metronidazole co-treated with Amphotericin B] results in increased activity of GPT protein]; [Vancomycin co-treated with Neomycin co-treated with Ampicillin co-treated with Metronidazole co-treated with Amphotericin B] results in increased activity of GPT protein; [Vancomycin co-treated with Neomycin co-treated with Metronidazole] inhibits the reaction [elemicin results in increased activity of GPT protein]
CTD
PMID:18930951 PMID:34979169 PMID:36464106
NCBI chr 7:108,416,646...108,419,495
Ensembl chr 7:108,416,642...108,419,494
G
Gpx1
glutathione peroxidase 1
multiple interactions
EXP
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in decreased expression of GPX1 protein
CTD
PMID:30545405
NCBI chr 8:109,026,905...109,028,031
Ensembl chr 8:109,026,905...109,028,024
G
Gpx6
glutathione peroxidase 6
increases expression
ISO
Vancomycin results in increased expression of GPX6 mRNA
CTD
PMID:18930951
NCBI chr17:43,408,472...43,416,091
Ensembl chr17:43,408,472...43,416,091
G
Grn
granulin precursor
decreases expression
ISO
Vancomycin results in decreased expression of GRN mRNA
CTD
PMID:18930951
NCBI chr10:87,387,672...87,393,777
Ensembl chr10:87,387,638...87,393,775
G
Gsta2
glutathione S-transferase alpha 2
increases expression
ISO
Vancomycin results in increased expression of GSTA2 mRNA
CTD
PMID:18930951
NCBI chr 8:79,184,535...79,196,827
Ensembl chr 8:79,184,322...79,196,798
G
Gsta3
glutathione S-transferase alpha 3
multiple interactions
EXP
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in decreased expression of GSTA3 mRNA
CTD
PMID:30545405
NCBI chr 9:23,658,574...23,684,240
Ensembl chr 9:23,658,574...23,684,240
G
Gstk1
glutathione S-transferase kappa 1
increases expression
ISO
Vancomycin results in increased expression of GSTK1 mRNA
CTD
PMID:18930951
NCBI chr 4:71,118,979...71,123,298
Ensembl chr 4:71,118,896...71,123,292
G
Gstm2
glutathione S-transferase mu 2
multiple interactions
EXP
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in decreased expression of GSTM2 mRNA
CTD
PMID:30545405
NCBI chr 2:195,624,015...195,628,774
Ensembl chr 2:195,544,426...195,628,961
G
Gstz1
glutathione S-transferase zeta 1
increases expression
ISO
Vancomycin results in increased expression of GSTZ1 mRNA
CTD
PMID:18930951
NCBI chr 6:106,794,594...106,805,284
Ensembl chr 6:106,794,074...106,805,284
G
Gucy1a1
guanylate cyclase 1 soluble subunit alpha 1
decreases expression
ISO
Vancomycin results in decreased expression of GUCY1A1 mRNA
CTD
PMID:18930951
NCBI chr 2:167,418,615...167,482,293
Ensembl chr 2:167,418,640...167,481,671
G
Gusb
glucuronidase, beta
decreases expression
ISO
Vancomycin results in decreased expression of GUSB mRNA
CTD
PMID:18930951
NCBI chr12:26,701,188...26,714,718
Ensembl chr12:26,697,951...26,726,905
G
Gys2
glycogen synthase 2
increases expression
ISO
Vancomycin results in increased expression of GYS2 mRNA
CTD
PMID:18930951
NCBI chr 4:175,365,054...175,406,228
Ensembl chr 4:175,365,054...175,406,228
G
H2ax
H2A.X variant histone
decreases expression
ISO
Vancomycin results in decreased expression of H2AX mRNA
CTD
PMID:18930951
NCBI chr 8:44,671,907...44,673,262
Ensembl chr 8:44,671,786...44,673,239
G
H6pd
hexose-6-phosphate dehydrogenase (glucose 1-dehydrogenase)
decreases expression
ISO
Vancomycin results in decreased expression of H6PD mRNA
CTD
PMID:18930951
NCBI chr 5:160,434,499...160,470,203
Ensembl chr 5:160,438,697...160,470,171
G
Haao
3-hydroxyanthranilate 3,4-dioxygenase
increases expression
ISO
Vancomycin results in increased expression of HAAO mRNA
CTD
PMID:18930951
NCBI chr 6:10,845,235...10,864,863
Ensembl chr 6:10,845,771...10,864,877
G
Hao2
hydroxyacid oxidase 2
increases expression
ISO
Vancomycin results in increased expression of HAO2 mRNA
CTD
PMID:18930951
NCBI chr 2:186,200,137...186,232,997
Ensembl chr 2:186,200,504...186,224,425
G
Havcr1
hepatitis A virus cellular receptor 1
decreases expression increases expression multiple interactions
ISO EXP
Vancomycin results in decreased expression of HAVCR1 mRNA Vancomycin results in increased expression of HAVCR1 mRNA JBP 485 inhibits the reaction [Vancomycin results in increased expression of HAVCR1 mRNA]
CTD
PMID:18289764 PMID:18930951 PMID:29964132
NCBI chr10:31,118,667...31,151,730
Ensembl chr10:31,119,088...31,151,698
G
Herpud1
homocysteine inducible ER protein with ubiquitin like domain 1
increases expression
ISO
Vancomycin results in increased expression of HERPUD1 mRNA
CTD
PMID:18930951
NCBI chr19:10,598,411...10,609,002
Ensembl chr19:10,598,417...10,618,424
G
Hexb
hexosaminidase subunit beta
multiple interactions
EXP
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in decreased expression of HEXB protein
CTD
PMID:30545405
NCBI chr 2:28,483,997...28,504,165
Ensembl chr 2:28,484,012...28,504,223
G
Hgd
homogentisate 1, 2-dioxygenase
increases expression
ISO
Vancomycin results in increased expression of HGD mRNA
CTD
PMID:18930951
NCBI chr11:63,086,750...63,138,325
Ensembl chr11:63,086,752...63,138,323
G
Hibadh
3-hydroxyisobutyrate dehydrogenase
increases expression
ISO
Vancomycin results in increased expression of HIBADH mRNA
CTD
PMID:18930951
NCBI chr 4:81,649,180...81,747,244
Ensembl chr 4:81,649,175...81,780,617
G
Hist1h4b
histone cluster 1 H4 family member B
increases expression
ISO
Vancomycin results in increased expression of H4C9 mRNA
CTD
PMID:18930951
NCBI chr17:42,480,467...42,484,912
Ensembl chr17:42,480,313...42,485,370
G
Hlf
HLF transcription factor, PAR bZIP family member
increases expression
ISO
Vancomycin results in increased expression of HLF mRNA
CTD
PMID:18930951
NCBI chr10:75,154,244...75,211,884
Ensembl chr10:75,154,507...75,211,935
G
Hmga1
high mobility group AT-hook 1
decreases expression
ISO
Vancomycin results in decreased expression of HMGA1 mRNA
CTD
PMID:18930951
NCBI chr20:5,611,088...5,618,755
Ensembl chr20:5,611,694...5,618,752
G
Hmgb2
high mobility group box 2
decreases expression
ISO
Vancomycin results in decreased expression of HMGB2 mRNA
CTD
PMID:18930951
NCBI chr16:32,710,651...32,713,230
Ensembl chr16:32,710,658...32,713,140
G
Hmgcr
3-hydroxy-3-methylglutaryl-CoA reductase
multiple interactions
ISO
[Sodium Selenite results in increased abundance of Selenium] inhibits the reaction [[Vancomycin co-treated with Neomycin co-treated with Ampicillin co-treated with Metronidazole co-treated with Amphotericin B] results in increased expression of HMGCR mRNA]; [Vancomycin co-treated with Neomycin co-treated with Ampicillin co-treated with Metronidazole co-treated with Amphotericin B] results in increased expression of HMGCR mRNA
CTD
PMID:36464106
NCBI chr 2:27,997,523...28,018,983
Ensembl chr 2:27,997,525...28,019,703
G
Hmox1
heme oxygenase 1
decreases expression increases expression multiple interactions
ISO EXP
Vancomycin results in decreased expression of HMOX1 mRNA Vancomycin results in increased expression of HMOX1 mRNA [Vancomycin co-treated with Neomycin co-treated with Metronidazole] promotes the reaction [Zinc Oxide analog results in increased expression of HMOX1 protein]
CTD
PMID:18289764 PMID:18930951 PMID:36535435
NCBI chr19:13,466,287...13,474,082
Ensembl chr19:13,467,244...13,474,079
G
Hnf4a
hepatocyte nuclear factor 4, alpha
increases expression
ISO
Vancomycin results in increased expression of HNF4A mRNA
CTD
PMID:18930951
NCBI chr 3:152,186,787...152,248,320
Ensembl chr 3:152,186,787...152,248,320
G
Hnmt
histamine N-methyltransferase
increases expression
ISO
Vancomycin results in increased expression of HNMT mRNA
CTD
PMID:18930951
NCBI chr 3:6,591,804...6,623,821
Ensembl chr 3:6,591,463...6,624,012
G
Hnrnpa1
heterogeneous nuclear ribonucleoprotein A1
decreases expression
ISO
Vancomycin results in decreased expression of HNRNPA1 mRNA
CTD
PMID:18930951
NCBI chr 7:134,375,318...134,381,610
Ensembl chr 7:134,375,150...134,381,609
G
Hnrnph2
heterogeneous nuclear ribonucleoprotein H2
multiple interactions
EXP
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of HNRNPH2 protein
CTD
PMID:30545405
NCBI chr X:97,780,890...97,786,846
Ensembl chr X:97,780,785...97,787,041
G
Hp
haptoglobin
multiple interactions
EXP
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of HP protein
CTD
PMID:30545405
NCBI chr19:37,539,626...37,544,178
Ensembl chr19:37,539,627...37,544,523
G
Hpd
4-hydroxyphenylpyruvate dioxygenase
increases expression
ISO
Vancomycin results in increased expression of HPD mRNA
CTD
PMID:18930951
NCBI chr12:33,381,397...33,392,750
Ensembl chr12:33,381,231...33,392,766
G
Hpgd
15-hydroxyprostaglandin dehydrogenase
increases expression
ISO
Vancomycin results in increased expression of HPGD mRNA
CTD
PMID:18930951
NCBI chr16:33,986,265...34,024,228
Ensembl chr16:33,986,266...34,024,228
G
Hsd17b14
hydroxysteroid (17-beta) dehydrogenase 14
increases expression
ISO
Vancomycin results in increased expression of HSD17B14 mRNA
CTD
PMID:18930951
NCBI chr 1:96,029,224...96,039,577
Ensembl chr 1:96,029,284...96,039,883
G
Hsd3b3
hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 3
increases expression
ISO
Vancomycin results in increased expression of HSD3B3 mRNA
CTD
PMID:18930951
NCBI chr 2:186,138,044...186,144,024
Ensembl chr 2:186,138,044...186,144,033
G
Hspb1
heat shock protein family B (small) member 1
decreases expression
ISO
Vancomycin results in decreased expression of HSPB1 mRNA
CTD
PMID:18930951
NCBI chr12:20,794,014...20,795,675
Ensembl chr12:20,794,028...20,795,743
G
Htr4
5-hydroxytryptamine receptor 4
multiple interactions
ISO
[Vancomycin co-treated with Neomycin co-treated with Metronidazole] promotes the reaction [Zinc Oxide results in increased expression of HTR4 mRNA]; [Vancomycin co-treated with Neomycin co-treated with Metronidazole] results in increased expression of HTR4 mRNA
CTD
PMID:36535435
NCBI chr18:55,765,981...55,949,921
Ensembl chr18:55,766,725...55,949,321
G
Icam1
intercellular adhesion molecule 1
decreases expression
ISO
Vancomycin results in decreased expression of ICAM1 mRNA
CTD
PMID:18930951
NCBI chr 8:19,553,063...19,565,438
Ensembl chr 8:19,553,645...19,565,438
G
Id4
inhibitor of DNA binding 4
increases expression
ISO
Vancomycin results in increased expression of ID4 mRNA
CTD
PMID:18930951
NCBI chr17:16,389,387...16,391,956
Ensembl chr17:16,389,387...16,392,470
G
Ier5
immediate early response 5
decreases expression
ISO
Vancomycin results in decreased expression of IER5 mRNA
CTD
PMID:18930951
NCBI chr13:67,270,134...67,272,226
Ensembl chr13:67,270,135...67,272,227
G
Ifi27
interferon, alpha-inducible protein 27
decreases expression
ISO
Vancomycin results in decreased expression of IFI27 mRNA
CTD
PMID:18930951
NCBI chr 6:122,590,461...122,596,996
Ensembl chr 6:122,590,472...122,779,294
G
Ifi35
interferon-induced protein 35
decreases expression
ISO
Vancomycin results in decreased expression of IFI35 mRNA
CTD
PMID:18930951
NCBI chr10:86,381,023...86,389,279
Ensembl chr10:86,381,010...86,389,952
G
Ifi44
interferon-induced protein 44
decreases expression
ISO
Vancomycin results in decreased expression of IFI44 mRNA
CTD
PMID:18930951
NCBI chr 2:240,626,058...240,643,879
Ensembl chr 2:240,626,066...240,643,844
G
Ifi44l
interferon-induced protein 44-like
decreases expression
ISO
Vancomycin results in decreased expression of IFI44L mRNA
CTD
PMID:18930951
NCBI chr 2:240,668,742...240,706,425
Ensembl chr 2:240,668,713...240,706,359
G
Ifih1
interferon induced with helicase C domain 1
decreases expression
ISO
Vancomycin results in decreased expression of IFIH1 mRNA
CTD
PMID:18930951
NCBI chr 3:47,228,980...47,275,403
Ensembl chr 3:47,227,364...47,275,456
G
Ifit2
interferon-induced protein with tetratricopeptide repeats 2
decreases expression
ISO
Vancomycin results in decreased expression of IFIT2 mRNA
CTD
PMID:18930951
NCBI chr 1:232,102,570...232,108,638
Ensembl chr 1:232,102,570...232,108,635
G
Ifit3
interferon-induced protein with tetratricopeptide repeats 3
decreases expression
ISO
Vancomycin results in decreased expression of IFIT3 mRNA
CTD
PMID:18930951
NCBI chr 1:232,114,166...232,119,311
Ensembl chr 1:232,114,166...232,119,307
G
Ifitm1
interferon induced transmembrane protein 1
decreases expression
ISO
Vancomycin results in decreased expression of IFITM1 mRNA
CTD
PMID:18930951
NCBI chr 1:196,067,163...196,069,169
Ensembl chr 1:196,067,963...196,069,169
G
Ifitm3
interferon induced transmembrane protein 3
decreases expression
ISO
Vancomycin results in decreased expression of IFITM3 mRNA
CTD
PMID:18930951
NCBI chr 1:196,111,026...196,112,135
Ensembl chr 1:196,111,043...196,112,203
G
Ifng
interferon gamma
multiple interactions
ISO
[Gentamicins co-treated with Vancomycin co-treated with Cefoxitin co-treated with Metronidazole] inhibits the reaction [Fluorides results in increased expression of IFNG mRNA]
CTD
PMID:37269894
NCBI chr 7:53,903,339...53,907,375
Ensembl chr 7:53,903,337...53,907,375
G
Ifngr1
interferon gamma receptor 1
decreases expression
ISO
Vancomycin results in decreased expression of IFNGR1 mRNA
CTD
PMID:18930951
NCBI chr 1:14,333,167...14,351,799
Ensembl chr 1:14,333,187...14,351,785
G
Igfbp1
insulin-like growth factor binding protein 1
affects expression increases expression
EXP ISO
Vancomycin affects the expression of IGFBP1 mRNA Vancomycin results in increased expression of IGFBP1 mRNA
CTD
PMID:18289764 PMID:18930951
NCBI chr14:82,047,415...82,052,482
Ensembl chr14:82,047,415...82,052,482
G
Igfbp5
insulin-like growth factor binding protein 5
increases expression
ISO
Vancomycin results in increased expression of IGFBP5 mRNA
CTD
PMID:18930951
NCBI chr 9:74,452,371...74,464,953
Ensembl chr 9:74,448,382...74,465,156
G
Igkc
immunoglobulin kappa constant
affects expression
EXP
Vancomycin affects the expression of IGKC mRNA
CTD
PMID:18289764
G
Igsf11
immunoglobulin superfamily, member 11
increases expression
ISO
Vancomycin results in increased expression of IGSF11 mRNA
CTD
PMID:18930951
NCBI chr11:61,733,139...61,884,059
Ensembl chr11:61,733,144...61,868,348
G
Igsf8
immunoglobulin superfamily, member 8
decreases expression
ISO
Vancomycin results in decreased expression of IGSF8 mRNA
CTD
PMID:18930951
NCBI chr13:84,770,348...84,781,534
Ensembl chr13:84,770,279...84,778,576
G
Ikbkb
inhibitor of nuclear factor kappa B kinase subunit beta
multiple interactions
ISO
[Gentamicins co-treated with Vancomycin co-treated with Cefoxitin co-treated with Metronidazole] inhibits the reaction [Fluorides results in increased expression of IKBKB mRNA]
CTD
PMID:37269894
NCBI chr16:69,319,487...69,373,251
Ensembl chr16:69,319,554...69,373,250
G
Il10
interleukin 10
multiple interactions
ISO
Vancomycin promotes the reaction [Lipopolysaccharides results in increased secretion of IL10 protein] [Gentamicins co-treated with Vancomycin co-treated with Cefoxitin co-treated with Metronidazole] inhibits the reaction [Fluorides results in increased expression of IL10 mRNA]
CTD
PMID:16939481 PMID:37269894
NCBI chr13:42,472,625...42,477,308
Ensembl chr13:42,472,839...42,477,313
G
Il18
interleukin 18
multiple interactions
ISO
[Neomycin co-treated with Metronidazole co-treated with Ampicillin co-treated with Vancomycin] inhibits the reaction [Methamphetamine results in increased secretion of IL18 protein]
CTD
PMID:35390362
NCBI chr 8:50,904,630...50,932,887
Ensembl chr 8:50,906,960...50,932,887
G
Il1b
interleukin 1 beta
multiple interactions
ISO
[Gentamicins co-treated with Vancomycin co-treated with Cefoxitin co-treated with Metronidazole] inhibits the reaction [Fluorides results in increased expression of IL1B mRNA]; [Neomycin co-treated with Metronidazole co-treated with Ampicillin co-treated with Vancomycin] inhibits the reaction [Methamphetamine results in increased expression of and results in increased secretion of IL1B protein]; [Neomycin co-treated with Metronidazole co-treated with Ampicillin co-treated with Vancomycin] inhibits the reaction [Methamphetamine results in increased expression of IL1B mRNA]; [Vancomycin co-treated with Neomycin co-treated with Cilastatin, Imipenem Drug Combination] inhibits the reaction [Doxorubicin results in increased expression of IL1B protein]; [Vancomycin co-treated with Neomycin co-treated with Cilastatin, Imipenem Drug Combination] inhibits the reaction [Nanotubes, Carbon promotes the reaction [Doxorubicin results in increased expression of IL1B protein]]
CTD
PMID:32068018 PMID:35390362 PMID:37269894
NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
G
Il6
interleukin 6
multiple interactions
ISO
[Ampicillin co-treated with Vancomycin co-treated with Neomycin co-treated with Metronidazole] inhibits the reaction [Dextran Sulfate results in increased expression of IL6 protein]; [Ampicillin co-treated with Vancomycin co-treated with Neomycin co-treated with Metronidazole] results in decreased expression of IL6 protein; [Gentamicins co-treated with Vancomycin co-treated with Cefoxitin co-treated with Metronidazole] inhibits the reaction [Fluorides results in increased expression of IL6 mRNA]; Dextran Sulfate inhibits the reaction [[Ampicillin co-treated with Vancomycin co-treated with Neomycin co-treated with Metronidazole] results in decreased expression of IL6 protein]
CTD
PMID:31442584 PMID:37269894
NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178
G
Il6st
interleukin 6 cytokine family signal transducer
decreases expression
ISO
Vancomycin results in decreased expression of IL6ST mRNA
CTD
PMID:18930951
NCBI chr 2:44,065,979...44,106,255
Ensembl chr 2:44,066,130...44,109,936
G
Inmt
indolethylamine N-methyltransferase
increases expression
ISO
Vancomycin results in increased expression of INMT mRNA
CTD
PMID:18930951
NCBI chr 4:84,318,197...84,322,493
Ensembl chr 4:84,318,197...84,322,493
G
Insig1
insulin induced gene 1
increases expression
ISO
Vancomycin results in increased expression of INSIG1 mRNA
CTD
PMID:18930951
NCBI chr 4:7,315,494...7,323,972
Ensembl chr 4:7,315,495...7,323,952
G
Insrr
insulin receptor-related receptor
increases expression
ISO
Vancomycin results in increased expression of INSRR mRNA
CTD
PMID:18930951
NCBI chr 2:173,255,335...173,274,800
Ensembl chr 2:173,255,414...173,274,800
G
Iqgap1
IQ motif containing GTPase activating protein 1
decreases expression
ISO
Vancomycin results in decreased expression of IQGAP1 mRNA
CTD
PMID:18930951
NCBI chr 1:134,679,581...134,769,776
Ensembl chr 1:134,679,586...134,769,755
G
Iqsec2
IQ motif and Sec7 domain ArfGEF 2
increases expression
ISO
Vancomycin results in increased expression of IQSEC2 mRNA
CTD
PMID:18930951
NCBI chr X:21,254,799...21,337,179
Ensembl chr X:21,254,914...21,336,584
G
Irf1
interferon regulatory factor 1
decreases expression
ISO
Vancomycin results in decreased expression of IRF1 mRNA
CTD
PMID:18930951
NCBI chr10:37,917,155...37,924,166
Ensembl chr10:37,916,670...37,924,166
G
Irf8
interferon regulatory factor 8
decreases expression
ISO
Vancomycin results in decreased expression of IRF8 mRNA
CTD
PMID:18930951
NCBI chr19:48,790,581...48,812,363
Ensembl chr19:48,790,588...48,811,829
G
Irf9
interferon regulatory factor 9
decreases expression
ISO
Vancomycin results in decreased expression of IRF9 mRNA
CTD
PMID:18930951
NCBI chr15:29,095,474...29,101,924
Ensembl chr15:29,095,789...29,101,236
G
Irgm
immunity-related GTPase M
decreases expression
ISO
Vancomycin results in decreased expression of IRGM mRNA
CTD
PMID:18930951
NCBI chr10:33,233,513...33,241,594
Ensembl chr10:33,233,455...33,241,578
G
Irs1
insulin receptor substrate 1
increases expression
ISO
Vancomycin results in increased expression of IRS1 mRNA
CTD
PMID:18930951
NCBI chr 9:83,552,964...83,605,797
Ensembl chr 9:83,548,944...83,606,122
G
Itga3
integrin subunit alpha 3
decreases expression
ISO
Vancomycin results in decreased expression of ITGA3 mRNA
CTD
PMID:18930951
NCBI chr10:79,990,160...80,022,206
Ensembl chr10:79,990,161...80,022,118
G
Itgb1
integrin subunit beta 1
decreases expression
ISO
Vancomycin results in decreased expression of ITGB1 mRNA
CTD
PMID:18930951
NCBI chr19:56,705,123...56,753,199
Ensembl chr19:56,705,171...56,753,195
G
Itpr2
inositol 1,4,5-trisphosphate receptor, type 2
increases expression
ISO
Vancomycin results in increased expression of ITPR2 mRNA
CTD
PMID:18930951
NCBI chr 4:179,028,594...179,434,657
Ensembl chr 4:179,027,281...179,404,164
G
Ivd
isovaleryl-CoA dehydrogenase
increases expression
ISO
Vancomycin results in increased expression of IVD mRNA
CTD
PMID:18930951
NCBI chr 3:105,851,710...105,872,144
Ensembl chr 3:105,851,683...105,872,575
G
Jpt1
Jupiter microtubule associated homolog 1
decreases expression
ISO
Vancomycin results in decreased expression of JPT1 mRNA
CTD
PMID:18930951
NCBI chr10:100,744,468...100,762,504
Ensembl chr10:100,686,797...100,784,513
G
Jun
Jun proto-oncogene, AP-1 transcription factor subunit
affects expression
EXP
Vancomycin affects the expression of JUN mRNA
CTD
PMID:18289764
NCBI chr 5:109,894,175...109,897,268
Ensembl chr 5:109,893,145...109,897,656
G
Kank3
KN motif and ankyrin repeat domains 3
decreases expression
ISO
Vancomycin results in decreased expression of KANK3 mRNA
CTD
PMID:18930951
NCBI chr 7:14,594,358...14,607,675
Ensembl chr 7:14,594,422...14,607,675
G
Kbtbd11
kelch repeat and BTB domain containing 11
increases expression
ISO
Vancomycin results in increased expression of KBTBD11 mRNA
CTD
PMID:18930951
NCBI chr16:74,618,291...74,638,010
Ensembl chr16:74,615,792...74,637,736
G
Kcnip2
potassium voltage-gated channel interacting protein 2
increases expression
ISO
Vancomycin results in increased expression of KCNIP2 mRNA
CTD
PMID:18930951
NCBI chr 1:244,641,147...244,664,939
Ensembl chr 1:244,641,150...244,664,874
G
Kcnj1
potassium inwardly-rectifying channel, subfamily J, member 1
increases expression
ISO
Vancomycin results in increased expression of KCNJ1 mRNA
CTD
PMID:18930951
NCBI chr 8:30,779,883...30,808,607
Ensembl chr 8:30,753,617...30,813,796
G
Kcnj15
potassium inwardly-rectifying channel, subfamily J, member 15
increases expression
ISO
Vancomycin results in increased expression of KCNJ15 mRNA
CTD
PMID:18930951
NCBI chr11:34,577,397...34,621,725
Ensembl chr11:34,577,363...34,621,952
G
Kcnk1
potassium two pore domain channel subfamily K member 1
decreases expression
ISO
Vancomycin results in decreased expression of KCNK1 mRNA
CTD
PMID:18930951
NCBI chr19:53,959,411...53,997,726
Ensembl chr19:53,959,657...53,997,724
G
Kcnk5
potassium two pore domain channel subfamily K member 5
increases expression
ISO
Vancomycin results in increased expression of KCNK5 mRNA
CTD
PMID:18930951
NCBI chr15:4,122,442...4,164,718
Ensembl chr15:4,122,442...4,164,718
G
Kctd1
potassium channel tetramerization domain containing 1
decreases expression
ISO
Vancomycin results in decreased expression of KCTD1 mRNA
CTD
PMID:18930951
NCBI chr18:6,122,390...6,316,434
Ensembl chr18:6,122,390...6,317,393
G
Khk
ketohexokinase
increases expression
ISO
Vancomycin results in increased expression of KHK mRNA
CTD
PMID:18930951
NCBI chr 6:25,445,298...25,455,834
Ensembl chr 6:25,445,300...25,455,717
G
Kif21a
kinesin family member 21A
increases expression
ISO
Vancomycin results in increased expression of KIF21A mRNA
CTD
PMID:18930951
NCBI chr 7:122,062,523...122,179,051
Ensembl chr 7:122,062,537...122,178,999
G
Kif22
kinesin family member 22
decreases expression
ISO
Vancomycin results in decreased expression of KIF22 mRNA
CTD
PMID:18930951
NCBI chr 1:181,635,347...181,650,351
Ensembl chr 1:181,635,183...181,650,401
G
Kl
Klotho
increases expression
ISO
Vancomycin results in increased expression of KL mRNA
CTD
PMID:18930951
NCBI chr12:490,402...531,417
Ensembl chr12:490,399...530,080
G
Klf12
KLF transcription factor 12
increases expression
ISO
Vancomycin results in increased expression of KLF12 mRNA
CTD
PMID:18930951
NCBI chr15:76,628,778...77,062,000
Ensembl chr15:76,637,654...77,062,056
G
Klf15
KLF transcription factor 15
increases expression
ISO
Vancomycin results in increased expression of KLF15 mRNA
CTD
PMID:18930951
NCBI chr 4:122,965,718...122,978,403
Ensembl chr 4:122,965,807...122,978,374
G
Klf6
KLF transcription factor 6
decreases expression
ISO
Vancomycin results in decreased expression of KLF6 mRNA
CTD
PMID:18930951
NCBI chr17:64,539,456...64,548,451
Ensembl chr17:64,531,463...64,588,570
G
Klk1b3
kallikrein 1-related peptidase B3
decreases expression
EXP
Vancomycin results in decreased expression of NGFG mRNA
CTD
PMID:18289764
NCBI chr 1:94,709,105...94,713,308
Ensembl chr 1:94,709,105...94,713,308
G
Kmo
kynurenine 3-monooxygenase
increases expression
ISO
Vancomycin results in increased expression of KMO mRNA
CTD
PMID:18930951
NCBI chr13:87,557,080...87,589,334
Ensembl chr13:87,557,286...87,588,881
G
Kng2
kininogen 2
multiple interactions
EXP
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of MAP1 protein
CTD
PMID:30545405
NCBI chr11:77,913,876...77,936,247
Ensembl chr11:77,909,612...78,002,971
G
Kpna2
karyopherin subunit alpha 2
decreases expression
ISO
Vancomycin results in decreased expression of KPNA2 mRNA
CTD
PMID:18930951
NCBI chr10:91,933,951...91,946,115
Ensembl chr10:91,933,951...91,946,150
G
Kpnb1
karyopherin subunit beta 1
decreases expression
ISO
Vancomycin results in decreased expression of KPNB1 mRNA
CTD
PMID:18930951
NCBI chr10:82,145,662...82,174,437
Ensembl chr10:82,145,420...82,174,605
G
Krt16
keratin 16
multiple interactions
EXP
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of KRT16 protein
CTD
PMID:30545405
NCBI chr10:85,168,357...85,171,816
Ensembl chr10:85,066,802...85,171,799
G
Krt18
keratin 18
decreases expression
ISO
Vancomycin results in decreased expression of KRT18 mRNA
CTD
PMID:18930951
NCBI chr 7:133,157,486...133,161,162
Ensembl chr 7:133,157,475...133,161,166
G
Krt7
keratin 7
decreases expression
ISO
Vancomycin results in decreased expression of KRT7 mRNA
CTD
PMID:18930951
NCBI chr 7:132,528,881...132,545,052
Ensembl chr 7:132,528,895...132,545,052
G
Krt8
keratin 8
decreases expression
ISO
Vancomycin results in decreased expression of KRT8 mRNA
CTD
PMID:18930951
NCBI chr 7:133,124,203...133,131,656
Ensembl chr 7:133,124,203...133,131,728
G
Kyat3
kynurenine aminotransferase 3
increases expression
ISO
Vancomycin results in increased expression of KYAT3 mRNA
CTD
PMID:18930951
NCBI chr 2:231,701,881...231,747,462
Ensembl chr 2:231,701,963...231,747,227
G
Kynu
kynureninase
increases expression
ISO
Vancomycin results in increased expression of KYNU mRNA
CTD
PMID:18930951
NCBI chr 3:27,778,646...27,929,470
Ensembl chr 3:27,778,772...27,929,488
G
L2hgdh
L-2-hydroxyglutarate dehydrogenase
increases expression
ISO
Vancomycin results in increased expression of L2HGDH mRNA
CTD
PMID:18930951
NCBI chr 6:88,164,429...88,205,585
Ensembl chr 6:88,164,440...88,205,578
G
Lactb2
lactamase, beta 2
increases expression
ISO
Vancomycin results in increased expression of LACTB2 mRNA
CTD
PMID:18930951
NCBI chr 5:5,569,080...5,591,843
Ensembl chr 5:5,569,067...5,596,429
G
Lamc2
laminin subunit gamma 2
decreases expression
ISO
Vancomycin results in decreased expression of LAMC2 mRNA
CTD
PMID:18930951
NCBI chr13:65,284,664...65,344,164
Ensembl chr13:65,284,664...65,344,200
G
Laptm5
lysosomal protein transmembrane 5
decreases expression
ISO
Vancomycin results in decreased expression of LAPTM5 mRNA
CTD
PMID:18930951
NCBI chr 5:143,087,759...143,109,807
Ensembl chr 5:143,087,759...143,109,807
G
Lcn2
lipocalin 2
increases expression
EXP
Vancomycin results in increased expression of LCN2 mRNA
CTD
PMID:18289764
NCBI chr 3:15,680,688...15,684,033
Ensembl chr 3:15,680,687...15,684,095
G
Lcp1
lymphocyte cytosolic protein 1
decreases expression
ISO
Vancomycin results in decreased expression of LCP1 mRNA
CTD
PMID:18930951
NCBI chr15:50,443,300...50,544,682
Ensembl chr15:50,488,149...50,544,680
G
Ldlr
low density lipoprotein receptor
multiple interactions
ISO
[Sodium Selenite results in increased abundance of Selenium] inhibits the reaction [[Vancomycin co-treated with Neomycin co-treated with Ampicillin co-treated with Metronidazole co-treated with Amphotericin B] results in increased expression of LDLR mRNA]; [Vancomycin co-treated with Neomycin co-treated with Ampicillin co-treated with Metronidazole co-treated with Amphotericin B] results in increased expression of LDLR mRNA
CTD
PMID:36464106
NCBI chr 8:20,270,020...20,292,981
Ensembl chr 8:20,270,041...20,294,580
G
Lep
leptin
multiple interactions
ISO
[Vancomycin co-treated with Neomycin co-treated with Metronidazole co-treated with elemicin] results in increased expression of LEP mRNA
CTD
PMID:34979169
NCBI chr 4:57,661,127...57,675,262
Ensembl chr 4:57,661,131...57,675,262
G
Lgals1
galectin 1
decreases expression
ISO
Vancomycin results in decreased expression of LGALS1 mRNA
CTD
PMID:18930951
NCBI chr 7:110,485,239...110,488,345
Ensembl chr 7:110,481,392...110,488,345
G
Lgals3
galectin 3
decreases expression
ISO
Vancomycin results in decreased expression of LGALS3 mRNA
CTD
PMID:18930951
NCBI chr15:20,620,083...20,632,019
Ensembl chr15:20,607,692...20,632,025
G
Lgals3bp
galectin 3 binding protein
decreases expression
ISO
Vancomycin results in decreased expression of LGALS3BP mRNA
CTD
PMID:18930951
NCBI chr10:103,619,912...103,629,251
Ensembl chr10:103,619,908...103,629,256
G
Lgals9
galectin 9
decreases expression
ISO
Vancomycin results in decreased expression of LGALS9 mRNA
CTD
PMID:18930951
NCBI chr10:63,907,018...63,930,224
Ensembl chr10:63,907,018...63,930,045
G
Lhfpl2
LHFPL tetraspan subfamily member 2
decreases expression
ISO
Vancomycin results in decreased expression of LHFPL2 mRNA
CTD
PMID:18930951
NCBI chr 2:25,281,771...25,428,128
Ensembl chr 2:25,281,901...25,427,950
G
Lhfpl6
LHFPL tetraspan subfamily member 6
decreases expression
ISO
Vancomycin results in decreased expression of LHFPL6 mRNA
CTD
PMID:18930951
NCBI chr 2:137,126,485...137,324,442
Ensembl chr 2:137,126,509...137,324,443
G
Lhx1
LIM homeobox 1
increases expression
ISO
Vancomycin results in increased expression of LHX1 mRNA
CTD
PMID:18930951
NCBI chr10:69,396,829...69,403,617
Ensembl chr10:69,396,829...69,403,617
G
Lin7a
lin-7 homolog A, crumbs cell polarity complex component
increases expression
ISO
Vancomycin results in increased expression of LIN7A mRNA
CTD
PMID:18930951
NCBI chr 7:42,586,704...42,742,609
Ensembl chr 7:42,586,719...42,730,550
G
Litaf
lipopolysaccharide-induced TNF factor
decreases expression
ISO
Vancomycin results in decreased expression of LITAF mRNA
CTD
PMID:18930951
NCBI chr10:4,656,308...4,692,981
Ensembl chr10:4,625,552...4,692,763
G
Lmna
lamin A/C
decreases expression
ISO
Vancomycin results in decreased expression of LMNA mRNA
CTD
PMID:18930951
NCBI chr 2:173,939,751...173,960,423
Ensembl chr 2:173,939,751...173,960,423
G
Lmo7
LIM domain 7
decreases expression
ISO
Vancomycin results in decreased expression of LMO7 mRNA
CTD
PMID:18930951
NCBI chr15:78,566,999...78,769,833
Ensembl chr15:78,567,023...78,769,783
G
Loxl1
lysyl oxidase-like 1
decreases expression
ISO
Vancomycin results in decreased expression of LOXL1 mRNA
CTD
PMID:18930951
NCBI chr 8:58,691,763...58,716,365
Ensembl chr 8:58,692,593...58,716,356
G
Lpar3
lysophosphatidic acid receptor 3
increases expression
ISO
Vancomycin results in increased expression of LPAR3 mRNA
CTD
PMID:18930951
NCBI chr 2:235,125,234...235,193,916
Ensembl chr 2:235,149,065...235,193,357
G
Lpin1
lipin 1
increases expression multiple interactions
ISO
Vancomycin results in increased expression of LPIN1 mRNA [Sodium Selenite results in increased abundance of Selenium] inhibits the reaction [[Vancomycin co-treated with Neomycin co-treated with Ampicillin co-treated with Metronidazole co-treated with Amphotericin B] results in increased expression of LPIN1 mRNA]; [Vancomycin co-treated with Neomycin co-treated with Ampicillin co-treated with Metronidazole co-treated with Amphotericin B] results in increased expression of LPIN1 mRNA
CTD
PMID:18930951 PMID:36464106
NCBI chr 6:39,309,198...39,417,034
Ensembl chr 6:39,312,748...39,417,097
G
Lpl
lipoprotein lipase
increases expression
ISO
Vancomycin results in increased expression of LPL mRNA
CTD
PMID:18930951
NCBI chr16:20,830,055...20,853,855
Ensembl chr16:20,829,465...20,855,249
G
Lrpap1
LDL receptor related protein associated protein 1
increases expression
ISO
Vancomycin results in increased expression of LRPAP1 mRNA
CTD
PMID:18930951
NCBI chr14:75,651,371...75,663,380
Ensembl chr14:75,651,376...75,665,414
G
Lrrc19
leucine rich repeat containing 19
increases expression
ISO
Vancomycin results in increased expression of LRRC19 mRNA
CTD
PMID:18930951
NCBI chr 5:109,494,891...109,507,948
Ensembl chr 5:109,497,121...109,507,938
G
Ly6e
lymphocyte antigen 6 family member E
decreases expression
ISO
Vancomycin results in decreased expression of LY6E mRNA
CTD
PMID:18930951
NCBI chr 7:106,935,530...106,939,689
Ensembl chr 7:106,935,761...106,939,689
G
Lyn
LYN proto-oncogene, Src family tyrosine kinase
decreases expression
ISO
Vancomycin results in decreased expression of LYN mRNA
CTD
PMID:18930951
NCBI chr 5:16,639,512...16,755,501
Ensembl chr 5:16,639,466...16,756,868
G
Lyplal1
lysophospholipase-like 1
increases expression
ISO
Vancomycin results in increased expression of LYPLAL1 mRNA
CTD
PMID:18930951
NCBI chr13:97,626,568...97,657,901
Ensembl chr13:97,626,451...97,657,867
G
Lyz2
lysozyme 2
decreases expression multiple interactions
ISO EXP
Vancomycin results in decreased expression of LYZ2 mRNA [Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of LYZ2 protein
CTD
PMID:18930951 PMID:30545405
NCBI chr 7:52,906,810...52,912,154
Ensembl chr 7:52,906,811...52,912,106
G
Mad2l1
mitotic arrest deficient 2 like 1
decreases expression
ISO
Vancomycin results in decreased expression of MAD2L1 mRNA
CTD
PMID:18930951
NCBI chr 4:95,906,692...95,918,885
Ensembl chr 4:95,906,817...95,913,470
G
Mad2l2
mitotic arrest deficient 2 like 2
decreases expression
ISO
Vancomycin results in decreased expression of MAD2L2 mRNA
CTD
PMID:18930951
NCBI chr 5:158,563,545...158,576,698
Ensembl chr 5:158,563,567...158,576,693
G
Mal2
mal, T-cell differentiation protein 2
decreases expression
ISO
Vancomycin results in decreased expression of MAL2 mRNA
CTD
PMID:18930951
NCBI chr 7:85,900,453...85,933,433
Ensembl chr 7:85,900,453...85,933,429
G
Map7
microtubule-associated protein 7
increases expression
ISO
Vancomycin results in increased expression of MAP7 mRNA
CTD
PMID:18930951
NCBI chr 1:14,910,433...15,037,574
Ensembl chr 1:14,910,551...15,037,574
G
Map7d1
MAP7 domain containing 1
decreases expression
ISO
Vancomycin results in decreased expression of MAP7D1 mRNA
CTD
PMID:18930951
NCBI chr 5:138,527,944...138,552,537
Ensembl chr 5:138,527,401...138,552,499
G
Mapk13
mitogen activated protein kinase 13
decreases expression
ISO
Vancomycin results in decreased expression of MAPK13 mRNA
CTD
PMID:18930951
NCBI chr20:6,835,277...6,845,500
Ensembl chr20:6,835,320...6,844,222
G
Mapk3
mitogen activated protein kinase 3
multiple interactions
EXP
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of MAPK3 protein
CTD
PMID:30545405
NCBI chr 1:181,366,646...181,372,863
Ensembl chr 1:181,366,637...181,372,863
G
Mapk4
mitogen-activated protein kinase 4
decreases expression
ISO
Vancomycin results in decreased expression of MAPK4 mRNA
CTD
PMID:18930951
NCBI chr18:67,512,805...67,661,271
Ensembl chr18:67,512,807...67,661,842
G
Mapt
microtubule-associated protein tau
increases expression
ISO
Vancomycin results in increased expression of MAPT mRNA
CTD
PMID:18930951
NCBI chr10:89,138,644...89,236,137
Ensembl chr10:89,138,627...89,236,129
G
Marchf10
membrane associated ring-CH-type finger 10
increases expression
ISO
Vancomycin results in increased expression of MARCHF10 mRNA
CTD
PMID:18930951
NCBI chr10:90,332,783...90,423,109
Ensembl chr10:90,332,784...90,421,588
G
Marcks
myristoylated alanine rich protein kinase C substrate
decreases expression
ISO
Vancomycin results in decreased expression of MARCKS mRNA
CTD
PMID:18930951
NCBI chr20:40,685,315...40,691,012
Ensembl chr20:40,685,315...40,691,012
G
Marcksl1
MARCKS-like 1
decreases expression
ISO
Vancomycin results in decreased expression of MARCKSL1 mRNA
CTD
PMID:18930951
NCBI chr 5:141,851,491...141,853,814
Ensembl chr 5:141,850,110...141,853,817
G
Mast4
microtubule associated serine/threonine kinase family member 4
decreases expression
ISO
Vancomycin results in decreased expression of MAST4 mRNA
CTD
PMID:18930951
NCBI chr 2:33,893,241...34,483,682
Ensembl chr 2:33,894,436...34,483,723
G
Mccc1
methylcrotonyl-CoA carboxylase subunit 1
increases expression
ISO
Vancomycin results in increased expression of MCCC1 mRNA
CTD
PMID:18930951
NCBI chr 2:118,799,147...118,851,181
Ensembl chr 2:118,799,150...118,851,222
G
Mccc2
methylcrotonyl-CoA carboxylase subunit 2
increases expression
ISO
Vancomycin results in increased expression of MCCC2 mRNA
CTD
PMID:18930951
NCBI chr 2:31,304,927...31,375,978
Ensembl chr 2:31,304,932...31,375,972
G
Mcm4
minichromosome maintenance complex component 4
decreases expression
ISO
Vancomycin results in decreased expression of MCM4 mRNA
CTD
PMID:18930951
NCBI chr11:85,258,443...85,272,144
Ensembl chr11:85,258,443...85,272,144
G
Mcm5
minichromosome maintenance complex component 5
decreases expression
ISO
Vancomycin results in decreased expression of MCM5 mRNA
CTD
PMID:18930951
NCBI chr19:13,483,030...13,504,389
Ensembl chr19:13,483,066...13,504,389
G
Mcm7
minichromosome maintenance complex component 7
decreases expression
ISO
Vancomycin results in decreased expression of MCM7 mRNA
CTD
PMID:18930951
NCBI chr12:17,042,207...17,049,470
Ensembl chr12:17,042,212...17,050,063
G
Mdh1
malate dehydrogenase 1
increases expression
ISO
Vancomycin results in increased expression of MDH1 mRNA
CTD
PMID:18930951
NCBI chr14:95,630,625...95,645,920
Ensembl chr14:95,630,306...95,645,925
G
Mep1b
meprin A subunit beta
increases expression
ISO
Vancomycin results in increased expression of MEP1B mRNA
CTD
PMID:18930951
NCBI chr18:12,366,126...12,392,840
Ensembl chr18:12,365,289...12,392,840
G
Mfge8
milk fat globule EGF and factor V/VIII domain containing
decreases expression
ISO
Vancomycin results in decreased expression of MFGE8 mRNA
CTD
PMID:18930951
NCBI chr 1:133,064,665...133,080,069
Ensembl chr 1:133,064,665...133,080,073
G
Mfsd2a
MFSD2 lysolipid transporter A, lysophospholipid
increases expression
ISO
Vancomycin results in increased expression of MFSD2A mRNA
CTD
PMID:18930951
NCBI chr 5:135,225,801...135,240,744
Ensembl chr 5:135,225,816...135,240,690
G
Mgam
maltase-glucoamylase
increases expression
ISO
Vancomycin results in increased expression of MGAM mRNA
CTD
PMID:18930951
NCBI chr 4:69,441,626...69,602,068
Ensembl chr 4:69,446,150...69,692,715
G
Mgat3
beta-1,4-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase
increases expression
ISO
Vancomycin results in increased expression of MGAT3 mRNA
CTD
PMID:18930951
NCBI chr 7:111,708,353...111,761,825
Ensembl chr 7:111,675,730...111,762,026
G
Mgll
monoglyceride lipase
increases expression
ISO
Vancomycin results in increased expression of MGLL mRNA
CTD
PMID:18930951
NCBI chr 4:121,192,186...121,294,187
Ensembl chr 4:121,192,195...121,294,179
G
Mgp
matrix Gla protein
increases expression decreases expression
EXP ISO
Vancomycin results in increased expression of MGP mRNA Vancomycin results in decreased expression of MGP mRNA
CTD
PMID:18289764 PMID:18930951
NCBI chr 4:169,766,290...169,769,612
Ensembl chr 4:169,766,279...169,769,667
G
Miox
myo-inositol oxygenase
increases expression
ISO
Vancomycin results in increased expression of MIOX mRNA
CTD
PMID:18930951
NCBI chr 7:120,405,031...120,407,529
Ensembl chr 7:120,405,031...120,407,537
G
Mlxip
MLX interacting protein
multiple interactions
ISO
[Vancomycin co-treated with Neomycin co-treated with Metronidazole] inhibits the reaction [elemicin results in increased expression of MLXIP mRNA]
CTD
PMID:34979169
NCBI chr12:33,128,524...33,192,300
Ensembl chr12:33,128,520...33,192,374
G
Mmut
methylmalonyl-CoA mutase
increases expression
ISO
Vancomycin results in increased expression of MMUT mRNA
CTD
PMID:18930951
NCBI chr 9:19,928,720...19,956,985
Ensembl chr 9:19,928,727...19,957,046
G
Morf4l2
mortality factor 4 like 2
decreases expression
ISO
Vancomycin results in decreased expression of MORF4L2 mRNA
CTD
PMID:18930951
NCBI chr X:100,082,562...100,093,658
Ensembl chr X:100,082,404...100,093,728
G
Mpeg1
macrophage expressed 1
decreases expression
ISO
Vancomycin results in decreased expression of MPEG1 mRNA
CTD
PMID:18930951
NCBI chr 1:209,452,176...209,456,692
Ensembl chr 1:209,452,133...209,458,855
G
Mpv17l
MPV17 mitochondrial inner membrane protein like
increases expression
ISO
Vancomycin results in increased expression of MPV17L mRNA
CTD
PMID:18930951
NCBI chr10:1,988,451...2,025,300
Ensembl chr10:1,988,136...2,007,649
G
Mr1
major histocompatibility complex, class I-related
affects expression
ISO
Vancomycin affects the expression of MR1 mRNA
CTD
PMID:25811541
NCBI chr13:67,298,362...67,317,985
Ensembl chr13:67,299,585...67,317,970
G
Mrtfb
myocardin related transcription factor B
decreases expression
ISO
Vancomycin results in decreased expression of MRTFB mRNA
CTD
PMID:18930951
NCBI chr10:1,116,315...1,278,106
Ensembl chr10:1,116,310...1,277,897
G
Msn
moesin
decreases expression
ISO
Vancomycin results in decreased expression of MSN mRNA
CTD
PMID:18930951
NCBI chr X:60,996,043...61,064,011
Ensembl chr X:60,995,951...61,065,628
G
Mt1
metallothionein 1
increases expression
EXP
Vancomycin results in increased expression of MT1A mRNA
CTD
PMID:18289764
NCBI chr19:10,826,032...10,827,048
Ensembl chr19:10,826,032...10,827,049 Ensembl chr17:10,826,032...10,827,049
G
Mt2A
metallothionein 2A
decreases expression
ISO
Vancomycin results in decreased expression of MT2 mRNA
CTD
PMID:18930951
NCBI chr19:10,832,009...10,832,783
Ensembl chr19:10,832,002...10,832,784
G
Mthfd1
methylenetetrahydrofolate dehydrogenase, cyclohydrolase and formyltetrahydrofolate synthetase 1
increases expression
ISO
Vancomycin results in increased expression of MTHFD1 mRNA
CTD
PMID:18930951
NCBI chr 6:94,977,862...95,045,375
Ensembl chr 6:94,977,862...95,045,372
G
Mtor
mechanistic target of rapamycin kinase
increases expression
ISO
Vancomycin results in increased expression of MTOR mRNA
CTD
PMID:18930951
NCBI chr 5:158,884,856...158,994,311
Ensembl chr 5:158,884,804...158,994,311
G
Mttp
microsomal triglyceride transfer protein
increases expression
ISO
Vancomycin results in increased expression of MTTP mRNA
CTD
PMID:18930951
NCBI chr 2:226,613,090...226,654,239
Ensembl chr 2:226,613,090...226,654,239
G
Muc1
mucin 1, cell surface associated
decreases expression
ISO
Vancomycin results in decreased expression of MUC1 mRNA
CTD
PMID:18930951
NCBI chr 2:174,635,989...174,640,738
Ensembl chr 2:174,635,995...174,640,733
G
Mvp
major vault protein
decreases expression
ISO
Vancomycin results in decreased expression of MVP mRNA
CTD
PMID:18930951
NCBI chr 1:181,594,734...181,622,336
Ensembl chr 1:181,594,734...181,622,380
G
Myadm
myeloid-associated differentiation marker
decreases expression
ISO
Vancomycin results in decreased expression of MYADM mRNA
CTD
PMID:18930951
NCBI chr 1:65,864,180...65,874,701
Ensembl chr 1:65,864,173...65,874,035
G
Myd88
MYD88, innate immune signal transduction adaptor
decreases expression multiple interactions
ISO
Vancomycin results in decreased expression of MYD88 mRNA [Gentamicins co-treated with Vancomycin co-treated with Cefoxitin co-treated with Metronidazole] inhibits the reaction [Fluorides results in increased expression of MYD88 mRNA]; [Neomycin co-treated with Metronidazole co-treated with Ampicillin co-treated with Vancomycin] inhibits the reaction [Methamphetamine results in increased expression of MYD88 mRNA]; [Neomycin co-treated with Metronidazole co-treated with Ampicillin co-treated with Vancomycin] inhibits the reaction [Methamphetamine results in increased expression of MYD88 protein]
CTD
PMID:18930951 PMID:35390362 PMID:37269894
NCBI chr 8:119,074,439...119,078,508
Ensembl chr 8:119,074,437...119,079,415
G
Myef2
myelin expression factor 2
decreases expression
ISO
Vancomycin results in decreased expression of MYEF2 mRNA
CTD
PMID:18930951
NCBI chr 3:112,338,241...112,374,122
Ensembl chr 3:112,338,241...112,374,181
G
Myh14
myosin heavy chain 14
multiple interactions
EXP
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of MYH14 protein
CTD
PMID:30545405
NCBI chr 1:95,096,266...95,158,861
Ensembl chr 1:95,096,266...95,158,836
G
Myh9
myosin, heavy chain 9
decreases expression
ISO
Vancomycin results in decreased expression of MYH9 mRNA
CTD
PMID:18930951
NCBI chr 7:109,343,718...109,424,457
Ensembl chr 7:109,343,706...109,424,457
G
Nap1l5
nucleosome assembly protein 1-like 5
increases expression
ISO
Vancomycin results in increased expression of NAP1L5 mRNA
CTD
PMID:18930951
NCBI chr 4:88,022,670...88,024,988
Ensembl chr 4:88,022,569...88,024,654
G
Nasp
nuclear autoantigenic sperm protein
decreases expression
ISO
Vancomycin results in decreased expression of NASP mRNA
CTD
PMID:18930951
NCBI chr 5:130,057,363...130,083,003
Ensembl chr 5:130,057,363...130,082,928
G
Nat8
N-acetyltransferase 8
increases expression
ISO
Vancomycin results in increased expression of NAT8 mRNA
CTD
PMID:18930951
NCBI chr 4:118,279,521...118,284,671
Ensembl chr 4:118,270,954...118,281,763
G
Nat8f1
N-acetyltransferase 8 (GCN5-related) family member 1
increases expression
ISO
Vancomycin results in increased expression of NAT8F1 mRNA
CTD
PMID:18930951
NCBI chr 4:118,336,208...118,342,923
Ensembl chr 4:118,332,862...118,344,035
G
Nat8f3
N-acetyltransferase 8 (GCN5-related) family member 3
increases expression
ISO
Vancomycin results in increased expression of NAT8F3 mRNA
CTD
PMID:18930951
NCBI chr 4:118,241,792...118,246,010
Ensembl chr 4:118,239,304...118,285,500
G
Ndufa13
NADH:ubiquinone oxidoreductase subunit A13
multiple interactions
EXP
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of NDUFA13 protein
CTD
PMID:30545405
NCBI chr16:19,526,633...19,533,567
Ensembl chr16:19,526,565...19,535,726
G
Ndufab1
NADH:ubiquinone oxidoreductase subunit AB1
multiple interactions
EXP
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of NDUFAB1 protein
CTD
PMID:30545405
NCBI chr 1:176,644,696...176,658,131
Ensembl chr 1:176,644,703...176,658,099
G
Ndufs4
NADH:ubiquinone oxidoreductase subunit S4
increases expression
ISO
Vancomycin results in increased expression of NDUFS4 mRNA
CTD
PMID:18930951
NCBI chr 2:45,951,327...46,061,829
Ensembl chr 2:45,951,313...46,061,846
G
Nectin2
nectin cell adhesion molecule 2
decreases expression
ISO
Vancomycin results in decreased expression of NECTIN2 mRNA
CTD
PMID:18930951
NCBI chr 1:79,372,123...79,407,379
Ensembl chr 1:79,372,119...79,407,360
G
Nedd4
NEDD4 E3 ubiquitin protein ligase
decreases expression
ISO
Vancomycin results in decreased expression of NEDD4 mRNA
CTD
PMID:18930951
NCBI chr 8:73,384,095...73,468,951
Ensembl chr 8:73,383,695...73,468,951
G
Nfkb1
nuclear factor kappa B subunit 1
decreases expression
ISO
Vancomycin results in decreased expression of NFKB1 mRNA
CTD
PMID:18930951
NCBI chr 2:224,016,214...224,132,135
Ensembl chr 2:224,016,214...224,110,404
G
Nfkbie
NFKB inhibitor epsilon
decreases expression
ISO
Vancomycin results in decreased expression of NFKBIE mRNA
CTD
PMID:18930951
NCBI chr 9:15,443,600...15,450,437
Ensembl chr 9:15,436,941...15,450,437
G
Nfkbiz
NFKB inhibitor zeta
decreases expression
ISO
Vancomycin results in decreased expression of NFKBIZ mRNA
CTD
PMID:18930951
NCBI chr11:44,782,676...44,810,722
Ensembl chr11:44,782,676...44,810,723
G
Nherf4
NHERF family PDZ scaffold protein 4
increases expression
ISO
Vancomycin results in increased expression of NHERF4 mRNA
CTD
PMID:18930951
NCBI chr 8:44,584,390...44,588,838
Ensembl chr 8:44,584,390...44,588,860
G
Niban1
niban apoptosis regulator 1
decreases expression
ISO
Vancomycin results in decreased expression of NIBAN1 mRNA
CTD
PMID:18930951
NCBI chr13:63,674,240...63,827,748
Ensembl chr13:63,674,171...63,827,729
G
Nid1
nidogen 1
decreases expression
ISO
Vancomycin results in decreased expression of NID1 mRNA
CTD
PMID:18930951
NCBI chr17:86,085,133...86,158,272
Ensembl chr17:86,085,077...86,158,267
G
Nipsnap1
nipsnap homolog 1
increases expression
ISO
Vancomycin results in increased expression of NIPSNAP1 mRNA
CTD
PMID:18930951
NCBI chr14:79,734,234...79,758,101
Ensembl chr14:79,734,209...79,758,098
G
Nipsnap3b
nipsnap homolog 3B
decreases expression
ISO
Vancomycin results in decreased expression of NIPSNAP3A mRNA
CTD
PMID:18930951
NCBI chr 5:67,637,644...67,669,698
Ensembl chr 5:67,614,036...67,669,700
G
Nit2
nitrilase family, member 2
increases expression
ISO
Vancomycin results in increased expression of NIT2 mRNA
CTD
PMID:18930951
NCBI chr11:43,363,839...43,378,713
Ensembl chr11:43,363,985...43,375,024
G
Nlrp6
NLR family, pyrin domain containing 6
increases expression
ISO
Vancomycin results in increased expression of NLRP6 mRNA
CTD
PMID:18930951
NCBI chr 1:196,004,854...196,011,615
Ensembl chr 1:196,004,953...196,011,113
G
Nmi
N-myc (and STAT) interactor
decreases expression
ISO
Vancomycin results in decreased expression of NMI mRNA
CTD
PMID:18930951
NCBI chr 3:36,415,607...36,439,716
Ensembl chr 3:36,415,607...36,439,498
G
Nnt
nicotinamide nucleotide transhydrogenase
increases expression
ISO
Vancomycin results in increased expression of NNT mRNA
CTD
PMID:18930951
NCBI chr 2:51,411,413...51,505,125
Ensembl chr 2:51,411,413...51,504,823
G
Nos2
nitric oxide synthase 2
multiple interactions
ISO
[Vancomycin co-treated with Neomycin co-treated with Cilastatin, Imipenem Drug Combination] inhibits the reaction [Doxorubicin results in increased expression of NOS2 mRNA]; [Vancomycin co-treated with Neomycin co-treated with Cilastatin, Imipenem Drug Combination] inhibits the reaction [Nanotubes, Carbon promotes the reaction [Doxorubicin results in increased expression of NOS2 mRNA]]
CTD
PMID:32068018
NCBI chr10:63,815,308...63,851,208
Ensembl chr10:63,815,308...63,851,210
G
Nox4
NADPH oxidase 4
increases expression
ISO
Vancomycin results in increased expression of NOX4 mRNA
CTD
PMID:18930951
NCBI chr 1:140,900,886...141,078,844
Ensembl chr 1:140,901,097...141,077,406
G
Npc1l1
NPC1 like intracellular cholesterol transporter 1
multiple interactions
ISO
[Vancomycin co-treated with Imipenem] results in decreased expression of NPC1L1 mRNA
CTD
PMID:24657338
NCBI chr14:81,071,448...81,091,113
Ensembl chr14:81,071,451...81,091,113
G
Npc2
NPC intracellular cholesterol transporter 2
multiple interactions
EXP
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in decreased expression of NPC2 protein
CTD
PMID:30545405
NCBI chr 6:104,397,239...104,418,161
Ensembl chr 6:104,378,644...104,418,155
G
Npdc1
neural proliferation, differentiation and control, 1
decreases expression
ISO
Vancomycin results in decreased expression of NPDC1 mRNA
CTD
PMID:18930951
NCBI chr 3:8,220,446...8,226,446
Ensembl chr 3:8,213,663...8,226,866
G
Nphs2
NPHS2 stomatin family member, podocin
increases expression
ISO
Vancomycin results in increased expression of NPHS2 mRNA
CTD
PMID:18930951
NCBI chr13:68,448,720...68,461,312
Ensembl chr13:68,448,926...68,461,313
G
Npm1
nucleophosmin 1
decreases expression
ISO
Vancomycin results in decreased expression of NPM1 mRNA
CTD
PMID:18930951
NCBI chr10:17,741,512...17,751,626
Ensembl chr10:17,739,941...17,751,645
G
Npy
neuropeptide Y
increases expression
ISO
Vancomycin results in increased expression of NPY mRNA
CTD
PMID:18930951
NCBI chr 4:78,881,294...78,888,495
Ensembl chr 4:78,881,264...78,888,495
G
Nr0b2
nuclear receptor subfamily 0, group B, member 2
multiple interactions
ISO
[Vancomycin co-treated with Imipenem] results in increased expression of NR0B2 mRNA
CTD
PMID:24657338
NCBI chr 5:145,779,294...145,782,609
Ensembl chr 5:145,779,294...145,782,609
G
Nr1d1
nuclear receptor subfamily 1, group D, member 1
increases expression
ISO
Vancomycin results in increased expression of NR1D1 mRNA
CTD
PMID:18930951
NCBI chr10:83,728,348...83,735,562
Ensembl chr10:83,728,318...83,735,705
G
Nr5a2
nuclear receptor subfamily 5, group A, member 2
multiple interactions
ISO
[Vancomycin co-treated with Imipenem] results in increased expression of NR5A2 mRNA
CTD
PMID:24657338
NCBI chr13:48,313,634...48,433,494
Ensembl chr13:48,316,301...48,433,326
G
Nras
NRAS proto-oncogene, GTPase
decreases expression
ISO
Vancomycin results in decreased expression of NRAS mRNA
CTD
PMID:18930951
NCBI chr 2:190,582,885...190,593,509
Ensembl chr 2:190,582,918...190,591,626
G
Nucb2
nucleobindin 2
decreases expression
ISO
Vancomycin results in decreased expression of NUCB2 mRNA
CTD
PMID:18930951
NCBI chr 1:170,750,830...170,787,356
Ensembl chr 1:170,750,877...170,787,353
G
Nudcd1
NudC domain containing 1
decreases expression
ISO
Vancomycin results in decreased expression of NUDCD1 mRNA
CTD
PMID:18930951
NCBI chr 7:75,550,650...75,595,976
Ensembl chr 7:75,550,346...75,595,900
G
Nudt21
nudix hydrolase 21
decreases expression
ISO
Vancomycin results in decreased expression of NUDT21 mRNA
CTD
PMID:18930951
NCBI chr19:10,974,800...10,993,841
Ensembl chr19:10,974,241...10,991,682
G
Nup62
nucleoporin 62
decreases expression
ISO
Vancomycin results in decreased expression of NUP62 mRNA
CTD
PMID:18930951
NCBI chr 1:95,298,995...95,314,902
Ensembl chr 1:95,295,526...95,315,174
G
Nupr1
nuclear protein 1, transcriptional regulator
decreases expression
ISO
Vancomycin results in decreased expression of NUPR1 mRNA
CTD
PMID:18930951
NCBI chr 1:181,213,292...181,215,327
Ensembl chr 1:181,213,368...181,215,281
G
Oat
ornithine aminotransferase
decreases expression
EXP
Vancomycin results in decreased expression of OAT mRNA
CTD
PMID:18289764
NCBI chr 1:187,347,862...187,367,644
Ensembl chr 1:187,347,865...187,367,682
G
Ocln
occludin
multiple interactions
ISO
[Neomycin co-treated with Metronidazole co-treated with Ampicillin co-treated with Vancomycin] inhibits the reaction [Methamphetamine results in decreased expression of OCLN mRNA]; [Neomycin co-treated with Metronidazole co-treated with Ampicillin co-treated with Vancomycin] inhibits the reaction [Methamphetamine results in decreased expression of OCLN protein]
CTD
PMID:35390362
NCBI chr 2:31,657,217...31,707,466
Ensembl chr 2:31,657,220...31,764,150
G
Olfm3
olfactomedin 3
increases expression
ISO
Vancomycin results in increased expression of OLFM3 mRNA
CTD
PMID:18930951
NCBI chr 2:202,729,610...202,952,120
Ensembl chr 2:202,729,936...202,952,112
G
Olfml3
olfactomedin-like 3
decreases expression
ISO
Vancomycin results in decreased expression of OLFML3 mRNA
CTD
PMID:18930951
NCBI chr 2:191,244,221...191,247,050
Ensembl chr 2:191,244,221...191,247,050
G
Osbpl1a
oxysterol binding protein-like 1A
increases expression
ISO
Vancomycin results in increased expression of OSBPL1A mRNA
CTD
PMID:18930951
NCBI chr18:3,904,006...4,094,635
Ensembl chr18:3,904,006...4,094,585
G
Osmr
oncostatin M receptor
decreases expression
ISO
Vancomycin results in decreased expression of OSMR mRNA
CTD
PMID:18930951
NCBI chr 2:55,907,119...55,961,373
Ensembl chr 2:55,907,132...55,961,262
G
Ostf1
osteoclast stimulating factor 1
decreases expression
ISO
Vancomycin results in decreased expression of OSTF1 mRNA
CTD
PMID:18930951
NCBI chr 1:216,002,037...216,049,226
Ensembl chr 1:216,002,044...216,049,221
G
Oxct1
3-oxoacid CoA transferase 1
increases expression
ISO
Vancomycin results in increased expression of OXCT1 mRNA
CTD
PMID:18930951
NCBI chr 2:53,236,370...53,384,715
Ensembl chr 2:53,236,368...53,384,714
G
P3h2
prolyl 3-hydroxylase 2
increases expression
ISO
Vancomycin results in increased expression of P3H2 mRNA
CTD
PMID:18930951
NCBI chr11:74,634,267...74,775,422
Ensembl chr11:74,634,267...74,775,421
G
P4ha2
prolyl 4-hydroxylase subunit alpha 2
decreases expression
ISO
Vancomycin results in decreased expression of P4HA2 mRNA
CTD
PMID:18930951
NCBI chr10:38,243,136...38,271,983
Ensembl chr10:38,243,139...38,287,314
G
Pafah1b3
platelet-activating factor acetylhydrolase 1b, catalytic subunit 3
decreases expression
ISO
Vancomycin results in decreased expression of PAFAH1B3 mRNA
CTD
PMID:18930951
NCBI chr 1:80,881,263...80,883,789
Ensembl chr 1:80,881,309...80,883,893
G
Pah
phenylalanine hydroxylase
increases expression
ISO
Vancomycin results in increased expression of PAH mRNA
CTD
PMID:18930951
NCBI chr 7:21,933,179...21,998,134
Ensembl chr 7:21,933,179...21,998,130
G
Pank1
pantothenate kinase 1
increases expression
ISO
Vancomycin results in increased expression of PANK1 mRNA
CTD
PMID:18930951
NCBI chr 1:232,324,718...232,395,445
Ensembl chr 1:232,328,430...232,396,829
G
Papss2
3'-phosphoadenosine 5'-phosphosulfate synthase 2
increases expression
ISO
Vancomycin results in increased expression of PAPSS2 mRNA
CTD
PMID:18930951
NCBI chr 1:230,454,314...230,539,332
Ensembl chr 1:230,454,426...230,539,331
G
Parp1
poly (ADP-ribose) polymerase 1
multiple interactions increases expression
EXP
1,5-dihydroxyisoquinoline inhibits the reaction [Vancomycin results in increased expression of PARP1 protein]
CTD
PMID:19833176
NCBI chr13:92,307,593...92,339,406
Ensembl chr13:92,307,586...92,339,404
G
Parp12
poly (ADP-ribose) polymerase family, member 12
decreases expression
ISO
Vancomycin results in decreased expression of PARP12 mRNA
CTD
PMID:18930951
NCBI chr 4:67,826,548...67,885,356
Ensembl chr 4:67,839,237...67,883,685
G
Parp14
poly (ADP-ribose) polymerase family, member 14
decreases expression
ISO
Vancomycin results in decreased expression of PARP14 mRNA
CTD
PMID:18930951
NCBI chr11:64,902,848...64,934,916
Ensembl chr11:64,902,785...64,934,916
G
Parp3
poly (ADP-ribose) polymerase family, member 3
decreases expression
ISO
Vancomycin results in decreased expression of PARP3 mRNA
CTD
PMID:18930951
NCBI chr 8:107,111,010...107,117,073
Ensembl chr 8:107,111,012...107,116,782
G
Parp8
poly (ADP-ribose) polymerase family, member 8
decreases expression
ISO
Vancomycin results in decreased expression of PARP8 mRNA
CTD
PMID:18930951
NCBI chr 2:48,679,405...48,848,700
Ensembl chr 2:48,679,436...48,849,253
G
Parp9
poly (ADP-ribose) polymerase family, member 9
decreases expression
ISO
Vancomycin results in decreased expression of PARP9 mRNA
CTD
PMID:18930951
NCBI chr11:64,780,977...64,814,995
Ensembl chr11:64,780,981...64,815,455
G
Pc
pyruvate carboxylase
increases expression
ISO
Vancomycin results in increased expression of PCX mRNA
CTD
PMID:18930951
NCBI chr 1:201,799,374...201,898,412
Ensembl chr 1:201,804,267...201,898,380
G
Pcbd1
pterin-4 alpha-carbinolamine dehydratase 1
increases expression
ISO
Vancomycin results in increased expression of PCBD1 mRNA
CTD
PMID:18930951
NCBI chr20:29,037,545...29,044,322
Ensembl chr20:28,953,864...29,044,292 Ensembl chr20:28,953,864...29,044,292
G
Pcca
propionyl-CoA carboxylase subunit alpha
increases expression
ISO
Vancomycin results in increased expression of PCCA mRNA
CTD
PMID:18930951
NCBI chr15:99,627,955...99,969,555
Ensembl chr15:99,627,982...99,968,266
G
Pck1
phosphoenolpyruvate carboxykinase 1
increases expression
ISO
Vancomycin results in increased expression of PCK1 mRNA
CTD
PMID:18930951
NCBI chr 3:161,930,256...161,936,205
Ensembl chr 3:161,930,256...161,936,191
G
Pcna
proliferating cell nuclear antigen
decreases expression
ISO
Vancomycin results in decreased expression of PCNA mRNA
CTD
PMID:18930951
NCBI chr 3:119,499,039...119,502,911
Ensembl chr 3:119,498,810...119,502,995
G
Pcolce
procollagen C-endopeptidase enhancer
decreases expression
ISO
Vancomycin results in decreased expression of PCOLCE mRNA
CTD
PMID:18930951
NCBI chr12:19,084,191...19,090,508
Ensembl chr12:19,084,210...19,090,508
G
Pcsk6
proprotein convertase subtilisin/kexin type 6
increases expression
ISO
Vancomycin results in increased expression of PCSK6 mRNA
CTD
PMID:18930951
NCBI chr 1:119,428,978...119,627,626
Ensembl chr 1:119,429,265...119,627,596
G
Pcyt2
phosphate cytidylyltransferase 2, ethanolamine
increases expression
ISO
Vancomycin results in increased expression of PCYT2 mRNA
CTD
PMID:18930951
NCBI chr10:105,888,769...105,896,182
Ensembl chr10:105,888,775...105,896,172
G
Pde1a
phosphodiesterase 1A
increases expression
ISO
Vancomycin results in increased expression of PDE1A mRNA
CTD
PMID:18930951
NCBI chr 3:64,745,140...65,025,178
Ensembl chr 3:64,747,269...65,024,874
G
Pde9a
phosphodiesterase 9A
increases expression
ISO
Vancomycin results in increased expression of PDE9A mRNA
CTD
PMID:18930951
NCBI chr20:9,469,809...9,562,949
Ensembl chr20:9,469,848...9,562,948
G
Pdgfa
platelet derived growth factor subunit A
decreases expression
ISO
Vancomycin results in decreased expression of PDGFA mRNA
CTD
PMID:18930951
NCBI chr12:15,645,549...15,667,056
Ensembl chr12:15,645,541...15,666,497
G
Pdgfb
platelet derived growth factor subunit B
decreases expression
ISO
Vancomycin results in decreased expression of PDGFB mRNA
CTD
PMID:18930951
NCBI chr 7:111,539,444...111,557,984
Ensembl chr 7:111,540,345...111,557,984
G
Pdgfrb
platelet derived growth factor receptor beta
decreases expression
ISO
Vancomycin results in decreased expression of PDGFRB mRNA
CTD
PMID:18930951
NCBI chr18:54,499,962...54,538,840
Ensembl chr18:54,499,964...54,538,843
G
Pdhb
pyruvate dehydrogenase E1 subunit beta
increases expression
ISO
Vancomycin results in increased expression of PDHB mRNA
CTD
PMID:18930951
NCBI chr15:16,752,561...16,758,503
Ensembl chr15:16,750,980...16,758,500
G
Pdk2
pyruvate dehydrogenase kinase 2
increases expression
ISO
Vancomycin results in increased expression of PDK2 mRNA
CTD
PMID:18930951
NCBI chr10:79,972,550...79,987,074
Ensembl chr10:79,972,556...79,987,085
G
Pdk4
pyruvate dehydrogenase kinase 4
decreases expression
ISO
Vancomycin results in decreased expression of PDK4 mRNA
CTD
PMID:18930951
NCBI chr 4:33,591,796...33,601,798
Ensembl chr 4:33,589,799...33,601,850
G
Pdlim1
PDZ and LIM domain 1
decreases expression
ISO
Vancomycin results in decreased expression of PDLIM1 mRNA
CTD
PMID:18930951
NCBI chr 1:239,042,372...239,091,074
Ensembl chr 1:239,042,385...239,091,076
G
Pdpn
podoplanin
decreases expression
ISO
Vancomycin results in decreased expression of PDPN mRNA
CTD
PMID:18930951
NCBI chr 5:155,601,691...155,635,656
Ensembl chr 5:155,601,691...155,635,656
G
Pdxkl1
pyridoxal kinase like 1
multiple interactions
EXP
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in decreased expression of PDXK protein
CTD
PMID:30545405
NCBI chr20:10,162,934...10,192,572
Ensembl chr20:10,164,099...10,192,739
G
Pdzd2
PDZ domain containing 2
increases expression
ISO
Vancomycin results in increased expression of PDZD2 mRNA
CTD
PMID:18930951
NCBI chr 2:61,384,614...61,770,516
Ensembl chr 2:61,386,381...61,770,524
G
Pea15
proliferation and apoptosis adaptor protein 15
decreases expression
ISO
Vancomycin results in decreased expression of PEA15 mRNA
CTD
PMID:18930951
NCBI chr13:84,657,815...84,667,437
Ensembl chr13:84,654,870...84,667,499
G
Pecr
peroxisomal trans-2-enoyl-CoA reductase
increases expression
ISO
Vancomycin results in increased expression of PECR mRNA
CTD
PMID:18930951
NCBI chr 9:73,897,877...73,926,511
Ensembl chr 9:73,897,880...73,926,511
G
Pfkm
phosphofructokinase, muscle
increases expression
ISO
Vancomycin results in increased expression of PFKM mRNA
CTD
PMID:18930951
NCBI chr 7:129,221,679...129,259,192
Ensembl chr 7:129,221,653...129,259,192
G
Pfn1
profilin 1
decreases expression multiple interactions
ISO EXP
Vancomycin results in decreased expression of PFN1 mRNA [Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of PFN1 protein
CTD
PMID:18930951 PMID:30545405
NCBI chr10:55,365,263...55,367,968
Ensembl chr10:55,365,262...55,527,631
G
Pfn3
profilin 3
increases expression
ISO
Vancomycin results in increased expression of PFN3 mRNA
CTD
PMID:18930951
NCBI chr17:9,217,595...9,218,122
G
Pgam1
phosphoglycerate mutase 1
multiple interactions
EXP
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of PGAM1 protein
CTD
PMID:30545405
NCBI chr 1:240,723,832...240,731,443
Ensembl chr 1:240,723,920...240,738,452
G
Pgam2
phosphoglycerate mutase 2
increases expression
ISO
Vancomycin results in increased expression of PGAM2 mRNA
CTD
PMID:18930951
NCBI chr14:80,681,796...80,683,907
Ensembl chr14:80,681,776...80,683,940
G
Pgap6
post-GPI attachment to proteins 6
increases expression
ISO
Vancomycin results in increased expression of PGAP6 mRNA
CTD
PMID:18930951
NCBI chr10:15,138,918...15,148,431
Ensembl chr10:15,138,959...15,148,431
G
Pgd
phosphogluconate dehydrogenase
decreases expression
ISO
Vancomycin results in decreased expression of PGD mRNA
CTD
PMID:18930951
NCBI chr 5:159,582,746...159,598,945
Ensembl chr 5:159,561,271...159,742,778
G
Pgm1
phosphoglucomutase 1
decreases expression
ISO
Vancomycin results in decreased expression of PGM1 mRNA
CTD
PMID:18930951
NCBI chr 5:114,595,298...114,654,728
Ensembl chr 5:114,595,293...114,654,728
G
Pim3
Pim-3 proto-oncogene, serine/threonine kinase
increases expression
ISO
Vancomycin results in increased expression of PIM3 mRNA
CTD
PMID:18930951
NCBI chr 7:119,953,377...119,956,587
Ensembl chr 7:119,953,175...119,956,587
G
Pink1
PTEN induced kinase 1
increases expression
ISO
Vancomycin results in increased expression of PINK1 mRNA
CTD
PMID:18930951
NCBI chr 5:150,530,523...150,542,635
Ensembl chr 5:150,530,523...150,542,635
G
Pip4k2a
phosphatidylinositol-5-phosphate 4-kinase type 2 alpha
decreases expression
ISO
Vancomycin results in decreased expression of PIP4K2A mRNA
CTD
PMID:18930951
NCBI chr17:81,496,669...81,668,180
Ensembl chr17:81,496,670...81,668,029
G
Pla2g4a
phospholipase A2 group 4A
decreases expression
ISO
Vancomycin results in decreased expression of PLA2G4A mRNA
CTD
PMID:18930951
NCBI chr13:61,877,818...62,022,261
Ensembl chr13:61,877,813...62,022,266
G
Pla2g7
phospholipase A2 group VII
decreases expression
ISO
Vancomycin results in decreased expression of PLA2G7 mRNA
CTD
PMID:18930951
NCBI chr 9:17,362,214...17,404,476
Ensembl chr 9:17,362,225...17,404,476
G
Plac8
placenta associated 8
decreases expression
ISO
Vancomycin results in decreased expression of PLAC8 mRNA
CTD
PMID:18930951
NCBI chr14:9,052,601...9,074,264
Ensembl chr14:9,063,048...9,074,264
G
Plec
plectin
decreases expression
ISO
Vancomycin results in decreased expression of PLEC mRNA
CTD
PMID:18930951
NCBI chr 7:107,887,764...107,949,100
Ensembl chr 7:107,887,764...107,945,467
G
Plekha7
pleckstrin homology domain containing A7
increases expression
ISO
Vancomycin results in increased expression of PLEKHA7 mRNA
CTD
PMID:18930951
NCBI chr 1:170,364,524...170,547,843
Ensembl chr 1:170,365,135...170,547,775
G
Plekhg2
pleckstrin homology and RhoGEF domain containing G2
decreases expression
ISO
Vancomycin results in decreased expression of PLEKHG2 mRNA
CTD
PMID:18930951
NCBI chr 1:83,651,902...83,665,063
Ensembl chr 1:83,647,748...83,665,063
G
Plin2
perilipin 2
decreases expression
ISO
Vancomycin results in decreased expression of PLIN2 mRNA
CTD
PMID:18930951
NCBI chr 5:101,156,648...101,211,738
Ensembl chr 5:101,154,411...101,242,319
G
Plp2
proteolipid protein 2
decreases expression
ISO
Vancomycin results in decreased expression of PLP2 mRNA
CTD
PMID:18930951
NCBI chr X:14,834,249...14,837,648
Ensembl chr X:14,834,231...14,838,514
G
Plscr1
phospholipid scramblase 1
decreases expression
ISO
Vancomycin results in decreased expression of PLSCR1 mRNA
CTD
PMID:18930951
NCBI chr 8:92,784,279...92,804,698
Ensembl chr 8:92,784,356...92,804,692
G
Plscr3
phospholipid scramblase 3
decreases expression
ISO
Vancomycin results in decreased expression of PLSCR3 mRNA
CTD
PMID:18930951
NCBI chr10:54,566,556...54,573,240
Ensembl chr10:54,566,873...54,578,709
G
Pmaip1
phorbol-12-myristate-13-acetate-induced protein 1
decreases expression
ISO
Vancomycin results in decreased expression of PMAIP1 mRNA
CTD
PMID:18930951
NCBI chr18:59,986,020...59,992,434
Ensembl chr18:59,986,017...59,992,429
G
Pmepa1
prostate transmembrane protein, androgen induced 1
decreases expression
ISO
Vancomycin results in decreased expression of PMEPA1 mRNA
CTD
PMID:18930951
NCBI chr 3:162,011,884...162,060,343
Ensembl chr 3:162,012,751...162,060,454
G
Pmm2
phosphomannomutase 2
multiple interactions
EXP
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of PMM2 protein
CTD
PMID:30545405
NCBI chr10:6,961,521...6,982,913
Ensembl chr10:6,961,709...6,983,098
G
Pold1
DNA polymerase delta 1, catalytic subunit
decreases expression
ISO
Vancomycin results in decreased expression of POLD1 mRNA
CTD
PMID:18930951
NCBI chr 1:95,025,462...95,041,559
Ensembl chr 1:95,025,499...95,036,465
G
Polr3e
RNA polymerase III subunit E
increases expression
ISO
Vancomycin results in increased expression of POLR3E mRNA
CTD
PMID:18930951
NCBI chr 1:175,466,091...175,494,679
Ensembl chr 1:175,466,127...175,494,667
G
Pon1
paraoxonase 1
decreases activity multiple interactions
EXP
Vancomycin results in decreased activity of PON1 protein zingerone affects the reaction [Vancomycin results in decreased activity of PON1 protein]
CTD
PMID:31454121
NCBI chr 4:33,294,737...33,325,759
Ensembl chr 4:33,294,722...33,321,360
G
Ppara
peroxisome proliferator activated receptor alpha
increases expression
ISO
Vancomycin results in increased expression of PPARA mRNA
CTD
PMID:18930951
NCBI chr 7:116,832,405...116,900,878
Ensembl chr 7:116,832,756...116,895,346
G
Ppargc1a
PPARG coactivator 1 alpha
increases expression
ISO
Vancomycin results in increased expression of PPARGC1A mRNA
CTD
PMID:18930951
NCBI chr14:58,860,752...59,516,525
Ensembl chr14:58,861,144...59,512,656
G
Ppm1m
protein phosphatase, Mg2+/Mn2+ dependent, 1M
decreases expression
ISO
Vancomycin results in decreased expression of PPM1M mRNA
CTD
PMID:18930951
NCBI chr 8:106,836,221...106,843,472
Ensembl chr 8:106,837,037...106,842,057
G
Ppp1ca
protein phosphatase 1 catalytic subunit alpha
multiple interactions
EXP
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of PPP1CA protein
CTD
PMID:30545405
NCBI chr 1:201,485,117...201,488,734
Ensembl chr 1:201,485,085...201,497,327
G
Ppp1cb
protein phosphatase 1 catalytic subunit beta
multiple interactions
EXP
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of PPP1CB protein
CTD
PMID:30545405
NCBI chr 6:23,958,813...23,992,841
Ensembl chr 6:23,960,998...23,992,824
G
Ppp1cc
protein phosphatase 1 catalytic subunit gamma
multiple interactions
EXP
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of PPP1CC protein
CTD
PMID:30545405
NCBI chr12:34,383,072...34,400,553
Ensembl chr12:34,383,072...34,400,553
G
Ppp1r14b
protein phosphatase 1, regulatory (inhibitor) subunit 14B
decreases expression
ISO
Vancomycin results in decreased expression of PPP1R14B mRNA
CTD
PMID:18930951
NCBI chr 1:204,165,210...204,167,320
Ensembl chr 1:204,163,299...204,167,319
G
Ppp1r16b
protein phosphatase 1, regulatory subunit 16B
increases expression
ISO
Vancomycin results in increased expression of PPP1R16B mRNA
CTD
PMID:18930951
NCBI chr 3:147,323,652...147,419,658
Ensembl chr 3:147,324,126...147,418,937
G
Ppp1r1a
protein phosphatase 1, regulatory (inhibitor) subunit 1A
increases expression
ISO
Vancomycin results in increased expression of PPP1R1A mRNA
CTD
PMID:18930951
NCBI chr 7:134,654,578...134,662,236
Ensembl chr 7:134,654,579...134,662,230
G
Ppp1r1b
protein phosphatase 1, regulatory (inhibitor) subunit 1B
increases expression
ISO
Vancomycin results in increased expression of PPP1R1B mRNA
CTD
PMID:18930951
NCBI chr10:83,347,731...83,356,775
Ensembl chr10:83,347,731...83,356,775
G
Pprc1
PPARG related coactivator 1
decreases expression
ISO
Vancomycin results in decreased expression of PPRC1 mRNA
CTD
PMID:18930951
NCBI chr 1:244,901,985...244,918,587
Ensembl chr 1:244,902,179...244,918,587
G
Prkaa2
protein kinase AMP-activated catalytic subunit alpha 2
increases expression
ISO
Vancomycin results in increased expression of PRKAA2 mRNA
CTD
PMID:18930951
NCBI chr 5:119,807,992...119,879,987
Ensembl chr 5:119,813,226...119,879,543
G
Prkcz
protein kinase C, zeta
increases expression
ISO
Vancomycin results in increased expression of PRKCZ mRNA
CTD
PMID:18930951
NCBI chr 5:165,817,786...165,930,386
Ensembl chr 5:165,819,466...165,930,367
G
Prlr
prolactin receptor
increases expression
ISO
Vancomycin results in increased expression of PRLR mRNA
CTD
PMID:18930951
NCBI chr 2:59,134,147...59,324,719
Ensembl chr 2:59,134,588...59,324,718
G
Prmt2
protein arginine methyltransferase 2
decreases expression
ISO
Vancomycin results in decreased expression of PRMT2 mRNA
CTD
PMID:18930951
NCBI chr20:12,394,748...12,420,643
Ensembl chr20:12,394,798...12,420,643
G
Prodh
proline dehydrogenase
increases expression
ISO
Vancomycin results in increased expression of PRODH mRNA
CTD
PMID:18930951
NCBI chr11:82,910,043...82,927,305
Ensembl chr11:82,910,137...82,927,305
G
Prodh2
proline dehydrogenase 2
increases expression
ISO
Vancomycin results in increased expression of PRODH2 mRNA
CTD
PMID:18930951
NCBI chr 1:85,753,558...85,767,165
Ensembl chr 1:85,753,644...85,767,162
G
Pros1
protein S
decreases expression
ISO
Vancomycin results in decreased expression of PROS1 mRNA
CTD
PMID:18930951
NCBI chr11:230,597...311,288
Ensembl chr11:230,696...311,286
G
Prss12
serine protease 12
increases expression
ISO
Vancomycin results in increased expression of PRSS12 mRNA
CTD
PMID:18930951
NCBI chr 2:211,624,134...211,684,126
Ensembl chr 2:211,624,134...211,684,126
G
Prss23
serine protease 23
decreases expression
ISO
Vancomycin results in decreased expression of PRSS23 mRNA
CTD
PMID:18930951
NCBI chr 1:143,402,725...143,422,182
Ensembl chr 1:143,401,396...143,422,091
G
Psma3
proteasome 20S subunit alpha 3
multiple interactions
EXP
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in decreased expression of PSMA3 protein
CTD
PMID:30545405
NCBI chr 6:89,483,741...89,503,775
Ensembl chr 6:89,483,727...89,504,965
G
Psmb10
proteasome 20S subunit beta 10
decreases expression
ISO
Vancomycin results in decreased expression of PSMB10 mRNA
CTD
PMID:18930951
NCBI chr19:33,830,958...33,833,442
Ensembl chr19:33,827,229...33,833,626
G
Psmb8
proteasome 20S subunit beta 8
decreases expression
ISO
Vancomycin results in decreased expression of PSMB8 mRNA
CTD
PMID:18930951
NCBI chr20:4,652,159...4,655,122
Ensembl chr20:4,652,159...4,655,283
G
Psmb9
proteasome 20S subunit beta 9
decreases expression
ISO
Vancomycin results in decreased expression of PSMB9 mRNA
CTD
PMID:18930951
NCBI chr20:4,667,044...4,672,512
Ensembl chr20:4,666,046...4,672,512
G
Psme1
proteasome activator subunit 1
decreases expression
ISO
Vancomycin results in decreased expression of PSME1 mRNA
CTD
PMID:18930951
NCBI chr15:29,069,012...29,071,888
Ensembl chr15:29,068,729...29,071,890
G
Psme2
proteasome activator subunit 2
decreases expression
ISO
Vancomycin results in decreased expression of PSME2 mRNA
CTD
PMID:18930951
NCBI chr15:29,078,495...29,082,794
Ensembl chr15:29,078,500...29,082,946
G
Ptgds
prostaglandin D2 synthase
decreases expression
ISO
Vancomycin results in decreased expression of PTGDS mRNA
CTD
PMID:18930951
NCBI chr 3:8,281,899...8,284,833
Ensembl chr 3:8,281,899...8,284,833
G
Ptger4
prostaglandin E receptor 4
decreases expression
ISO
Vancomycin results in decreased expression of PTGER4 mRNA
CTD
PMID:18930951
NCBI chr 2:54,330,563...54,347,451
Ensembl chr 2:54,335,424...54,346,670
G
Ptpn18
protein tyrosine phosphatase, non-receptor type 18
decreases expression
ISO
Vancomycin results in decreased expression of PTPN18 mRNA
CTD
PMID:18930951
NCBI chr 9:36,672,325...36,689,963
Ensembl chr 9:36,672,362...36,690,995
G
Ptpn22
protein tyrosine phosphatase, non-receptor type 22
decreases expression
ISO
Vancomycin results in decreased expression of PTPN22 mRNA
CTD
PMID:18930951
NCBI chr 2:191,366,761...191,414,782
Ensembl chr 2:191,366,808...191,414,779
G
Ptpn23
protein tyrosine phosphatase, non-receptor type 23
decreases expression
ISO
Vancomycin results in decreased expression of PTPN23 mRNA
CTD
PMID:18930951
NCBI chr 8:110,360,804...110,383,271
Ensembl chr 8:110,360,804...110,383,271
G
Ptprc
protein tyrosine phosphatase, receptor type, C
decreases expression
ISO
Vancomycin results in decreased expression of PTPRC mRNA
CTD
PMID:18930951
NCBI chr13:49,596,193...49,708,283
Ensembl chr13:49,596,193...49,708,692
G
Ptprd
protein tyrosine phosphatase, receptor type, D
increases expression
ISO
Vancomycin results in increased expression of PTPRD mRNA
CTD
PMID:18930951
NCBI chr 5:90,046,993...90,698,977 NCBI chr 5:91,122,354...91,641,754
Ensembl chr 5:90,048,966...92,369,396
G
Pttg1
PTTG1 regulator of sister chromatid separation, securin
decreases expression
ISO
Vancomycin results in decreased expression of PTTG1 mRNA
CTD
PMID:18930951
NCBI chr10:27,893,466...27,904,965
Ensembl chr10:27,893,689...27,904,837
G
Pvalb
parvalbumin
increases expression
ISO
Vancomycin results in increased expression of PVALB mRNA
CTD
PMID:18930951
NCBI chr 7:109,772,939...109,787,954
Ensembl chr 7:109,772,593...109,784,561
G
Pvr
PVR cell adhesion molecule
decreases expression
ISO
Vancomycin results in decreased expression of PVR mRNA
CTD
PMID:18930951
NCBI chr 1:79,561,294...79,576,700
Ensembl chr 1:79,546,879...79,576,715
G
Pxmp2
peroxisomal membrane protein 2
increases expression
ISO
Vancomycin results in increased expression of PXMP2 mRNA
CTD
PMID:18930951
NCBI chr12:46,394,051...46,404,561
Ensembl chr12:46,394,193...46,404,557
G
Pycard
PYD and CARD domain containing
decreases expression
ISO
Vancomycin results in decreased expression of PYCARD mRNA
CTD
PMID:18930951
NCBI chr 1:182,601,657...182,603,013
Ensembl chr 1:182,601,174...182,602,955
G
Qdpr
quinoid dihydropteridine reductase
increases expression
ISO
Vancomycin results in increased expression of QDPR mRNA
CTD
PMID:18930951
NCBI chr14:65,670,251...65,683,853
Ensembl chr14:65,670,131...65,683,854
G
Rab11fip4
RAB11 family interacting protein 4
increases expression
ISO
Vancomycin results in increased expression of RAB11FIP4 mRNA
CTD
PMID:18930951
NCBI chr10:64,550,109...64,658,123
Ensembl chr10:64,550,177...64,654,759
G
Rab13
RAB13, member RAS oncogene family
decreases expression
ISO
Vancomycin results in decreased expression of RAB13 mRNA
CTD
PMID:18930951
NCBI chr 2:175,674,894...175,680,043
Ensembl chr 2:175,675,005...175,680,036
G
Rab3ip
RAB3A interacting protein
increases expression
ISO
Vancomycin results in increased expression of RAB3IP mRNA
CTD
PMID:18930951
NCBI chr 7:52,531,461...52,575,295
Ensembl chr 7:52,532,401...52,561,043
G
Rab8b
RAB8B, member RAS oncogene family
decreases expression
ISO
Vancomycin results in decreased expression of RAB8B mRNA
CTD
PMID:18930951
NCBI chr 8:67,458,921...67,536,466
Ensembl chr 8:67,458,923...67,536,384
G
Ralb
RAS like proto-oncogene B
multiple interactions
EXP
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in decreased expression of RALB protein
CTD
PMID:30545405
NCBI chr13:30,588,036...30,624,199
Ensembl chr13:30,588,033...30,624,202
G
Ran
RAN, member RAS oncogene family
decreases expression multiple interactions
ISO EXP
Vancomycin results in decreased expression of RAN mRNA [Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of RAN protein
CTD
PMID:18930951 PMID:30545405
NCBI chr12:27,674,049...27,678,598
Ensembl chr12:27,674,050...27,678,276
G
Rap1b
RAP1B, member of RAS oncogene family
decreases expression
ISO
Vancomycin results in decreased expression of RAP1B mRNA
CTD
PMID:18930951
NCBI chr 7:53,423,039...53,456,349
Ensembl chr 7:53,423,130...53,456,370
G
Rap1gap
Rap1 GTPase-activating protein
increases expression
ISO
Vancomycin results in increased expression of RAP1GAP mRNA
CTD
PMID:18930951
NCBI chr 5:149,873,987...149,939,254
Ensembl chr 5:149,892,019...149,939,253
G
Rarres2
retinoic acid receptor responder 2
decreases expression
ISO
Vancomycin results in decreased expression of RARRES2 mRNA
CTD
PMID:18930951
NCBI chr 4:77,522,549...77,525,733
Ensembl chr 4:77,522,535...77,525,556
G
Rbm3
RNA binding motif protein 3
decreases expression
ISO
Vancomycin results in decreased expression of RBM3 mRNA
CTD
PMID:18930951
NCBI chr X:14,348,909...14,352,387
Ensembl chr X:14,348,910...14,353,580
G
Rbp1
retinol binding protein 1
decreases expression
ISO
Vancomycin results in decreased expression of RBP1 mRNA
CTD
PMID:18930951
NCBI chr 8:99,025,218...99,046,740
Ensembl chr 8:99,025,206...99,046,743
G
Rbpms
RNA binding protein, mRNA processing factor
decreases expression
ISO
Vancomycin results in decreased expression of RBPMS mRNA
CTD
PMID:18930951
NCBI chr16:58,239,370...58,395,424
Ensembl chr16:58,239,474...58,395,426
G
Rcc2
regulator of chromosome condensation 2
decreases expression
ISO
Vancomycin results in decreased expression of RCC2 mRNA
CTD
PMID:18930951
NCBI chr 5:152,994,406...153,017,223
Ensembl chr 5:152,993,665...153,017,205
G
Rcn1
reticulocalbin 1
decreases expression
ISO
Vancomycin results in decreased expression of RCN1 mRNA
CTD
PMID:18930951
NCBI chr 3:91,841,052...91,855,295
Ensembl chr 3:91,841,052...91,855,295
G
Rcn3
reticulocalbin 3
decreases expression
ISO
Vancomycin results in decreased expression of RCN3 mRNA
CTD
PMID:18930951
NCBI chr 1:95,564,503...95,573,762
Ensembl chr 1:95,564,380...95,573,725
G
Rdh10
retinol dehydrogenase 10
decreases expression
ISO
Vancomycin results in decreased expression of RDH10 mRNA
CTD
PMID:18930951
NCBI chr 5:3,186,671...3,215,572
Ensembl chr 5:3,188,445...3,215,572
G
Rela
RELA proto-oncogene, NF-kB subunit
multiple interactions
ISO
[Gentamicins co-treated with Vancomycin co-treated with Cefoxitin co-treated with Metronidazole] inhibits the reaction [Fluorides results in increased expression of RELA mRNA]; [Neomycin co-treated with Metronidazole co-treated with Ampicillin co-treated with Vancomycin] inhibits the reaction [Methamphetamine results in increased expression of RELA mRNA]; [Neomycin co-treated with Metronidazole co-treated with Ampicillin co-treated with Vancomycin] inhibits the reaction [Methamphetamine results in increased expression of RELA protein]
CTD
PMID:35390362 PMID:37269894
NCBI chr 1:202,925,001...202,935,484
Ensembl chr 1:202,924,945...202,935,484
G
Rfc4
replication factor C subunit 4
decreases expression
ISO
Vancomycin results in decreased expression of RFC4 mRNA
CTD
PMID:18930951
NCBI chr11:77,749,642...77,764,123
Ensembl chr11:77,749,638...77,764,122
G
Rhbg
Rh family B glycoprotein
increases expression
ISO
Vancomycin results in increased expression of RHBG mRNA
CTD
PMID:18930951
NCBI chr 2:173,704,852...173,717,380
Ensembl chr 2:173,704,562...173,717,321
G
Rhcg
Rh family, C glycoprotein
increases expression
ISO
Vancomycin results in increased expression of RHCG mRNA
CTD
PMID:18930951
NCBI chr 1:133,531,704...133,555,902
Ensembl chr 1:133,531,716...133,555,876
G
Rhob
ras homolog family member B
decreases expression
ISO
Vancomycin results in decreased expression of RHOB mRNA
CTD
PMID:18930951
NCBI chr 6:31,363,752...31,365,926
Ensembl chr 6:31,363,548...31,366,108
G
Rhobtb3
Rho-related BTB domain containing 3
decreases expression
ISO
Vancomycin results in decreased expression of RHOBTB3 mRNA
CTD
PMID:18930951
NCBI chr 2:5,363,388...5,419,164
Ensembl chr 2:5,363,388...5,419,041
G
Rhoc
ras homolog family member C
decreases expression
ISO
Vancomycin results in decreased expression of RHOC mRNA
CTD
PMID:18930951
NCBI chr 2:192,287,065...192,293,292
Ensembl chr 2:192,287,130...192,295,306
G
Rida
reactive intermediate imine deaminase A homolog
multiple interactions
EXP
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in decreased expression of RIDA protein
CTD
PMID:30545405
NCBI chr 7:65,691,429...65,705,257
Ensembl chr 7:65,691,435...65,705,716
G
Rig1
RNA sensor RIG-1
decreases expression
ISO
Vancomycin results in decreased expression of RIGI mRNA
CTD
PMID:18930951
NCBI chr 5:55,321,351...55,369,947
Ensembl chr 5:55,321,235...55,370,819
G
Rnf186
ring finger protein 186
increases expression
ISO
Vancomycin results in increased expression of RNF186 mRNA
CTD
PMID:18930951
NCBI chr 5:151,210,492...151,211,716
Ensembl chr 5:151,210,492...151,211,716
G
Rpl30
ribosomal protein L30
multiple interactions
EXP
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of RPL30 protein
CTD
PMID:30545405
NCBI chr 7:65,648,266...65,651,401
Ensembl chr 7:65,645,991...65,651,363 Ensembl chr10:65,645,991...65,651,363 Ensembl chr10:65,645,991...65,651,363
G
Rpn2
ribophorin II
multiple interactions
EXP
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of RPN2 protein
CTD
PMID:30545405
NCBI chr 3:145,941,787...145,989,271
Ensembl chr 3:145,941,839...145,989,543
G
Rps23
ribosomal protein S23
multiple interactions
EXP
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of RPS23 protein
CTD
PMID:30545405
NCBI chr 2:22,079,339...22,080,909
Ensembl chr 2:22,079,302...22,080,918
G
Rps25
ribosomal protein s25
decreases expression
ISO
Vancomycin results in decreased expression of RPS25 mRNA
CTD
PMID:18930951
NCBI chr 8:44,733,623...44,735,999
Ensembl chr 8:44,733,029...44,737,271
G
Rps27l
ribosomal protein S27-like
multiple interactions
EXP
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of RPS27L protein
CTD
PMID:30545405
NCBI chr 8:67,562,483...67,567,418
Ensembl chr 8:67,562,483...67,567,418
G
Rras
RAS related
decreases expression
ISO
Vancomycin results in decreased expression of RRAS mRNA
CTD
PMID:18930951
NCBI chr 1:95,500,582...95,504,362
Ensembl chr 1:95,500,566...95,504,357
G
Rrm1
ribonucleotide reductase catalytic subunit M1
decreases expression
ISO
Vancomycin results in decreased expression of RRM1 mRNA
CTD
PMID:18930951
NCBI chr 1:156,823,960...156,848,262
Ensembl chr 1:156,823,960...156,848,261
G
RT1-Ba
RT1 class II, locus Ba
decreases expression
ISO
Vancomycin results in decreased expression of H2-AA mRNA
CTD
PMID:18930951
NCBI chr20:4,575,134...4,579,727
Ensembl chr20:4,575,134...4,579,744
G
RT1-Bb
RT1 class II, locus Bb
decreases expression
ISO
Vancomycin results in decreased expression of H2-AB1 mRNA
CTD
PMID:18930951
NCBI chr20:4,596,558...4,602,201
Ensembl chr20:4,596,559...4,607,597
G
RT1-Da
RT1 class II, locus Da
decreases expression
ISO
Vancomycin results in decreased expression of H2-EA mRNA
CTD
PMID:18930951
NCBI chr20:4,513,464...4,518,457
Ensembl chr20:4,512,911...4,518,455
G
RT1-Db1
RT1 class II, locus Db1
decreases expression
ISO
Vancomycin results in decreased expression of H2-EB1 mRNA
CTD
PMID:18930951
NCBI chr20:4,548,664...4,558,237
Ensembl chr20:4,548,666...4,558,258
G
RT1-DMb
RT1 class II, locus DMb
affects expression multiple interactions
ISO EXP
Vancomycin affects the expression of HLA-DMB mRNA [Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in decreased expression of RT1-DMB protein
CTD
PMID:25811541 PMID:30545405
NCBI chr20:4,693,102...4,700,340
Ensembl chr20:4,693,103...4,700,340
G
Rtn4
reticulon 4
decreases expression
ISO
Vancomycin results in decreased expression of RTN4 mRNA
CTD
PMID:18930951
NCBI chr14:103,450,074...103,497,687
Ensembl chr14:103,449,930...103,497,686
G
Rtn4ip1
reticulon 4 interacting protein 1
increases expression
ISO
Vancomycin results in increased expression of RTN4IP1 mRNA
CTD
PMID:18930951
NCBI chr20:47,382,251...47,422,747
Ensembl chr20:47,382,234...47,422,338
G
S100a10
S100 calcium binding protein A10
decreases expression multiple interactions
ISO EXP
Vancomycin results in decreased expression of S100A10 mRNA [Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of S100A10 protein
CTD
PMID:18930951 PMID:30545405
NCBI chr 2:179,221,012...179,229,659
Ensembl chr 2:179,220,887...179,229,661
G
S100a11
S100 calcium binding protein A11
decreases expression multiple interactions
ISO EXP
Vancomycin results in decreased expression of S100A11 mRNA [Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of S100A11 protein
CTD
PMID:18930951 PMID:30545405
NCBI chr 2:179,191,688...179,197,098
Ensembl chr 2:179,191,715...179,197,044
G
S100a4
S100 calcium-binding protein A4
decreases expression
ISO
Vancomycin results in decreased expression of S100A4 mRNA
CTD
PMID:18930951
NCBI chr 2:176,090,951...176,093,258
Ensembl chr 2:176,091,804...176,093,254
G
S100a6
S100 calcium binding protein A6
decreases expression
ISO
Vancomycin results in decreased expression of S100A6 mRNA
CTD
PMID:18930951
NCBI chr 2:176,100,619...176,102,181
Ensembl chr 2:176,100,899...176,102,180
G
S100g
S100 calcium binding protein G
increases expression
ISO
Vancomycin results in increased expression of S100G mRNA
CTD
PMID:18930951
NCBI chr X:31,705,853...31,708,422
Ensembl chr X:31,705,866...31,708,433
G
Samhd1
SAM and HD domain containing deoxynucleoside triphosphate triphosphohydrolase 1
decreases expression
ISO
Vancomycin results in decreased expression of SAMHD1 mRNA
CTD
PMID:18930951
NCBI chr 3:145,761,549...145,794,420
Ensembl chr 3:145,761,558...145,794,386
G
Sardh
sarcosine dehydrogenase
increases expression
ISO
Vancomycin results in increased expression of SARDH mRNA
CTD
PMID:18930951
NCBI chr 3:10,510,553...10,575,342
Ensembl chr 3:10,510,553...10,573,874
G
Sash1
SAM and SH3 domain containing 1
decreases expression
ISO
Vancomycin results in decreased expression of SASH1 mRNA
CTD
PMID:18930951
NCBI chr 1:3,119,915...3,418,536
Ensembl chr 1:3,121,332...3,439,870
G
Scarb2
scavenger receptor class B, member 2
multiple interactions
EXP
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in decreased expression of SCARB2 protein
CTD
PMID:30545405
NCBI chr14:15,558,271...15,609,813
Ensembl chr14:15,558,236...15,609,813
G
Scd
stearoyl-CoA desaturase
increases expression
ISO
Vancomycin results in increased expression of SCD1 mRNA
CTD
PMID:18930951
NCBI chr 1:243,269,745...243,282,878
Ensembl chr 1:243,269,747...243,282,562
G
Scin
scinderin
decreases expression
ISO
Vancomycin results in decreased expression of SCIN mRNA
CTD
PMID:18930951
NCBI chr 6:57,109,500...57,188,123
Ensembl chr 6:57,109,403...57,188,242
G
Scn4b
sodium voltage-gated channel beta subunit 4
increases expression
ISO
Vancomycin results in increased expression of SCN4B mRNA
CTD
PMID:18930951
NCBI chr 8:45,446,580...45,462,294
Ensembl chr 8:45,446,215...45,462,292
G
Scrn3
secernin 3
increases expression
ISO
Vancomycin results in increased expression of SCRN3 mRNA
CTD
PMID:18930951
NCBI chr 3:58,188,820...58,213,623
Ensembl chr 3:58,188,889...58,213,623
G
Sdc1
syndecan 1
decreases expression
ISO
Vancomycin results in decreased expression of SDC1 mRNA
CTD
PMID:18930951
NCBI chr 6:31,562,799...31,585,267
Ensembl chr 6:31,562,739...31,585,264
G
Sectm1b
secreted and transmembrane 1B
increases expression
ISO
Vancomycin results in increased expression of SECTM1 mRNA
CTD
PMID:18930951
NCBI chr10:106,324,070...106,333,779
Ensembl chr10:106,325,203...106,333,769
G
Selenbp1
selenium binding protein 1
increases expression
ISO
Vancomycin results in increased expression of SELENBP1 mRNA
CTD
PMID:18930951
NCBI chr 2:182,494,004...182,504,594
Ensembl chr 2:182,493,978...182,504,594
G
Selenow
selenoprotein W
decreases expression
ISO
Vancomycin results in decreased expression of SELENOW mRNA
CTD
PMID:18930951
NCBI chr 1:76,599,441...76,604,514
Ensembl chr 1:76,598,779...76,604,724 Ensembl chr 1:76,598,779...76,604,724
G
Sema3c
semaphorin 3C
decreases expression
ISO
Vancomycin results in decreased expression of SEMA3C mRNA
CTD
PMID:18930951
NCBI chr 4:17,583,212...17,747,234
Ensembl chr 4:17,583,212...17,746,534
G
Sema4g
semaphorin 4G
increases expression
ISO
Vancomycin results in increased expression of SEMA4G mRNA
CTD
PMID:18930951
NCBI chr 1:243,849,979...243,865,343
Ensembl chr 1:243,853,854...243,865,341
G
Sephs2
selenophosphate synthetase 2
increases expression
ISO
Vancomycin results in increased expression of SEPHS2 mRNA
CTD
PMID:18930951
NCBI chr 1:181,893,146...181,895,464
Ensembl chr 1:181,892,599...181,895,497
G
Serinc2
serine incorporator 2
decreases expression
ISO
Vancomycin results in decreased expression of SERINC2 mRNA
CTD
PMID:18930951
NCBI chr 5:142,592,308...142,614,628
Ensembl chr 5:142,592,309...142,618,364
G
Serpina6
serpin family A member 6
increases expression
ISO
Vancomycin results in increased expression of SERPINA6 mRNA
CTD
PMID:18930951
NCBI chr 6:122,780,040...122,790,274
Ensembl chr 6:122,780,043...122,790,349
G
Serpinb6a
serpin family B member 6A
decreases expression multiple interactions
ISO EXP
Vancomycin results in decreased expression of SERPINB6A mRNA [Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of SERPINB6 protein
CTD
PMID:18930951 PMID:30545405
NCBI chr17:30,871,468...30,989,703
Ensembl chr17:30,871,468...31,014,427
G
Serpinb9
serpin family B member 9
decreases expression
ISO
Vancomycin results in decreased expression of SERPINB9 mRNA
CTD
PMID:18930951
NCBI chr17:31,420,118...31,443,237
Ensembl chr17:31,420,125...31,443,230
G
Serpine2
serpin family E member 2
decreases expression
ISO
Vancomycin results in decreased expression of SERPINE2 mRNA
CTD
PMID:18930951
NCBI chr 9:81,124,746...81,188,866
Ensembl chr 9:81,124,804...81,188,826
G
Serping1
serpin family G member 1
decreases expression
ISO
Vancomycin results in decreased expression of SERPING1 mRNA
CTD
PMID:18930951
NCBI chr 3:69,842,726...69,852,583
Ensembl chr 3:69,842,739...69,852,034
G
Sfrp1
secreted frizzled-related protein 1
increases expression
ISO
Vancomycin results in increased expression of SFRP1 mRNA
CTD
PMID:18930951
NCBI chr16:68,575,763...68,614,180
Ensembl chr16:68,575,763...68,614,286
G
Sfxn2
sideroflexin 2
increases expression
ISO
Vancomycin results in increased expression of SFXN2 mRNA
CTD
PMID:18930951
NCBI chr 1:245,447,014...245,459,312
Ensembl chr 1:245,447,015...245,468,411 Ensembl chr 1:245,447,015...245,468,411
G
Sgk2
serum/glucocorticoid regulated kinase 2
increases expression
ISO
Vancomycin results in increased expression of SGK2 mRNA
CTD
PMID:18930951
NCBI chr 3:151,644,102...151,669,480
Ensembl chr 3:151,644,102...151,669,480
G
Sh3bgrl3
SH3 domain binding glutamate-rich protein like 3
decreases expression
ISO
Vancomycin results in decreased expression of SH3BGRL3 mRNA
CTD
PMID:18930951
NCBI chr 5:146,354,152...146,355,525
Ensembl chr 5:146,354,152...146,355,331
G
Shh
sonic hedgehog signaling molecule
increases expression
ISO
Vancomycin results in increased expression of SHH mRNA
CTD
PMID:18930951
NCBI chr 4:6,954,017...6,963,170
Ensembl chr 4:6,954,017...6,963,170
G
Shisa4
shisa family member 4
decreases expression
ISO
Vancomycin results in decreased expression of SHISA4 mRNA
CTD
PMID:18930951
NCBI chr13:46,799,735...46,803,816
Ensembl chr13:46,799,772...46,803,998
G
Shmt1
serine hydroxymethyltransferase 1
increases expression
ISO
Vancomycin results in increased expression of SHMT1 mRNA
CTD
PMID:18930951
NCBI chr10:45,468,698...45,490,833
Ensembl chr10:45,468,700...45,497,820
G
Shmt2
serine hydroxymethyltransferase 2
increases expression multiple interactions
ISO EXP
Vancomycin results in increased expression of SHMT2 mRNA [Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of SHMT2 protein
CTD
PMID:18930951 PMID:30545405
NCBI chr 7:63,358,961...63,364,293
Ensembl chr 7:63,358,961...63,364,236
G
Sirt3
sirtuin 3
increases expression
ISO
Vancomycin results in increased expression of SIRT3 mRNA
CTD
PMID:18930951
NCBI chr 1:195,942,066...195,964,472
Ensembl chr 1:195,942,073...195,964,808
G
Skap2
src kinase associated phosphoprotein 2
decreases expression
ISO
Vancomycin results in decreased expression of SKAP2 mRNA
CTD
PMID:18930951
NCBI chr 4:80,948,832...81,100,900
Ensembl chr 4:80,950,580...81,100,891
G
Slc10a1
solute carrier family 10 member 1
multiple interactions
ISO
[Vancomycin co-treated with Imipenem] results in increased expression of SLC10A1 mRNA
CTD
PMID:24657338
NCBI chr 6:100,613,045...100,626,670
Ensembl chr 6:100,613,045...100,626,670
G
Slc12a1
solute carrier family 12 member 1
increases expression
ISO
Vancomycin results in increased expression of SLC12A1 mRNA
CTD
PMID:18930951
NCBI chr 3:112,406,140...112,482,913
Ensembl chr 3:112,406,140...112,482,899
G
Slc12a3
solute carrier family 12 member 3
increases expression
ISO
Vancomycin results in increased expression of SLC12A3 mRNA
CTD
PMID:18930951
NCBI chr19:10,630,651...10,679,250
Ensembl chr19:10,631,393...10,669,091
G
Slc13a2
solute carrier family 13 member 2
increases expression
ISO
Vancomycin results in increased expression of SLC13A2 mRNA
CTD
PMID:18930951
NCBI chr10:63,291,813...63,319,127
Ensembl chr10:63,291,815...63,319,127
G
Slc13a3
solute carrier family 13 member 3
increases expression
ISO
Vancomycin results in increased expression of SLC13A3 mRNA
CTD
PMID:18930951
NCBI chr 3:154,141,878...154,204,604
Ensembl chr 3:154,141,872...154,204,606
G
Slc13a4
solute carrier family 13 member 4
increases expression
ISO
Vancomycin results in increased expression of SLC13A4 mRNA
CTD
PMID:18930951
NCBI chr 4:63,943,369...63,988,852
Ensembl chr 4:63,943,395...63,988,857
G
Slc14a2
solute carrier family 14 member 2
decreases expression
ISO
Vancomycin results in decreased expression of SLC14A2 mRNA
CTD
PMID:18930951
NCBI chr18:71,612,460...72,039,462
Ensembl chr18:71,612,460...71,792,968
G
Slc16a7
solute carrier family 16 member 7
increases expression
ISO
Vancomycin results in increased expression of SLC16A7 mRNA
CTD
PMID:18930951
NCBI chr 7:61,043,667...61,211,547
Ensembl chr 7:61,051,167...61,154,994
G
Slc16a9
solute carrier family 16, member 9
increases expression
ISO
Vancomycin results in increased expression of SLC16A9 mRNA
CTD
PMID:18930951
NCBI chr20:18,335,862...18,377,125
Ensembl chr20:18,335,862...18,377,022
G
Slc18a1
solute carrier family 18 member A1
increases expression
ISO
Vancomycin results in increased expression of SLC18A1 mRNA
CTD
PMID:18930951
NCBI chr16:20,653,268...20,687,051
Ensembl chr16:20,653,508...20,687,051
G
Slc22a12
solute carrier family 22 member 12
increases expression
ISO
Vancomycin results in increased expression of SLC22A12 mRNA
CTD
PMID:18930951
NCBI chr 1:203,845,039...203,852,496
Ensembl chr 1:203,845,048...203,853,555
G
Slc22a13
solute carrier family 22 member 13
increases expression
ISO
Vancomycin results in increased expression of SLC22A13 mRNA
CTD
PMID:18930951
NCBI chr 8:118,922,367...118,934,020
Ensembl chr 8:118,922,367...118,953,635
G
Slc22a18
solute carrier family 22, member 18
increases expression
ISO
Vancomycin results in increased expression of SLC22A18 mRNA
CTD
PMID:18930951
NCBI chr 1:198,670,626...198,694,977
Ensembl chr 1:198,671,731...198,694,975
G
Slc22a2
solute carrier family 22 member 2
decreases expression multiple interactions
EXP
Vancomycin results in decreased expression of SLC22A2 mRNA; Vancomycin results in decreased expression of SLC22A2 protein JBP 485 inhibits the reaction [Vancomycin results in decreased expression of SLC22A2 mRNA]; JBP 485 inhibits the reaction [Vancomycin results in decreased expression of SLC22A2 protein]
CTD
PMID:29964132
NCBI chr 1:48,121,061...48,163,268
Ensembl chr 1:48,121,061...48,163,268
G
Slc22a25
solute carrier family 22, member 25
increases expression
ISO
Vancomycin results in increased expression of SLC22A19 mRNA
CTD
PMID:18930951
NCBI chr 1:205,338,698...205,498,486
Ensembl chr 1:205,338,699...205,433,085
G
Slc22a4
solute carrier family 22 member 4
increases expression
ISO
Vancomycin results in increased expression of SLC22A4 mRNA
CTD
PMID:18930951
NCBI chr10:38,133,333...38,179,932
Ensembl chr10:38,133,322...38,179,720
G
Slc22a5
solute carrier family 22 member 5
increases expression
ISO
Vancomycin results in increased expression of SLC22A5 mRNA
CTD
PMID:18930951
NCBI chr10:38,008,303...38,035,474
Ensembl chr10:38,008,311...38,035,309
G
Slc22a6
solute carrier family 22 member 6
increases expression multiple interactions decreases expression
ISO EXP
Vancomycin results in increased expression of SLC22A6 mRNA JBP 485 inhibits the reaction [Vancomycin results in decreased expression of SLC22A6 mRNA]; JBP 485 inhibits the reaction [Vancomycin results in decreased expression of SLC22A6 protein] Vancomycin results in decreased expression of SLC22A6 mRNA; Vancomycin results in decreased expression of SLC22A6 protein
CTD
PMID:18930951 PMID:29964132
NCBI chr 1:205,522,579...205,531,179
Ensembl chr 1:205,522,729...205,531,173
G
Slc22a7
solute carrier family 22 member 7
increases expression multiple interactions
ISO
Vancomycin results in increased expression of SLC22A7 mRNA [Vancomycin co-treated with Neomycin co-treated with Ampicillin co-treated with Metronidazole co-treated with Amphotericin B] results in increased expression of SLC22A7 mRNA
CTD
PMID:18930951 PMID:36464106
NCBI chr 9:14,547,073...14,554,354
Ensembl chr 9:14,547,849...14,553,921
G
Slc22a8
solute carrier family 22 member 8
increases expression decreases expression multiple interactions
ISO EXP
Vancomycin results in increased expression of SLC22A8 mRNA Vancomycin results in decreased expression of SLC22A8 mRNA; Vancomycin results in decreased expression of SLC22A8 protein JBP 485 inhibits the reaction [Vancomycin results in decreased expression of SLC22A8 mRNA]; JBP 485 inhibits the reaction [Vancomycin results in decreased expression of SLC22A8 protein]
CTD
PMID:18930951 PMID:29964132
NCBI chr 1:205,496,331...205,516,378
Ensembl chr 1:205,498,084...205,517,450
G
Slc25a10
solute carrier family 25 member 10
increases expression
ISO
Vancomycin results in increased expression of SLC25A10 mRNA
CTD
PMID:18930951
NCBI chr10:105,765,598...105,775,159
Ensembl chr10:105,765,372...105,773,556
G
Slc25a15
solute carrier family 25 member 15
increases expression
ISO
Vancomycin results in increased expression of SLC25A15 mRNA
CTD
PMID:18930951
NCBI chr16:69,631,581...69,654,869
Ensembl chr16:69,634,414...69,653,010
G
Slc25a16
solute carrier family 25 member 16
increases expression
ISO
Vancomycin results in increased expression of SLC25A16 mRNA
CTD
PMID:18930951
NCBI chr20:25,691,474...25,717,558
Ensembl chr20:25,662,055...25,716,319
G
Slc25a25
solute carrier family 25 member 25
increases expression
ISO
Vancomycin results in increased expression of SLC25A25 mRNA
CTD
PMID:18930951
NCBI chr 3:15,708,702...15,742,195
Ensembl chr 3:15,708,703...15,742,216
G
Slc25a36
solute carrier family 25 member 36
increases expression
ISO
Vancomycin results in increased expression of SLC25A36 mRNA
CTD
PMID:18930951
NCBI chr 8:97,659,848...97,693,735
Ensembl chr 8:97,662,127...97,693,703
G
Slc26a1
solute carrier family 26 member 1
increases expression
ISO
Vancomycin results in increased expression of SLC26A1 mRNA
CTD
PMID:18930951
NCBI chr14:1,040,565...1,045,851
Ensembl chr14:1,040,243...1,045,849
G
Slc26a4
solute carrier family 26 member 4
increases expression
ISO
Vancomycin results in increased expression of SLC26A4 mRNA
CTD
PMID:18930951
NCBI chr 6:48,107,575...48,153,762
Ensembl chr 6:48,107,588...48,145,703
G
Slc26a7
solute carrier family 26 member 7
increases expression
ISO
Vancomycin results in increased expression of SLC26A7 mRNA
CTD
PMID:18930951
NCBI chr 5:27,884,400...28,021,865
Ensembl chr 5:27,887,042...28,021,658
G
Slc27a5
solute carrier family 27 member 5
multiple interactions
ISO
[Vancomycin co-treated with Imipenem] results in increased expression of SLC27A5 mRNA
CTD
PMID:24657338
NCBI chr 1:73,616,556...73,627,149
Ensembl chr 1:73,616,564...73,627,172
G
Slc2a12
solute carrier family 2 member 12
increases expression
ISO
Vancomycin results in increased expression of SLC2A12 mRNA
CTD
PMID:18930951
NCBI chr 1:22,803,068...22,862,204
Ensembl chr 1:22,804,418...22,860,971
G
Slc2a4
solute carrier family 2 member 4
increases expression
ISO
Vancomycin results in increased expression of SLC2A4 mRNA
CTD
PMID:18930951
NCBI chr10:54,666,015...54,671,581
Ensembl chr10:54,666,015...54,671,565
G
Slc2a5
solute carrier family 2 member 5
increases expression
ISO
Vancomycin results in increased expression of SLC2A5 mRNA
CTD
PMID:18930951
NCBI chr 5:160,583,055...160,609,994
Ensembl chr 5:160,583,234...160,611,106
G
Slc34a1
solute carrier family 34 member 1
increases expression
ISO
Vancomycin results in increased expression of SLC34A1 mRNA
CTD
PMID:18930951
NCBI chr17:9,218,876...9,233,852
Ensembl chr17:9,218,876...9,233,852
G
Slc34a3
solute carrier family 34 member 3
increases expression
ISO
Vancomycin results in increased expression of SLC34A3 mRNA
CTD
PMID:18930951
NCBI chr 3:8,044,294...8,050,034
Ensembl chr 3:8,044,296...8,049,970
G
Slc36a1
solute carrier family 36 member 1
increases expression
ISO
Vancomycin results in increased expression of SLC36A1 mRNA
CTD
PMID:18930951
NCBI chr10:39,319,062...39,357,374
Ensembl chr10:39,324,337...39,354,217
G
Slc37a4
solute carrier family 37 member 4
increases expression
ISO
Vancomycin results in increased expression of SLC37A4 mRNA
CTD
PMID:18930951
NCBI chr 8:44,723,216...44,729,301
Ensembl chr 8:44,723,339...44,729,301
G
Slc38a2
solute carrier family 38, member 2
decreases expression
ISO
Vancomycin results in decreased expression of SLC38A2 mRNA
CTD
PMID:18930951
NCBI chr 7:127,851,267...127,863,482
Ensembl chr 7:127,851,267...127,863,436
G
Slc38a3
solute carrier family 38, member 3
increases expression
ISO
Vancomycin results in increased expression of SLC38A3 mRNA
CTD
PMID:18930951
NCBI chr 8:108,323,889...108,339,959
Ensembl chr 8:108,323,894...108,339,988
G
Slc39a14
solute carrier family 39 member 14
decreases expression
ISO
Vancomycin results in decreased expression of SLC39A14 mRNA
CTD
PMID:18930951
NCBI chr15:45,376,806...45,423,549
Ensembl chr15:45,376,917...45,423,524
G
Slc39a5
solute carrier family 39 member 5
increases expression
ISO
Vancomycin results in increased expression of SLC39A5 mRNA
CTD
PMID:18930951
NCBI chr 7:822,873...830,865
Ensembl chr 7:824,818...830,242
G
Slc39a6
solute carrier family 39 member 6
decreases expression
ISO
Vancomycin results in decreased expression of SLC39A6 mRNA
CTD
PMID:18930951
NCBI chr18:15,864,874...15,885,417
Ensembl chr18:15,864,875...15,885,417
G
Slc39a8
solute carrier family 39 member 8
increases expression
ISO
Vancomycin results in increased expression of SLC39A8 mRNA
CTD
PMID:18930951
NCBI chr 2:224,171,787...224,319,326
Ensembl chr 2:224,256,654...224,319,129
G
Slc3a1
solute carrier family 3 member 1
multiple interactions
EXP
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of SLC3A1 protein
CTD
PMID:30545405
NCBI chr 6:9,608,169...9,641,881
Ensembl chr 6:9,608,178...9,641,907
G
Slc41a2
solute carrier family 41 member 2
decreases expression
ISO
Vancomycin results in decreased expression of SLC41A2 mRNA
CTD
PMID:18930951
NCBI chr 7:20,383,714...20,491,178
Ensembl chr 7:20,383,757...20,491,166
G
Slc43a2
solute carrier family 43 member 2
increases expression
ISO
Vancomycin results in increased expression of SLC43A2 mRNA
CTD
PMID:18930951
NCBI chr10:60,375,462...60,420,838
Ensembl chr10:60,376,559...60,418,244
G
Slc44a1
solute carrier family 44 member 1
decreases expression
ISO
Vancomycin results in decreased expression of SLC44A1 mRNA
CTD
PMID:18930951
NCBI chr 5:68,061,941...68,241,912
Ensembl chr 5:68,063,618...68,241,909
G
Slc44a2
solute carrier family 44 member 2
decreases expression
ISO
Vancomycin results in decreased expression of SLC44A2 mRNA
CTD
PMID:18930951
NCBI chr 8:19,870,867...19,905,345
Ensembl chr 8:19,870,888...19,905,342
G
Slc44a3
solute carrier family 44, member 3
decreases expression
ISO
Vancomycin results in decreased expression of SLC44A3 mRNA
CTD
PMID:18930951
NCBI chr 2:209,552,138...209,628,182
Ensembl chr 2:209,552,144...209,629,044
G
Slc4a1
solute carrier family 4 member 1 (Diego blood group)
increases expression
ISO
Vancomycin results in increased expression of SLC4A1 mRNA
CTD
PMID:18930951
NCBI chr10:87,306,865...87,323,132
Ensembl chr10:87,306,872...87,323,117
G
Slc4a9
solute carrier family 4 member 9
increases expression
ISO
Vancomycin results in increased expression of SLC4A9 mRNA
CTD
PMID:18930951
NCBI chr18:28,128,740...28,144,554
Ensembl chr18:28,128,740...28,141,543
G
Slc51a
solute carrier family 51 member A
multiple interactions
ISO
[Vancomycin co-treated with Imipenem] results in decreased expression of SLC51A mRNA
CTD
PMID:24657338
NCBI chr11:68,299,086...68,313,485
Ensembl chr11:68,299,086...68,313,485
G
Slc5a11
solute carrier family 5 member 11
increases expression
ISO
Vancomycin results in increased expression of SLC5A11 mRNA
CTD
PMID:18930951
NCBI chr 1:177,735,511...177,795,193
Ensembl chr 1:177,756,561...177,795,193
G
Slc5a12
solute carrier family 5 member 12
increases expression
ISO
Vancomycin results in increased expression of SLC5A12 mRNA
CTD
PMID:18930951
NCBI chr 3:97,179,326...97,228,405
Ensembl chr 3:97,179,326...97,228,405
G
Slc5a2
solute carrier family 5 member 2
increases expression
ISO
Vancomycin results in increased expression of SLC5A2 mRNA
CTD
PMID:18930951
NCBI chr 1:182,847,185...182,853,309
Ensembl chr 1:182,847,106...182,853,306
G
Slc5a8
solute carrier family 5 member 8
increases expression
ISO
Vancomycin results in increased expression of SLC5A8 mRNA
CTD
PMID:18930951
NCBI chr 7:23,272,891...23,313,811
Ensembl chr 7:23,272,427...23,314,642
G
Slc5a9
solute carrier family 5 member 9
increases expression
ISO
Vancomycin results in increased expression of SLC5A9 mRNA
CTD
PMID:18930951
NCBI chr 5:126,709,762...126,733,468
Ensembl chr 5:126,709,769...126,733,468
G
Slc6a19
solute carrier family 6 member 19
increases expression
ISO
Vancomycin results in increased expression of SLC6A19 mRNA
CTD
PMID:18930951
NCBI chr 1:29,586,191...29,604,964
Ensembl chr 1:29,586,195...29,604,962
G
Slc6a20a
solute carrier family 6 member 20a
increases expression
ISO
Vancomycin results in increased expression of SLC6A20 mRNA
CTD
PMID:18930951
NCBI chr 8:123,282,325...123,322,609
Ensembl chr 8:123,281,472...123,322,573
G
Slc6a4
solute carrier family 6 member 4
increases expression
ISO
Vancomycin results in increased expression of SLC6A4 mRNA
CTD
PMID:18930951
NCBI chr10:61,824,208...61,858,924
Ensembl chr10:61,826,123...61,858,384
G
Slc7a1
solute carrier family 7 member 1
decreases expression
ISO
Vancomycin results in decreased expression of SLC7A1 mRNA
CTD
PMID:18930951
NCBI chr12:6,628,288...6,703,849
Ensembl chr12:6,628,007...6,703,849
G
Slc7a12
solute carrier family 7 (cationic amino acid transporter, y+ system), member 12
increases expression
ISO
Vancomycin results in increased expression of SLC7A12 mRNA
CTD
PMID:18930951
NCBI chr 2:87,079,724...87,146,875
Ensembl chr 2:87,079,749...87,146,875
G
Slc7a7
solute carrier family 7 member 7
increases expression
ISO
Vancomycin results in increased expression of SLC7A7 mRNA
CTD
PMID:18930951
NCBI chr15:27,822,088...27,873,121
Ensembl chr15:27,822,091...27,865,648
G
Slc7a8
solute carrier family 7 member 8
increases expression
ISO
Vancomycin results in increased expression of SLC7A8 mRNA
CTD
PMID:18930951
NCBI chr15:28,183,013...28,242,717
Ensembl chr15:28,183,015...28,242,717
G
Slc8a1
solute carrier family 8 member A1
increases expression
ISO
Vancomycin results in increased expression of SLC8A1 mRNA
CTD
PMID:18930951
NCBI chr 6:13,194,609...13,547,369
Ensembl chr 6:13,194,662...13,535,628
G
Slc9a8
solute carrier family 9 member A8
increases expression
ISO
Vancomycin results in increased expression of SLC9A8 mRNA
CTD
PMID:18930951
NCBI chr 3:156,147,855...156,198,497
Ensembl chr 3:156,148,104...156,198,471
G
Slco1a4
solute carrier organic anion transporter family, member 1a4
multiple interactions
ISO
[Vancomycin co-treated with Imipenem] results in decreased expression of SLCO1A4 mRNA
CTD
PMID:24657338
NCBI chr 4:174,710,004...174,764,810
Ensembl chr 4:174,710,004...175,254,573
G
Slco1b2
solute carrier organic anion transporter family member 1B2
multiple interactions
ISO
[Vancomycin co-treated with Imipenem] results in increased expression of SLCO1B2 mRNA
CTD
PMID:24657338
NCBI chr 4:174,551,463...174,619,988
Ensembl chr 4:174,551,480...174,619,981
G
Slco2b1
solute carrier organic anion transporter family, member 2b1
multiple interactions
ISO
[Vancomycin co-treated with Imipenem] results in increased expression of SLCO2B1 mRNA
CTD
PMID:24657338
NCBI chr 1:153,959,288...154,007,294
Ensembl chr 1:153,959,293...154,007,353
G
Slco3a1
solute carrier organic anion transporter family, member 3a1
decreases expression
ISO
Vancomycin results in decreased expression of SLCO3A1 mRNA
CTD
PMID:18930951
NCBI chr 1:128,106,232...128,388,043
Ensembl chr 1:128,106,228...128,387,925
G
Smad2
SMAD family member 2
decreases expression
ISO
Vancomycin results in decreased expression of SMAD2 mRNA
CTD
PMID:18930951
NCBI chr18:69,849,884...69,918,926
Ensembl chr18:69,850,377...69,912,323
G
Smc4
structural maintenance of chromosomes 4
decreases expression
ISO
Vancomycin results in decreased expression of SMC4 mRNA
CTD
PMID:18930951
NCBI chr 2:153,240,243...153,268,722
Ensembl chr 2:153,240,283...153,271,571
G
Smpd2
sphingomyelin phosphodiesterase 2
multiple interactions
EXP
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of SMPD2 protein
CTD
PMID:30545405
NCBI chr20:44,986,229...44,989,343
Ensembl chr20:44,986,231...44,989,441
G
Sms
spermine synthase
increases expression
ISO
Vancomycin results in increased expression of SMS mRNA
CTD
PMID:18930951
NCBI chr X:37,516,949...37,572,657
Ensembl chr X:37,516,931...37,570,822
G
Snord22
small nucleolar RNA, C/D box 22
decreases expression
ISO
Vancomycin results in decreased expression of SNORD22 mRNA
CTD
PMID:18930951
NCBI chr11:9,097,799...9,097,923
Ensembl chr11:9,097,799...9,097,923
G
Snrpg
small nuclear ribonucleoprotein polypeptide G
decreases expression
ISO
Vancomycin results in decreased expression of SNRPG mRNA
CTD
PMID:18930951
NCBI chr 4:118,812,278...118,819,827
Ensembl chr 4:118,812,252...118,819,826
G
Socs2
suppressor of cytokine signaling 2
decreases expression
ISO
Vancomycin results in decreased expression of SOCS2 mRNA
CTD
PMID:18930951
NCBI chr 7:30,006,360...30,045,161
Ensembl chr 7:30,008,578...30,043,548
G
Sod2
superoxide dismutase 2
increases expression
ISO
Vancomycin results in increased expression of SOD2 mRNA
CTD
PMID:18930951
NCBI chr 1:47,638,318...47,645,163
Ensembl chr 1:47,636,528...47,645,189
G
Sod3
superoxide dismutase 3
increases expression
ISO
Vancomycin results in increased expression of SOD3 mRNA
CTD
PMID:18930951
NCBI chr14:58,610,104...58,615,845
Ensembl chr14:58,609,958...58,615,990
G
Sord
sorbitol dehydrogenase
increases expression
ISO
Vancomycin results in increased expression of SORD mRNA
CTD
PMID:18930951
NCBI chr 3:109,184,697...109,216,133
Ensembl chr 3:109,184,676...109,216,133
G
Sox4
SRY-box transcription factor 4
decreases expression
ISO
Vancomycin results in decreased expression of SOX4 mRNA
CTD
PMID:18930951
NCBI chr17:35,667,809...35,672,515
Ensembl chr17:35,667,537...35,673,665
G
Sparc
secreted protein acidic and cysteine rich
decreases expression
ISO
Vancomycin results in decreased expression of SPARC mRNA
CTD
PMID:18930951
NCBI chr10:39,516,394...39,538,252
Ensembl chr10:39,516,406...39,538,396
G
Sparcl1
SPARC like 1
decreases expression
ISO
Vancomycin results in decreased expression of SPARCL1 mRNA
CTD
PMID:18930951
NCBI chr14:5,632,816...5,663,866
Ensembl chr14:5,632,569...5,663,865
G
Spon1
spondin 1
decreases expression
ISO
Vancomycin results in decreased expression of SPON1 mRNA
CTD
PMID:18930951
NCBI chr 1:167,929,049...168,228,239
Ensembl chr 1:167,928,972...168,228,226
G
Spp1
secreted phosphoprotein 1
increases expression
ISO EXP
Vancomycin results in increased expression of SPP1 mRNA
CTD
PMID:18289764 PMID:18930951
NCBI chr14:5,308,885...5,315,120
Ensembl chr14:5,308,885...5,315,162
G
Spp2
secreted phosphoprotein 2
increases expression
ISO
Vancomycin results in increased expression of SPP2 mRNA
CTD
PMID:18930951
NCBI chr 9:89,006,858...89,026,676
Ensembl chr 9:89,007,175...89,026,688
G
Sprr1a
small proline-rich protein 1A
decreases expression
ISO
Vancomycin results in decreased expression of SPRR1A mRNA
CTD
PMID:18930951
NCBI chr 2:178,055,096...178,057,012
Ensembl chr 2:178,055,096...178,057,063
G
Spsb4
splA/ryanodine receptor domain and SOCS box containing 4
increases expression
ISO
Vancomycin results in increased expression of SPSB4 mRNA
CTD
PMID:18930951
NCBI chr 8:97,536,519...97,609,757
Ensembl chr 8:97,536,520...97,609,787
G
Sptlc2
serine palmitoyltransferase, long chain base subunit 2
decreases expression
ISO
Vancomycin results in decreased expression of SPTLC2 mRNA
CTD
PMID:18930951
NCBI chr 6:106,948,682...107,031,532
Ensembl chr 6:106,950,949...107,031,542
G
Sqle
squalene epoxidase
decreases expression multiple interactions
ISO
Vancomycin results in decreased expression of SQLE mRNA [Vancomycin co-treated with Neomycin co-treated with Ampicillin co-treated with Metronidazole co-treated with Amphotericin B] results in increased expression of SQLE mRNA
CTD
PMID:18930951 PMID:36464106
NCBI chr 7:90,867,973...90,883,623
Ensembl chr 7:90,868,011...90,883,618
G
Sqstm1
sequestosome 1
multiple interactions
ISO
[Vancomycin co-treated with Neomycin co-treated with Metronidazole] promotes the reaction [Zinc Oxide analog results in increased expression of SQSTM1 protein]
CTD
PMID:36535435
NCBI chr10:34,525,517...34,536,670
Ensembl chr10:34,525,519...34,536,673
G
Srebf1
sterol regulatory element binding transcription factor 1
multiple interactions
ISO
[Sodium Selenite results in increased abundance of Selenium] inhibits the reaction [[Vancomycin co-treated with Neomycin co-treated with Ampicillin co-treated with Metronidazole co-treated with Amphotericin B] results in increased expression of SREBF1 mRNA]; [Vancomycin co-treated with Neomycin co-treated with Ampicillin co-treated with Metronidazole co-treated with Amphotericin B] results in increased expression of SREBF1 mRNA
CTD
PMID:36464106
NCBI chr10:45,007,637...45,029,650
Ensembl chr10:45,007,637...45,029,650
G
Srebf2
sterol regulatory element binding transcription factor 2
multiple interactions
ISO
[Vancomycin co-treated with Neomycin co-treated with Ampicillin co-treated with Metronidazole co-treated with Amphotericin B] results in increased expression of SREBF2 mRNA
CTD
PMID:36464106
NCBI chr 7:113,663,202...113,720,850
Ensembl chr 7:113,663,202...113,720,848
G
Srr
serine racemase
increases expression
ISO
Vancomycin results in increased expression of SRR mRNA
CTD
PMID:18930951
NCBI chr10:59,769,563...59,786,688
Ensembl chr10:59,769,571...59,787,011
G
Ssbp4
single stranded DNA binding protein 4
decreases expression
ISO
Vancomycin results in decreased expression of SSBP4 mRNA
CTD
PMID:18930951
NCBI chr16:18,828,014...18,838,941
Ensembl chr16:18,828,054...18,838,947
G
Sst
somatostatin
multiple interactions
ISO
[Vancomycin co-treated with Neomycin co-treated with Metronidazole] promotes the reaction [Zinc Oxide results in increased expression of SST mRNA]; [Vancomycin co-treated with Neomycin co-treated with Metronidazole] results in increased expression of SST mRNA
CTD
PMID:36535435
NCBI chr11:76,956,896...76,958,173
Ensembl chr11:76,956,896...76,958,173
G
Sstr2
somatostatin receptor 2
multiple interactions
ISO
[Vancomycin co-treated with Neomycin co-treated with Metronidazole] promotes the reaction [Zinc Oxide results in increased expression of SSTR2 mRNA]
CTD
PMID:36535435
NCBI chr10:98,664,204...98,671,370
Ensembl chr10:98,664,216...98,674,351
G
St6gal1
ST6 beta-galactoside alpha-2,6-sialyltransferase 1
decreases expression
ISO
Vancomycin results in decreased expression of ST6GAL1 mRNA
CTD
PMID:18930951
NCBI chr11:77,526,837...77,653,474
Ensembl chr11:77,526,837...77,653,310
G
Stab1
stabilin 1
decreases expression
ISO
Vancomycin results in decreased expression of STAB1 mRNA
CTD
PMID:18930951
NCBI chr16:6,330,435...6,360,934
Ensembl chr16:6,330,444...6,360,923
G
Stab2
stabilin 2
increases expression
ISO
Vancomycin results in increased expression of STAB2 mRNA
CTD
PMID:18930951
NCBI chr 7:21,249,426...21,433,051
Ensembl chr 7:21,249,391...21,434,042
G
Stard4
StAR-related lipid transfer domain containing 4
increases expression
ISO
Vancomycin results in increased expression of STARD4 mRNA
CTD
PMID:18930951
NCBI chr18:24,814,683...24,830,024
Ensembl chr18:24,817,107...24,830,024
G
Stat1
signal transducer and activator of transcription 1
decreases expression
ISO
Vancomycin results in decreased expression of STAT1 mRNA
CTD
PMID:18930951
NCBI chr 9:49,419,561...49,459,969
Ensembl chr 9:49,419,340...49,588,540
G
Stat3
signal transducer and activator of transcription 3
decreases expression
ISO
Vancomycin results in decreased expression of STAT3 mRNA
CTD
PMID:18930951
NCBI chr10:85,811,206...85,863,057
Ensembl chr10:85,811,218...85,863,057
G
Steap1
STEAP family member 1
decreases expression
ISO
Vancomycin results in decreased expression of STEAP1 mRNA
CTD
PMID:18930951
NCBI chr 4:28,276,972...28,287,484
Ensembl chr 4:28,276,909...28,287,479
G
Stk17b
serine/threonine kinase 17b
decreases expression
ISO
Vancomycin results in decreased expression of STK17B mRNA
CTD
PMID:18930951
NCBI chr 9:55,307,485...55,338,085
Ensembl chr 9:55,307,668...55,338,031
G
Sucnr1
succinate receptor 1
increases expression
ISO
Vancomycin results in increased expression of SUCNR1 mRNA
CTD
PMID:18930951
NCBI chr 2:144,219,066...144,230,568
Ensembl chr 2:144,219,122...144,230,034
G
Suox
sulfite oxidase
increases expression
ISO
Vancomycin results in increased expression of SUOX mRNA
CTD
PMID:18930951
NCBI chr 7:1,103,149...1,107,156
Ensembl chr 7:1,103,151...1,107,038
G
Susd2
sushi domain containing 2
increases expression
ISO
Vancomycin results in increased expression of SUSD2 mRNA
CTD
PMID:18930951
NCBI chr20:13,017,516...13,024,820
Ensembl chr20:13,017,477...13,024,903
G
Sv2a
synaptic vesicle glycoprotein 2a
increases expression
ISO
Vancomycin results in increased expression of SV2A mRNA
CTD
PMID:18930951
NCBI chr 2:183,741,489...183,757,290
Ensembl chr 2:183,741,547...183,756,927
G
Syce2
synaptonemal complex central element protein 2
decreases expression
ISO
Vancomycin results in decreased expression of SYCE2 mRNA
CTD
PMID:18930951
NCBI chr19:23,266,236...23,291,265
Ensembl chr19:23,268,869...23,300,980
G
Syde2
synapse defective Rho GTPase homolog 2
increases expression
ISO
Vancomycin results in increased expression of SYDE2 mRNA
CTD
PMID:18930951
NCBI chr 2:234,897,975...234,930,994
Ensembl chr 2:234,897,717...234,930,994
G
Syngr2
synaptogyrin 2
increases expression
ISO
Vancomycin results in increased expression of SYNGR2 mRNA
CTD
PMID:18930951
NCBI chr10:103,029,903...103,034,473
Ensembl chr10:103,029,917...103,034,473
G
Sytl2
synaptotagmin-like 2
decreases expression
ISO
Vancomycin results in decreased expression of SYTL2 mRNA
CTD
PMID:18930951
NCBI chr 1:144,272,870...144,379,310
Ensembl chr 1:144,273,360...144,379,222
G
Tacc2
transforming, acidic coiled-coil containing protein 2
decreases expression
ISO
Vancomycin results in decreased expression of TACC2 mRNA
CTD
PMID:18930951
NCBI chr 1:185,139,223...185,327,881
Ensembl chr 1:185,116,111...185,327,881
G
Tacstd2
tumor-associated calcium signal transducer 2
decreases expression
ISO
Vancomycin results in decreased expression of TACSTD2 mRNA
CTD
PMID:18930951
NCBI chr 4:96,707,950...96,709,650
Ensembl chr 4:96,707,951...96,709,650
G
Tagln
transgelin
decreases expression
ISO
Vancomycin results in decreased expression of TAGLN mRNA
CTD
PMID:18930951
NCBI chr 8:46,224,939...46,230,413
Ensembl chr 8:46,222,472...46,230,668
G
Tagln2
transgelin 2
decreases expression
ISO
Vancomycin results in decreased expression of TAGLN2 mRNA
CTD
PMID:18930951
NCBI chr13:84,966,980...84,973,973
Ensembl chr13:84,967,009...84,973,972
G
Tap2
transporter 2, ATP binding cassette subfamily B member
decreases expression
ISO
Vancomycin results in decreased expression of TAP2 mRNA
CTD
PMID:18930951
NCBI chr20:4,636,347...4,650,387
Ensembl chr20:4,636,357...4,650,407
G
Tapbp
TAP binding protein
decreases expression
ISO
Vancomycin results in decreased expression of TAPBP mRNA
CTD
PMID:18930951
NCBI chr20:4,956,937...4,966,191
Ensembl chr20:4,956,937...4,966,181
G
Tars1
threonyl-tRNA synthetase 1
multiple interactions
EXP
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of TARS1 protein
CTD
PMID:30545405
NCBI chr 2:60,368,893...60,387,715
Ensembl chr 2:60,367,796...60,387,717
G
Tax1bp3
Tax1 binding protein 3
decreases expression
ISO
Vancomycin results in decreased expression of TAX1BP3 mRNA
CTD
PMID:18930951
NCBI chr10:57,795,845...57,800,363
Ensembl chr10:57,795,382...57,800,363
G
Tcea3
transcription elongation factor A3
increases expression
ISO
Vancomycin results in increased expression of TCEA3 mRNA
CTD
PMID:18930951
NCBI chr 5:148,476,941...148,509,452
Ensembl chr 5:148,476,941...148,509,448
G
Tcf19
transcription factor 19
decreases expression
ISO
Vancomycin results in decreased expression of TCF19 mRNA
CTD
PMID:18930951
NCBI chr20:3,218,756...3,222,861
Ensembl chr20:3,218,693...3,223,271
G
Tcn2
transcobalamin 2
increases expression
ISO
Vancomycin results in increased expression of TCN2 mRNA
CTD
PMID:18930951
NCBI chr14:78,813,343...78,828,549
Ensembl chr14:78,813,343...78,828,489
G
Tes
testin LIM domain protein
decreases expression
ISO
Vancomycin results in decreased expression of TES mRNA
CTD
PMID:18930951
NCBI chr 4:45,365,304...45,403,829
Ensembl chr 4:45,365,285...45,403,829
G
Tf
transferrin
decreases expression
ISO
Vancomycin results in decreased expression of TRF mRNA
CTD
PMID:18930951
NCBI chr 8:103,789,780...103,816,487
Ensembl chr 8:103,767,995...103,816,511
G
Tgfb1
transforming growth factor, beta 1
multiple interactions
ISO
[Gentamicins co-treated with Vancomycin co-treated with Cefoxitin co-treated with Metronidazole] inhibits the reaction [Fluorides results in increased expression of TGFB1 mRNA]
CTD
PMID:37269894
NCBI chr 1:81,196,532...81,212,848
Ensembl chr 1:81,196,532...81,212,847
G
Tgfb1i1
transforming growth factor beta 1 induced transcript 1
decreases expression
ISO
Vancomycin results in decreased expression of TGFB1I1 mRNA
CTD
PMID:18930951
NCBI chr 1:182,828,553...182,835,465
Ensembl chr 1:182,828,544...182,837,080
G
Tgfbr2
transforming growth factor, beta receptor 2
decreases expression
ISO
Vancomycin results in decreased expression of TGFBR2 mRNA
CTD
PMID:18930951
NCBI chr 8:115,794,537...115,883,615
Ensembl chr 8:115,794,537...115,883,228
G
Tgif1
TGFB-induced factor homeobox 1
decreases expression
ISO
Vancomycin results in decreased expression of TGIF1 mRNA
CTD
PMID:18930951
NCBI chr 9:110,748,094...110,757,714
Ensembl chr 9:110,720,921...110,757,802
G
Tgm1
transglutaminase 1
decreases expression
ISO
Vancomycin results in decreased expression of TGM1 mRNA
CTD
PMID:18930951
NCBI chr15:29,191,039...29,206,000
Ensembl chr15:29,191,041...29,204,523
G
Tgm2
transglutaminase 2
decreases expression
ISO
Vancomycin results in decreased expression of TGM2 mRNA
CTD
PMID:18930951
NCBI chr 3:146,772,684...146,801,924
Ensembl chr 3:146,772,687...146,801,981
G
Thrb
thyroid hormone receptor beta
increases expression
ISO
Vancomycin results in increased expression of THRB mRNA
CTD
PMID:18930951
NCBI chr15:7,685,180...8,031,920
Ensembl chr15:7,685,180...7,882,916
G
Timd2
T-cell immunoglobulin and mucin domain containing 2
decreases expression
ISO
Vancomycin results in decreased expression of TIMD2 mRNA
CTD
PMID:18930951
NCBI chr10:31,060,308...31,101,262
Ensembl chr10:31,060,326...31,094,623
G
Timp1
TIMP metallopeptidase inhibitor 1
increases expression
EXP
Vancomycin results in increased expression of TIMP1 mRNA
CTD
PMID:18289764
NCBI chr X:1,212,969...1,217,714
Ensembl chr X:1,212,972...1,217,664
G
Timp3
TIMP metallopeptidase inhibitor 3
increases expression
ISO
Vancomycin results in increased expression of TIMP3 mRNA
CTD
PMID:18930951
NCBI chr 7:17,520,827...17,571,850
Ensembl chr 7:17,521,919...17,571,839
G
Tjp1
tight junction protein 1
multiple interactions
ISO
[Neomycin co-treated with Metronidazole co-treated with Ampicillin co-treated with Vancomycin] inhibits the reaction [Methamphetamine results in decreased expression of TJP1 mRNA]; [Neomycin co-treated with Metronidazole co-treated with Ampicillin co-treated with Vancomycin] inhibits the reaction [Methamphetamine results in decreased expression of TJP1 protein]
CTD
PMID:35390362
NCBI chr 1:118,849,838...119,094,492
Ensembl chr 1:118,849,838...119,094,432
G
Tk1
thymidine kinase 1
decreases expression
ISO
Vancomycin results in decreased expression of TK1 mRNA
CTD
PMID:18930951
NCBI chr10:103,034,755...103,046,125
Ensembl chr10:103,031,521...103,046,920
G
Tln2
talin 2
increases expression
ISO
Vancomycin results in increased expression of TLN2 mRNA
CTD
PMID:18930951
NCBI chr 8:67,830,920...68,252,240
Ensembl chr 8:67,834,326...68,252,219
G
Tlr2
toll-like receptor 2
multiple interactions
ISO
[Gentamicins co-treated with Vancomycin co-treated with Cefoxitin co-treated with Metronidazole] inhibits the reaction [Fluorides results in increased expression of TLR2 mRNA]
CTD
PMID:37269894
NCBI chr 2:169,200,620...169,206,819
Ensembl chr 2:169,197,419...169,206,630
G
Tlr4
toll-like receptor 4
multiple interactions
ISO
[Neomycin co-treated with Metronidazole co-treated with Ampicillin co-treated with Vancomycin] inhibits the reaction [Methamphetamine results in increased expression of TLR4 mRNA]; [Neomycin co-treated with Metronidazole co-treated with Ampicillin co-treated with Vancomycin] inhibits the reaction [Methamphetamine results in increased expression of TLR4 protein]; TLR4 gene mutant form results in decreased susceptibility to [Neomycin co-treated with Metronidazole co-treated with Ampicillin co-treated with Vancomycin]
CTD
PMID:35390362
NCBI chr 5:80,145,867...80,159,501
Ensembl chr 5:80,145,826...80,159,628
G
Tm9sf2
transmembrane 9 superfamily member 2
multiple interactions
EXP
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of TM9SF2 protein
CTD
PMID:30545405
NCBI chr15:99,201,556...99,254,054
Ensembl chr15:99,201,489...99,254,049
G
Tmcc3
transmembrane and coiled-coil domain family 3
decreases expression
ISO
Vancomycin results in decreased expression of TMCC3 mRNA
CTD
PMID:18930951
NCBI chr 7:28,893,972...29,171,935
Ensembl chr 7:28,893,967...29,171,926
G
Tmed10
transmembrane p24 trafficking protein 10
multiple interactions
EXP
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of TMED10 protein
CTD
PMID:30545405
NCBI chr 6:104,991,843...105,026,705
Ensembl chr 6:104,991,838...105,026,753
G
Tmed6
transmembrane p24 trafficking protein 6
increases expression
ISO
Vancomycin results in increased expression of TMED6 mRNA
CTD
PMID:18930951
NCBI chr19:34,966,813...34,972,900
Ensembl chr19:34,966,813...34,972,900
G
Tmem64
transmembrane protein 64
increases expression
ISO
Vancomycin results in increased expression of TMEM64 mRNA
CTD
PMID:18930951
NCBI chr 5:28,698,947...28,745,384
Ensembl chr 5:28,698,918...28,745,330
G
Tmod3
tropomodulin 3
decreases expression
ISO
Vancomycin results in decreased expression of TMOD3 mRNA
CTD
PMID:18930951
NCBI chr 8:76,248,978...76,310,855
Ensembl chr 8:76,248,979...76,310,977
G
Tmsb10
thymosin, beta 10
decreases expression increases expression
ISO EXP
Vancomycin results in decreased expression of TMSB10 mRNA Vancomycin results in increased expression of TMSB10 mRNA
CTD
PMID:18289764 PMID:18930951
NCBI chr 4:105,009,959...105,011,095
Ensembl chr 4:105,009,212...105,011,028
G
Tmsb4x
thymosin beta 4, X-linked
decreases expression
ISO
Vancomycin results in decreased expression of TMSB4X mRNA
CTD
PMID:18930951
NCBI chr X:27,144,666...27,146,667
Ensembl chr X:27,128,610...27,146,667
G
Tnf
tumor necrosis factor
multiple interactions
ISO
[Ampicillin co-treated with Vancomycin co-treated with Neomycin co-treated with Metronidazole] inhibits the reaction [Dextran Sulfate results in increased expression of TNF protein]; [Ampicillin co-treated with Vancomycin co-treated with Neomycin co-treated with Metronidazole] results in decreased expression of TNF protein; [Gentamicins co-treated with Vancomycin co-treated with Cefoxitin co-treated with Metronidazole] inhibits the reaction [Fluorides results in increased expression of TNF mRNA]; [Neomycin co-treated with Metronidazole co-treated with Ampicillin co-treated with Vancomycin] inhibits the reaction [Methamphetamine results in increased expression of and results in increased secretion of TNF protein]; [Neomycin co-treated with Metronidazole co-treated with Ampicillin co-treated with Vancomycin] inhibits the reaction [Methamphetamine results in increased expression of TNF mRNA]; [Vancomycin co-treated with Neomycin co-treated with Cilastatin, Imipenem Drug Combination] inhibits the reaction [Doxorubicin results in increased expression of TNF protein]; [Vancomycin co-treated with Neomycin co-treated with Cilastatin, Imipenem Drug Combination] inhibits the reaction [Nanotubes, Carbon promotes the reaction [Doxorubicin results in increased expression of TNF protein]]; Dextran Sulfate inhibits the reaction [[Ampicillin co-treated with Vancomycin co-treated with Neomycin co-treated with Metronidazole] results in decreased expression of TNF protein]
CTD
PMID:31442584 PMID:32068018 PMID:35390362 PMID:37269894
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
G
Tnfaip8
TNF alpha induced protein 8
increases expression
ISO
Vancomycin results in increased expression of TNFAIP8 mRNA
CTD
PMID:18930951
NCBI chr18:43,183,854...43,299,512
Ensembl chr18:43,183,916...43,299,517
G
Tnfrsf12a
TNF receptor superfamily member 12A
decreases expression
ISO
Vancomycin results in decreased expression of TNFRSF12A mRNA
CTD
PMID:18930951
NCBI chr10:12,707,077...12,709,071
Ensembl chr10:12,689,890...12,709,045
G
Tnfrsf1a
TNF receptor superfamily member 1A
decreases expression
ISO
Vancomycin results in decreased expression of TNFRSF1A mRNA
CTD
PMID:18930951
NCBI chr 4:158,150,815...158,163,592
Ensembl chr 4:158,150,820...158,163,591
G
Tnip1
TNFAIP3 interacting protein 1
decreases expression
ISO
Vancomycin results in decreased expression of TNIP1 mRNA
CTD
PMID:18930951
NCBI chr10:39,037,048...39,084,328
Ensembl chr10:39,037,058...39,077,625
G
Tns1
tensin 1
increases expression
ISO
Vancomycin results in increased expression of TNS1 mRNA
CTD
PMID:18930951
NCBI chr 9:75,491,886...75,702,853
Ensembl chr 9:75,495,814...75,703,225
G
Topbp1
DNA topoisomerase II binding protein 1
decreases expression
ISO
Vancomycin results in decreased expression of TOPBP1 mRNA
CTD
PMID:18930951
NCBI chr 8:103,887,805...103,931,662
Ensembl chr 8:103,887,865...103,931,674
G
Tor3a
torsin family 3, member A
decreases expression
ISO
Vancomycin results in decreased expression of TOR3A mRNA
CTD
PMID:18930951
NCBI chr13:68,769,893...68,798,738
Ensembl chr13:68,769,605...68,798,475
G
Tpk1
thiamin pyrophosphokinase 1
increases expression
ISO
Vancomycin results in increased expression of TPK1 mRNA
CTD
PMID:18930951
NCBI chr 4:72,170,134...72,557,707
Ensembl chr 4:72,170,134...72,557,694
G
Tpm1
tropomyosin 1
decreases expression
ISO
Vancomycin results in decreased expression of TPM1 mRNA
CTD
PMID:18930951
NCBI chr 8:67,635,479...67,662,330
Ensembl chr 8:67,635,479...67,662,802
G
Tpm2
tropomyosin 2
decreases expression
ISO
Vancomycin results in decreased expression of TPM2 mRNA
CTD
PMID:18930951
NCBI chr 5:57,770,919...57,780,278
Ensembl chr 5:57,770,864...57,779,992
G
Tpm3
tropomyosin 3
decreases expression
ISO
Vancomycin results in decreased expression of TPM3 mRNA
CTD
PMID:18930951
NCBI chr 2:175,517,198...175,545,014
Ensembl chr 2:175,517,226...175,545,013
G
Tpm4
tropomyosin 4
decreases expression
ISO
Vancomycin results in decreased expression of TPM4 mRNA
CTD
PMID:18930951
NCBI chr16:17,684,415...17,698,456
Ensembl chr16:17,683,195...17,705,984
G
Tpmt
thiopurine S-methyltransferase
increases expression
ISO
Vancomycin results in increased expression of TPMT mRNA
CTD
PMID:18930951
NCBI chr17:17,644,088...17,662,709
Ensembl chr17:17,644,173...17,662,709
G
Traf2
Tnf receptor-associated factor 2
decreases expression
ISO
Vancomycin results in decreased expression of TRAF2 mRNA
CTD
PMID:18930951
NCBI chr 3:8,341,950...8,366,609
Ensembl chr 3:8,341,951...8,366,538
G
Traf6
TNF receptor associated factor 6
multiple interactions
ISO
[Gentamicins co-treated with Vancomycin co-treated with Cefoxitin co-treated with Metronidazole] inhibits the reaction [Fluorides results in increased expression of TRAF6 mRNA]; [Neomycin co-treated with Metronidazole co-treated with Ampicillin co-treated with Vancomycin] inhibits the reaction [Methamphetamine results in increased expression of TRAF6 mRNA]; [Neomycin co-treated with Metronidazole co-treated with Ampicillin co-treated with Vancomycin] inhibits the reaction [Methamphetamine results in increased expression of TRAF6 protein]
CTD
PMID:35390362 PMID:37269894
NCBI chr 3:87,963,517...87,988,316
Ensembl chr 3:87,963,514...87,983,507
G
Trex1
three prime repair exonuclease 1
decreases expression
ISO
Vancomycin results in decreased expression of TREX1 mRNA
CTD
PMID:18930951
NCBI chr 8:109,706,613...109,707,913
Ensembl chr 8:109,706,613...109,708,796
G
Trim47
tripartite motif-containing 47
decreases expression
ISO
Vancomycin results in decreased expression of TRIM47 mRNA
CTD
PMID:18930951
NCBI chr10:101,337,573...101,342,044
Ensembl chr10:101,337,573...101,342,044
G
Trim63
tripartite motif containing 63
increases expression
ISO
Vancomycin results in increased expression of TRIM63 mRNA
CTD
PMID:18930951
NCBI chr 5:146,533,492...146,547,332
Ensembl chr 5:146,533,507...146,547,322
G
Tsc22d1
TSC22 domain family, member 1
decreases expression
ISO
Vancomycin results in decreased expression of TSC22D1 mRNA
CTD
PMID:18930951
NCBI chr15:51,750,489...51,850,958
Ensembl chr15:51,749,510...51,850,958
G
Tspan4
tetraspanin 4
decreases expression
ISO
Vancomycin results in decreased expression of TSPAN4 mRNA
CTD
PMID:18930951
NCBI chr 1:196,571,307...196,593,842
Ensembl chr 1:196,572,228...196,617,448
G
Tspan6
tetraspanin 6
decreases expression
ISO
Vancomycin results in decreased expression of TSPAN6 mRNA
CTD
PMID:18930951
NCBI chr X:97,092,394...97,099,659
Ensembl chr X:97,092,388...97,099,309
G
Tspo
translocator protein
decreases expression
ISO
Vancomycin results in decreased expression of TSPO mRNA
CTD
PMID:18930951
NCBI chr 7:114,720,188...114,730,450
Ensembl chr 7:114,720,188...114,730,450
G
Ttr
transthyretin
increases expression
ISO
Vancomycin results in increased expression of TTR mRNA
CTD
PMID:18930951
NCBI chr18:11,941,791...11,951,008
Ensembl chr18:11,943,789...11,951,008
G
Tuba1a
tubulin, alpha 1A
decreases expression
ISO
Vancomycin results in decreased expression of TUBA1A mRNA
CTD
PMID:18930951
NCBI chr 7:130,113,214...130,116,880
Ensembl chr 7:130,081,032...130,196,186
G
Tubal3
tubulin, alpha-like 3
multiple interactions
EXP
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of TUBAL3 protein
CTD
PMID:30545405
NCBI chr17:66,323,733...66,332,423
Ensembl chr17:66,323,733...66,335,355
G
Tubb5
tubulin, beta 5 class I
decreases expression
ISO
Vancomycin results in decreased expression of TUBB5 mRNA
CTD
PMID:18930951
NCBI chr20:2,912,779...2,916,928
Ensembl chr20:2,912,778...2,916,940
G
Tubb6
tubulin, beta 6 class V
decreases expression
ISO
Vancomycin results in decreased expression of TUBB6 mRNA
CTD
PMID:18930951
NCBI chr18:60,943,394...60,953,031
Ensembl chr18:60,943,375...60,954,418
G
Tuft1
tuftelin 1
decreases expression
ISO
Vancomycin results in decreased expression of TUFT1 mRNA
CTD
PMID:18930951
NCBI chr 2:182,259,457...182,306,296
Ensembl chr 2:182,260,398...182,306,192
G
Twf1
twinfilin actin-binding protein 1
multiple interactions
EXP
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of TWF1 protein
CTD
PMID:30545405
NCBI chr 7:125,715,938...125,727,834
Ensembl chr 7:125,716,015...125,727,894
G
Txn1
thioredoxin 1
multiple interactions
ISO
[Vancomycin co-treated with Neomycin co-treated with Metronidazole] promotes the reaction [Zinc Oxide analog results in increased expression of TXN1 protein]
CTD
PMID:36535435
NCBI chr 5:72,712,334...72,724,564
Ensembl chr 5:72,711,933...72,724,629
G
Txndc5
thioredoxin domain containing 5
multiple interactions
EXP
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of TXNDC5 protein
CTD
PMID:30545405
NCBI chr17:26,289,880...26,318,025
Ensembl chr17:26,289,880...26,318,025
G
Tyrobp
transmembrane immune signaling adaptor Tyrobp
decreases expression
ISO
Vancomycin results in decreased expression of TYROBP mRNA
CTD
PMID:18930951
NCBI chr 1:85,672,931...85,676,856
Ensembl chr 1:85,672,994...85,676,848
G
Ucp2
uncoupling protein 2
decreases expression
ISO
Vancomycin results in decreased expression of UCP2 mRNA
CTD
PMID:18930951
NCBI chr 1:154,839,242...154,845,612
Ensembl chr 1:154,839,209...154,845,611
G
Ugp2
UDP-glucose pyrophosphorylase 2
increases expression
ISO
Vancomycin results in increased expression of UGP2 mRNA
CTD
PMID:18930951
NCBI chr14:95,456,330...95,497,483
Ensembl chr14:95,456,330...95,496,830
G
Ugt3a1
UDP glycosyltransferase family 3 member A1
increases expression
ISO
Vancomycin results in increased expression of UGT3A1 mRNA
CTD
PMID:18930951
NCBI chr 2:58,327,058...58,350,186
Ensembl chr 2:58,334,603...58,350,186
G
Unc13b
unc-13 homolog B
decreases expression
ISO
Vancomycin results in decreased expression of UNC13B mRNA
CTD
PMID:18930951
NCBI chr 5:57,288,999...57,504,110
Ensembl chr 5:57,289,227...57,502,926
G
Unc5c
unc-5 netrin receptor C
increases expression
ISO
Vancomycin results in increased expression of UNC5C mRNA
CTD
PMID:18930951
NCBI chr 2:230,180,353...230,535,219
Ensembl chr 2:230,180,951...230,535,217
G
Unc93b1
unc-93 homolog B1, TLR signaling regulator
decreases expression
ISO
Vancomycin results in decreased expression of UNC93B1 mRNA
CTD
PMID:18930951
NCBI chr 1:201,167,388...201,178,343
Ensembl chr 1:201,152,693...201,178,338
G
Upb1
beta-ureidopropionase 1
increases expression
ISO
Vancomycin results in increased expression of UPB1 mRNA
CTD
PMID:18930951
NCBI chr20:13,217,252...13,243,590
Ensembl chr20:13,217,258...13,243,590
G
Uqcrc1
ubiquinol-cytochrome c reductase core protein 1
multiple interactions
EXP
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of UQCRC1 protein
CTD
PMID:30545405
NCBI chr 8:109,589,735...109,601,481
Ensembl chr 8:109,589,706...109,601,480
G
Uqcrfs1
ubiquinol-cytochrome c reductase, Rieske iron-sulfur polypeptide 1
multiple interactions
EXP
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of UQCRFS1 protein
CTD
PMID:30545405
NCBI chr17:33,977,908...33,982,478
Ensembl chr17:33,977,921...33,982,479
G
Uqcrh
ubiquinol-cytochrome c reductase hinge protein
multiple interactions
EXP
[Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of UQCRH protein
CTD
PMID:30545405
NCBI chr 5:129,545,978...129,554,173
Ensembl chr 5:129,545,984...129,554,242
G
Vasp
vasodilator-stimulated phosphoprotein
decreases expression
ISO
Vancomycin results in decreased expression of VASP mRNA
CTD
PMID:18930951
NCBI chr 1:78,910,009...78,925,791
Ensembl chr 1:78,910,011...78,925,061
G
Vat1
vesicle amine transport 1
decreases expression
ISO
Vancomycin results in decreased expression of VAT1 mRNA
CTD
PMID:18930951
NCBI chr10:86,389,549...86,397,167
Ensembl chr10:86,389,545...86,397,224
G
Vcam1
vascular cell adhesion molecule 1
decreases expression
ISO
Vancomycin results in decreased expression of VCAM1 mRNA
CTD
PMID:18930951
NCBI chr 2:204,038,120...204,057,852
Ensembl chr 2:204,038,114...204,057,958
G
Vcl
vinculin
decreases expression
ISO
Vancomycin results in decreased expression of VCL mRNA
CTD
PMID:18930951
NCBI chr15:3,265,776...3,355,586
Ensembl chr15:3,265,815...3,355,606
G
Vegfa
vascular endothelial growth factor A
increases expression
ISO
Vancomycin results in increased expression of VEGFA mRNA
CTD
PMID:18930951
NCBI chr 9:14,955,300...14,970,641
Ensembl chr 9:14,955,300...14,970,641
G
Vim
vimentin
increases expression decreases expression
EXP ISO
Vancomycin results in increased expression of VIM mRNA Vancomycin results in decreased expression of VIM mRNA
CTD
PMID:18289764 PMID:18930951
NCBI chr17:76,668,701...76,677,186
Ensembl chr17:76,668,647...76,677,187
G
Vldlr
very low density lipoprotein receptor
increases expression
ISO
Vancomycin results in increased expression of VLDLR mRNA
CTD
PMID:18930951
NCBI chr 1:224,813,539...224,850,400
Ensembl chr 1:224,814,377...224,845,920
G
Vrk1
VRK serine/threonine kinase 1
decreases expression
ISO
Vancomycin results in decreased expression of VRK1 mRNA
CTD
PMID:18930951
NCBI chr 6:124,914,770...124,981,508
Ensembl chr 6:124,914,855...124,981,436
G
Vwa5a
von Willebrand factor A domain containing 5A
decreases expression
ISO
Vancomycin results in decreased expression of VWA5A mRNA
CTD
PMID:18930951
NCBI chr 8:38,815,176...38,848,674
Ensembl chr 8:38,815,210...38,839,112
G
Wfdc2
WAP four-disulfide core domain 2
decreases expression
ISO
Vancomycin results in decreased expression of WFDC2 mRNA
CTD
PMID:18930951
NCBI chr 3:153,286,946...153,314,832
Ensembl chr 3:153,286,131...153,292,807
G
Wnk1
WNK lysine deficient protein kinase 1
increases expression
ISO
Vancomycin results in increased expression of WNK1 mRNA
CTD
PMID:18930951
NCBI chr 4:153,128,334...153,253,905
Ensembl chr 4:153,128,334...153,253,905
G
Xylb
xylulokinase
increases expression
ISO
Vancomycin results in increased expression of XYLB mRNA
CTD
PMID:18930951
NCBI chr 8:119,093,466...119,128,858
Ensembl chr 8:119,096,029...119,128,848
G
Ybx2
Y box binding protein 2
increases expression
ISO
Vancomycin results in increased expression of YBX2 mRNA
CTD
PMID:18930951
NCBI chr10:54,659,719...54,665,371
Ensembl chr10:54,659,719...54,665,371
G
Zfp385b
zinc finger protein 385B
increases expression
ISO
Vancomycin results in increased expression of ZFP385B mRNA
CTD
PMID:18930951
NCBI chr 3:62,355,182...62,640,417
Ensembl chr 3:62,355,196...62,640,510
G
Zmynd10
zinc finger, MYND-type containing 10
increases expression
ISO
Vancomycin results in increased expression of ZMYND10 mRNA
CTD
PMID:18930951
NCBI chr 8:108,220,386...108,224,745
Ensembl chr 8:108,220,386...108,224,744
G
Zscan21
zinc finger and SCAN domain containing 21
decreases expression
ISO
Vancomycin results in decreased expression of ZSCAN21 mRNA
CTD
PMID:18930951
NCBI chr12:16,998,496...17,024,167
Ensembl chr12:16,998,538...17,013,506
G
Zwint
ZW10 interacting kinetochore protein
decreases expression
ISO
Vancomycin results in decreased expression of ZWINT mRNA
CTD
PMID:18930951
NCBI chr20:15,938,157...15,953,997
Ensembl chr20:15,938,157...15,953,957
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all